
<html lang="en"     class="pb-page"  data-request-id="8c38a1dd-21b5-49e8-9787-a6b4e4a07139"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00598;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Ralf  Glatthar" /></meta><meta name="dc.Creator" content="Aleksandar  Stojanovic" /></meta><meta name="dc.Creator" content="Thomas  Troxler" /></meta><meta name="dc.Creator" content="Henri  Mattes" /></meta><meta name="dc.Creator" content="Henrik  Möbitz" /></meta><meta name="dc.Creator" content="Rene  Beerli" /></meta><meta name="dc.Creator" content="Joachim  Blanz" /></meta><meta name="dc.Creator" content="Ernst  Gassmann" /></meta><meta name="dc.Creator" content="Peter  Drückes" /></meta><meta name="dc.Creator" content="Gabriele  Fendrich" /></meta><meta name="dc.Creator" content="Sascha  Gutmann" /></meta><meta name="dc.Creator" content="Georg  Martiny-Baron" /></meta><meta name="dc.Creator" content="Fiona  Spence" /></meta><meta name="dc.Creator" content="Jeff  Hornfeld" /></meta><meta name="dc.Creator" content="John Edmonson  Peel" /></meta><meta name="dc.Creator" content="Helmut  Sparrer" /></meta><meta name="dc.Description" content="Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically interve..." /></meta><meta name="Description" content="Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically interve..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 17, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00598" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00598" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00598" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00598" /></link>
        
    
    

<title>Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00598" /></meta><meta property="og:title" content="Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0020.jpeg" /></meta><meta property="og:description" content="Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis. We report the discovery and chemical optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα. Pharmacological profiling in vivo revealed a high metabolism of these compounds in rats which was demonstrated to be predominantly attributed to aldehyde oxidase. Due to the very low activity of hepatic AO in the dog, the selected candidate 32 displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness. Taken together, the described compounds both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate therapeutic target for inflammatory diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00598"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00598">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00598&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00598&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00598&amp;href=/doi/10.1021/acs.jmedchem.6b00598" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7544-7560</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00516" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00645" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Glatthar">Ralf Glatthar</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aleksandar++Stojanovic">Aleksandar Stojanovic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Troxler">Thomas Troxler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henri++Mattes">Henri Mattes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henrik++M%C3%B6bitz">Henrik Möbitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rene++Beerli">Rene Beerli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joachim++Blanz">Joachim Blanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ernst++Gassmann">Ernst Gassmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Dr%C3%BCckes">Peter Drückes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriele++Fendrich">Gabriele Fendrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sascha++Gutmann">Sascha Gutmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georg++Martiny-Baron">Georg Martiny-Baron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fiona++Spence">Fiona Spence</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Hornfeld">Jeff Hornfeld</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+Edmonson++Peel">John Edmonson Peel</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helmut++Sparrer">Helmut Sparrer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Global Discovery Chemistry, <sup>‡</sup>Analytical Sciences, <sup>§</sup>Center for Proteomic Chemistry, <sup>∥</sup>Preclinical Safety, and <sup>⊥</sup>Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 6968471; e-mail: <a href="/cdn-cgi/l/email-protection#ddafbcb1bbf3bab1bca9a9b5bcaf9db3b2abbcafa9b4aef3beb2b0"><span class="__cf_email__" data-cfemail="2351424f450d444f4257574b4251634d4c554251574a500d404c4e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00598&amp;href=/doi/10.1021%2Facs.jmedchem.6b00598" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7544–7560</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 9, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 April 2016</li><li><span class="item_label"><b>Published</b> online</span>17 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00598" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00598</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7544%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRalf%2BGlatthar%252C%2BAleksandar%2BStojanovic%252C%2BThomas%2BTroxler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D16%26contentID%3Dacs.jmedchem.6b00598%26title%3DDiscovery%2Bof%2BImidazoquinolines%2Bas%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BSelective%252C%2Band%2Bin%2BVivo%2BEfficacious%2BCancer%2BOsaka%2BThyroid%2B%2528COT%2529%2BKinase%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7560%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00598"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1914</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00598" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Glatthar&quot;},{&quot;first_name&quot;:&quot;Aleksandar&quot;,&quot;last_name&quot;:&quot;Stojanovic&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Troxler&quot;},{&quot;first_name&quot;:&quot;Henri&quot;,&quot;last_name&quot;:&quot;Mattes&quot;},{&quot;first_name&quot;:&quot;Henrik&quot;,&quot;last_name&quot;:&quot;Möbitz&quot;},{&quot;first_name&quot;:&quot;Rene&quot;,&quot;last_name&quot;:&quot;Beerli&quot;},{&quot;first_name&quot;:&quot;Joachim&quot;,&quot;last_name&quot;:&quot;Blanz&quot;},{&quot;first_name&quot;:&quot;Ernst&quot;,&quot;last_name&quot;:&quot;Gassmann&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Drückes&quot;},{&quot;first_name&quot;:&quot;Gabriele&quot;,&quot;last_name&quot;:&quot;Fendrich&quot;},{&quot;first_name&quot;:&quot;Sascha&quot;,&quot;last_name&quot;:&quot;Gutmann&quot;},{&quot;first_name&quot;:&quot;Georg&quot;,&quot;last_name&quot;:&quot;Martiny-Baron&quot;},{&quot;first_name&quot;:&quot;Fiona&quot;,&quot;last_name&quot;:&quot;Spence&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Hornfeld&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Edmonson Peel&quot;},{&quot;first_name&quot;:&quot;Helmut&quot;,&quot;last_name&quot;:&quot;Sparrer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7544-7560&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00598&quot;},&quot;abstract&quot;:&quot;Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis. We report the discovery and chemical optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα. Pharmacological profiling in vivo revealed a high metabolism of these compounds in rats which was demonstrated to be predominantly attributed to aldehyde oxidase. Due to the very low activity of hepatic AO in the dog, the selected candidate 32 displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness. Taken together, the described compounds both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate the&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00598&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00598" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00598&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00598" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00598&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00598" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00598&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00598&amp;href=/doi/10.1021/acs.jmedchem.6b00598" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00598" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00598" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00598%26sid%3Dliteratum%253Aachs%26pmid%3D27502541%26genre%3Darticle%26aulast%3DGlatthar%26date%3D2016%26atitle%3DDiscovery%2Bof%2BImidazoquinolines%2Bas%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BSelective%252C%2Band%2Bin%2BVivo%2BEfficacious%2BCancer%2BOsaka%2BThyroid%2B%2528COT%2529%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D16%26spage%3D7544%26epage%3D7560%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/jmcmar.2016.59.issue-16/20160825/jmcmar.2016.59.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory diseases such as rheumatoid arthritis. We report the discovery and chemical optimization of a novel series of COT kinase inhibitors, with unprecedented nanomolar potency for the inhibition of TNFα. Pharmacological profiling in vivo revealed a high metabolism of these compounds in rats which was demonstrated to be predominantly attributed to aldehyde oxidase. Due to the very low activity of hepatic AO in the dog, the selected candidate <b>32</b> displayed significant blood exposure in dogs which resulted in a clear prevention of inflammation-driven lameness. Taken together, the described compounds both potently and selectively inhibit COT kinase in primary human cells and ameliorate inflammatory pathologies in vivo, supporting the notion that COT is an appropriate therapeutic target for inflammatory diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer Osaka thyroid (COT) kinase, also called Tpl2 or MAP3K8, plays an important role in the regulation of the inflammatory response and the progression of some cancers.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The function of COT kinase is crucial for the secretion of various cytokines and chemokines in macrophages. COT kinase activity is required to process TNFα and IL-1β.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Consequently, COT kinase ko mice are protected in models of endotoxic shock.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> COT kinase forms a heterotrimeric complex with p105, one of the five members of the NFκB transcription factor family, and ABIN-2.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Signal-induced degradation of p105 to p50 allows COT kinase to dissociate and mediate activation of the Erk pathway and also JNK in fibroblasts or pancreatic cells, possibly via MKK4.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Since COT kinase is downstream of IKK2, the NFκB pathway is not affected. At the same time, all or most ligands activating the canonical NFκB pathway via the family of TNF-receptors (TNF, CD40, etc.), the IL-1/Toll-like receptor (TLR2/3/4/7/9, IL-1R), or NOD2 can activate COT kinase via IKK2. This molecular organization of the signaling pathway coordinates input of pro-inflammatory receptors to the ERK pathway. Growth factor receptors, which are also known to feed into the ERK pathway, use different MAP3 kinases and scaffold proteins to assemble different signaling complexes that allow separation of the COT- and RAF-dependent pathways on the molecular level (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, COT kinase has been located downstream of the IL-17 receptor, with consequences for inflammatory indication and cancers.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COT kinase signaling pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The critical location of COT kinase in a key pro-inflammatory pathway has made it an attractive target for LMW cytokine inhibition therapy. Elevated levels of these cytokines have been clinically implicated as mediators of a number of autoimmune diseases, in particular, the pain and joint destruction characteristic of rheumatoid arthritis.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Since COT kinase appears to affect primarily macrophage-derived pro-inflammatory targets, all diseases with underlying persistent macrophage activation may be considered as therapeutic opportunities for pharmacological intervention. The spectrum of potential indications may range from acute macrophage activation syndromes (e.g., pancreatitis or gout), to low grade activation of macrophages in adipose tissue leading to type 2 diabetes.</div><div class="NLM_p">In comparison to other MAP kinases for which several inhibitors have advanced to clinical trials over the past years, drug discovery activities on COT inhibition are still in their infancy. In fact, there are only a few reports in the literature describing COT inhibitor scaffolds.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Representative compounds of these are shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and include 1,7-naphthyridine-3-carbonitrile (<b>1</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> quinoline-carbonitrile (<b>2</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> indazole (<b>3</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> thieno[2,3-<i>c</i>]pyridines (<b>4</b>, <b>5</b>),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> and thieno[3,2-<i>d</i>]pyrimidine (<b>6</b>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Whereas most of these inhibitors demonstrate good kinase selectivity profiles combined with a reasonable correlation of enzymatic COT inhibition and functional blockade of TNFα release in primary human monocytes (PBMCs), potency in whole blood assays is significantly reduced, which limits their potential as drug candidates. A general complication that has hampered faster progress in drug development for this target is the difficulty to obtain high-quality protein and crystal structures of COT kinase, which impeded structure-based drug design approaches.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative compounds of COT kinase inhibitor scaffolds reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Only recently, we reported on the successful production of highly pure COT protein and the first X-ray cocrystal structures of COT kinase with the two inhibitors <b>7</b> and <b>8</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Here we present the discovery, optimization, and characterization of a novel class of potent, selective, and in vivo efficacious COT kinase inhibitors, namely imidazonaphthyridines of type <b>A</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). In addition, we disclose an X-ray structure of an imidazonaphthyridine cocrystallized with COT kinase showing a very different protein conformation compared to our two previously reported structures. The new structural insights facilitated rational optimization of kinase selectivity and potency of this scaffold. Furthermore, we report on the pharmacokinetic profile of selected compounds in vivo in different species and the metabolic fate of this compound class.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. COT kinase inhibitors: pyrrolopyridine (<b>7</b>), aminopyridine (<b>8</b>), and imidazonaphthyridine scaffold <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds of type <b>A</b> were prepared according to the general syntheses described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Nitration of the commercially available hydroxynaphthyridine <b>9</b> to <b>10</b>, followed by a Suzuki coupling, afforded intermediates <b>11</b>–<b>14</b>. Subsequent chlorination using phosphoryl trichloride followed by conversion of the crude chlorides with the corresponding aniline building blocks <b>35–37, 40</b>, <b>44</b>, and <b>47</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) provided the nitronaphthyridines <b>15</b>–<b>23</b>. Reduction of the nitro group followed by cyclization of the diamino intermediates with triethyl orthoformate resulted in the final compounds <b>24</b>–<b>32</b> in low to moderate yields (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Optically active compounds <b>33</b> and <b>34</b> were obtained by enantiomer separation of racemic <b>32</b> with chiral preparative HPLC. The synthesis of the noncommercial aniline building blocks is described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Aminobenzothiazole <b>40</b> was prepared in one step from commercially available 2-chlorobenzo[<i>d</i>]thiazol-6-amine (<b>38</b>) and 2-morpholinoethanamine (<b>39</b>) by an aromatic substitution reaction. For coupling of the sterically hindered 1-morpholinopropan-2-amine (<b>42</b>), the strongly activated nitro derivatives <b>41</b> and <b>45</b> were needed. Amino building blocks <b>44</b> and <b>47</b> were then obtained by reduction of the corresponding intermediate nitro derivatives <b>43</b> and <b>46</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds of Type <b>A</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) HNO<sub>3</sub>, propanoic acid, 130 °C, 56%; (b) (hetero-)arylboronic acid, Pd(OAc)<sub>2</sub>, SPhos, K<sub>2</sub>CO<sub>3</sub>, solvent, 100–130 °C, 65–94%; (c) 1. POCl<sub>3</sub>, N(n-Pr)<sub>3</sub>, DMF, 75 °C, 1 min or POCl<sub>3</sub>, Et<sub>3</sub>N, −15 °C to rt. 2. Y-NH<sub>2</sub>, Et<sub>3</sub>N, solvent, rt or Y-NH<sub>2</sub>, HCl, solvent, rt, 18–76%; (d) 1. H<sub>2</sub>, Pd/C, MeOH, rt or SnCl<sub>2</sub>, conc. HCl, EtOH, rt or Fe, AcOH, H<sub>2</sub>O/THF, 60 °C or aq. Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMF, rt. 2. CH(OEt)<sub>3</sub>, EtOH 120–150 °C or 1. H<sub>2</sub>/Pd/C, EtOH, rt. 2. CH(OEt)<sub>3</sub>, EtOH 120–150 °C, 15–30%. For structures of intermediates <b>11</b>–<b>23</b>; see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Aniline Building Blocks Y-NH<sub>2</sub>: (I) Commercial Compounds <b>35–37</b> and (II) Synthesis of the Noncommericial Compounds <b>40</b>, <b>44</b>, and <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 5 equiv Et<sub>3</sub>N, dioxane 130 °C, 80%; (b) 2 equiv K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 94%; (c) Ra–Ni, H<sub>2</sub> (1 atm), THF, rt 82%; (d) 2 equiv K<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 78%; (e) 10% Pd/C, H<sub>2</sub> (1 atm), MeOH, rt, 97%.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Benzimidazole Substituted Derivatives <b>50–-59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 1. POCl<sub>3</sub>, N(n-Pr)<sub>3</sub>, DMF, 75 °C; 2. 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine, HCl-dioxane, DMF, rt, 50%; (b) 1. H<sub>2</sub>, Raney-Ni, MeOH, rt; 2. CH(OEt)<sub>3</sub>, EtOH, HCl, 145 °C, 55%. (c) (hetero-) arylboronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O/EtOH, 140 °C, 4–49% or piperidine, 160 °C, 67%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Profiles of the Original HTS Hit <b>60</b> and Key Derivatives <b>61</b>, <b>24</b>, <b>50</b>, and <b>25</b> during Early Optimization</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0016.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center"><b>60</b></th><th class="colsep0 rowsep0" align="center"><b>61</b></th><th class="colsep0 rowsep0" align="center"><b>24</b></th><th class="colsep0 rowsep0" align="center"><b>50</b></th><th class="colsep0 rowsep0" align="center"><b>25</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">COT IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">2.60</td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Kinase selectivity<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">18/36</td><td class="colsep0 rowsep0" align="left">6/42</td><td class="colsep0 rowsep0" align="left">4/58</td><td class="colsep0 rowsep0" align="left">6/72</td><td class="colsep0 rowsep0" align="left">2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a>/72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cLogP<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">4.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Enzymatic COT kinase assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Kinase selectivity displayed as number of kinases inhibited with at least IC<sub>50</sub> < 5 μM in relation to the total number of kinases tested from the Novartis kinase selectivity panel. For assay description see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">FLT3 (563-D835Y-993): IC<sub>50</sub> < 0.34 μM and MKNK2: IC<sub>50</sub> < 1.4 μM.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Octanol/water partition coefficient.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></div></div><div class="NLM_p last">The benzimidazole substituted derivatives <b>50</b>–<b>59</b> were prepared as outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Chlorination of intermediate <b>10</b>, followed by conversion of the crude chloride with 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine, afforded the aminonaphthyridine <b>48</b>. Reduction of the nitro group followed by cyclization of the diamino intermediate with triethyl orthoformate resulted in the chloro-precursor <b>49</b>, which was coupled under palladium catalyzed conditions with corresponding boronic acids to afford the final compounds <b>50</b>–<b>58</b> or by a S<sub>N</sub>Ar reaction with piperidine to <b>59</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3 Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening of our in-house library provided the single digit micromolar (IC<sub>50</sub>: 2.6 μM) and fairly unselective imidazoquinoline hit <b>60</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Initial SAR exploration around the imidazoquinoline core resulted in the 7-chloro substituted derivative <b>61</b>, which was of surprisingly higher selectivity when compared to corresponding nonsubstituted analog <b>60</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Speculating that kinase selectivity can be influenced via position 7 of the tricyclic core, together with our aim to reduce the lipophilicity of the scaffold, the 7-nitrogen containing imidazonaphthyridine analog <b>24</b> was prepared. We were pleased to notice that compound <b>24</b> not only maintained the beneficial selectivity profile previously observed for <b>61</b>, but also displayed a 16-fold gain in potency as measured in the enzymatic COT assay. Subsequent substituent modification in position 1 resulted in candidates <b>50</b> and <b>25</b>. Compound <b>50</b> was used for a wider SAR exploration in position 8. Unfortunately, only little diversity was tolerated, with 3-thiophene remaining the most potent subtstituent in this position (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The most promising compound from initial scaffold exploration was the 1-quinoline substituted derivative <b>25</b>, which showed low nanomolar potency on COT (IC<sub>50</sub>: 0.02 μM) paired with an exquisite kinase selectivity profile across 72 kinases, including MAP kinases involved in TNFα production, such as p38, JNK, and ERK.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure Activity Relationship in Position 8 of Benzimidazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0017.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0018.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Enzymatic COT kinase assay.</p></div></div><div></div></div><div class="NLM_p">In order to investigate the selectivity of the scaffold in a cellular context, lead compound <b>25</b> was incubated with human epidermoid carcinoma A431 cells (ATCC No.: CRL.1555) followed by activation of the MEK/ERK pathway via either the pro-inflammatory TNF receptor or the COT-independent EGF receptor that signals via the RAS/RAF pathway (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The A431 cell line allows the pERK readout to be downstream of the two pathways in one cell type. COT-dependency of the TNF-pathway was shown by siRNA knockdown (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>). As expected, the literature known MEK inhibitor (<i>R</i>)-<i>N</i>-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide (PD-0325901), which was inactive in our COT biochemical assay (IC<sub>50</sub> COT: >25 μM, data not shown), was highly active in both pathway readouts (IC<sub>50</sub> EGF: 0.038 μM, IC<sub>50</sub> TNF: <0.014 μM, data not shown). In contrast, compound <b>25</b> did not affect the phosphorylation of ERK post EGF-stimulation (IC<sub>50</sub> > 10 μM), whereas the levels of pERK were significantly reduced after TNF-stimulation (IC<sub>50</sub>: 0.061 ± 0.008 μM). We also tested compound <b>25</b> in primary human PBMCs post LPS stimulation. The IC<sub>50</sub> of <b>25</b> for the inhibition of pERK was 0.54 ± 0.14 μM, suggesting an interference of <b>25</b> with a target on the pro-inflammatory pathway which nicely correlated with the functional blockade of TNFα-release (IC<sub>50</sub>: 0.44 ± 0.19 μM), confirming the postulated role of COT kinase on the regulation of TNFα production.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Importantly, <b>25</b> did not affect NFκB pathway signaling, as shown by the absence of inhibition of p65-phosphorylation (IC<sub>50</sub> > 25 μM), confirming lack of interaction with an upstream target of COT.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacologic profile of compound <b>25</b> in PBMCs after LPS stimulation (graph and table) and in A431 after EGF- and TNF-stimulation (table).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although compound <b>25</b> nicely matched the desired kinase and pathway selectivity, several other properties, in particular aqueous solubility and activity in a whole blood assay, were not ideal. Furthermore, the thiophene substituent in position 8 was not considered acceptable based on the well documented risk of thiophene-related toxicity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Building on available SAR information at this position (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), we switched to the phenyl analog <b>26</b>, which turned out to be roughly 4-fold less potent (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The 2-methyl-benzo[<i>d</i>]thiazole substituent in position 1 (compound <b>27</b>) proved to be an equally potent replacement to the quinoline moiety of analog <b>26</b>. With the goal to increase the solubility of the scaffold, we investigated whether the 2-methyl group of the benzo[<i>d</i>]thiazole could be used as an exit vector for the introduction of an ionizable moiety. Although the weakly basic 2-morpholinethylamine substituted derivative <b>28</b> did only result in an improved solubility at pH 1, the 5-fold gain in enzymatic potency was very encouraging and suggestive of an additional protein–ligand interaction.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Lead Optimization and in Vitro Profiles of Compounds <b>25–34</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0019.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="/"> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Compd</th><th class="colsep0 rowsep0" align="center" char=".">COT<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">pERK<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">TNFα<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">hWB TNFα<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">LogP<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="/">Solubility<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">hPPB<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">1.78</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char="/"><4/6</td><td class="colsep0 rowsep0" align="char" char=".">>99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0.096</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/"><4/<4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">0.080</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/"><4/<4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char="/"><4/>1000</td><td class="colsep0 rowsep0" align="char" char=".">>99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">1.01</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char="/">9/>1000</td><td class="colsep0 rowsep0" align="char" char=".">>99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char="/">60/>1000</td><td class="colsep0 rowsep0" align="char" char=".">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char="/">13/261</td><td class="colsep0 rowsep0" align="char" char=".">>99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char="/">136/>1000</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char="/">135/>1000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">0.038</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Enzymatic COT kinase assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">PBMCs.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Human whole blood.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Octanol/water partition coefficient.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Equilibrium solubility at pH 6.8/pH 4.0 (assay details in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Human plasma protein binding assessed by rapid quilibrium dialysis (assay details in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></div></div><div class="NLM_p">Compound <b>28</b> was the first imidazonaphthyridine that could be cocrystallized with human COT protein and for which an X-ray structure (2.7 Å) was solved (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Top (a) and side (b) views of the crystal structure of imidazonaphthyridine (<b>28</b>) (blue sticks) in complex with human COT kinase protein (66–395) at 2.7 Å resolution. Key residues are shown as sticks. The unique P-loop inset (residues 133–144) is colored in red, and polar interactions of <b>28</b> with the protein and selected water molecules are shown as red dashed lines. The inset in part b shows a comparison of the P-loop conformations in COT·<b>28</b> versus a indazole cocrystal structure (green, only β1−β2 and ligand shown, pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4y85">4y85</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray structure of <b>28</b> in complex with COT revealed an unusual binding mode and several features that were not expected from the sequence alignment. Strikingly, a unique 15-amino acid insert is found before the GxGxxG motif of the P-loop, disrupting the typical β1/β2 β sheet. Another unexpected observation was the frame shift in helix-αC, with Asp178, instead of Glu180, forming the salt bridge with Lys167. COT shares this substitution with MEK4–7 and M3K12/13, as observed in the structures of MEK4 (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3alo">3alo</a>, DOI: 10.1016/j.bbrc.2010.08.071), MEK6 (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3vn9">3vn9</a>, DOI: 10.1093/jb/mvs023) and MEK7 (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2dyl">2dyl</a>).</div><div class="NLM_p">The P-loop insert wraps around the ligand and creates an unusual ATP pocket shape that bears little resemblance to our previously published COT·indazole cocrystal structure (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b inset).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The P-loop conformation in complex with <b>28</b> exposes the morpholine ethylamine side chain to solvent, explaining why substitutions in this region are tolerated. This contrasts with the potency loss that we observed upon introduction of solubilizing groups to our previous scaffolds which induced much more buried P-loop pockets.</div><div class="NLM_p">Whereas the morpholine was originally intended as solubilizing group, it was found to interact with the catalytic Lys167 via a water molecule, explaining the potency increase of <b>28</b> compared to <b>27</b>. We assume that pyridine analogues <b>30</b>, <b>32</b>, and <b>33</b> form a similar water mediated interaction with Lys167 (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>). The aliphatic side chain conformation in <b>28</b> involves an unfavorable dihedral angle, which may explain the potency increase of the α–Me substitution in <b>29</b>–<b>33</b>. The core and aromatic side chains of <b>28</b> engage in tight stacking interactions with P-loop residues Trp132, Ile134, and Val152. The amino group of the benzothiazole hydrogen bonds to a water occupying the Mg coordination site between Asn258 and Asp270.</div><div class="NLM_p">Although the C-terminal part of the pocket resembles a typical active kinase conformation (e.g., pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1atp">1atp</a>), the hinge is distorted due to the flexibility of the gk+2/3 Asp209-Gly210 motif. This creates space for a water molecule that hydrogen bonds the 7-N of the core and the buried carbonyl of Glu208 and connects to the two conserved waters hydrogen bonding the DFG motif. Due to its location in a region that is hydrophobic in most other kinases, the polar 7-N acceptor carries a desolvation penalty that may be responsible for the increased selectivity of the naphthyridines over the quinoline analogs. To visualize the untypical hinge conformation, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> shows the crystal structure of COT in complex with <b>28</b> overlaid with its closest phylogenetic neighbor, NIK.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overlay of the X-ray structure of imidazonaphthyridine (<b>28</b>) (blue) with human COT kinase protein (66–395, white) and with the closest related kinase, NIK (MAP3K14, magenta (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dn5">4dn5</a>)). Key residues are shown as sticks. The hinge in COT is distorted, enabling the typical hydrogen bond pattern with a shifted core of <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The nanomolar enzymatic potency of <b>28</b> nicely translated into a potent cellular blockade of pERK (IC<sub>50</sub>: 0.28 μM) and TNFα (IC<sub>50</sub>: 0.27 μM) in human PBMCs. Compound <b>29</b>, bearing an additional α-methyl substituent at the 2-morpholinethylamine group, further improved enzymatic activity, potentially a consequence of the less constrained conformation of the aliphatic side chain caused by the α–Me group. However, a significant potency drop for <b>28</b> and <b>29</b> was observed comparing TNFα release data from human PBMCs and human whole blood, which was hypothesized to relate to the high lipophilicity of the compounds. Reduction of LogP by more than one log unit could be accomplished by replacing the phenyl by a 4-pyridyl substituent in position 8. Resulting compound <b>30</b> was the first derivative of the series showing submicromolar activity (IC<sub>50</sub>: 0.60 μM) in the human whole blood assay, likely a consequence of the improved physicochemical profile. This hypothesis is also supported by comparing <b>30</b> to the far more lipophilic and in human whole blood inactive 2-thiophene analog <b>31</b>. Based on the similar enzymatic potency of the quinoline <b>26</b> and benzo[<i>d</i>]thiazole <b>27</b>, we investigated the feasibility of attaching the aliphatic 1-morpholinopropan-2-amine side chain also to the quinoline bicycle. Resulting compound <b>32</b> showed a slightly superior profile to the corresponding benzo[<i>d</i>]thiazole analog <b>30</b>, particularly an increased activity in the human whole blood assay (IC<sub>50</sub>: 0.20 μM) and a further improvement in solubility. Separation of racemic <b>32</b> by chiral HPLC afforded the two enantiomers, of which the <i>R</i>-eutomer <b>33</b> showed around 10-fold higher potency in the COT biochemical assay (IC<sub>50</sub>: 0.004 μM) compared to the <i>S</i>-eutomer <b>34</b> (IC<sub>50</sub>: 0.038 μM). The <i>R</i>-eutomer <b>33</b> and racemic <b>32</b> were screened against an in-house panel of kinases, confirming a high selectivity, as already observed for compound <b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Compound <b>33</b> was further subjected to pharmacokinetic profiling in rats. After administration of an intravenous dose of 1 mg/kg, a very high plasma clearance (221 mL·min<sup>–1</sup>· kg<sup>–1</sup>) was measured, vastly exceeding the hepatic blood flow. Extension of rat PK profiling to a wider set of compounds resulted in a surprisingly big difference in in vivo clearance for the two close analogs, the 4-pyridyl derivative <b>30</b> (297 mL·min<sup>–1</sup>·kg<sup>–1</sup>) and corresponding 2-thiophene <b>31</b> (40 mL·min<sup>–1</sup>·kg<sup>–1</sup>), which was not expected based on the similarly short half-life (<3 min) in rat liver microsomes in vitro. In order to understand the difference in in vivo clearance, we decided to study the biotransformation of the scaffold in more detail. Therefore, compounds <b>30</b> and <b>31</b> were incubated with rat liver microsomes in vitro and were also administered intravenously (3 mg/kg) to bile-duct cannulated rats in vivo. Metabolism investigation for <b>30</b> revealed a poor correlation between in vitro and in vivo metabolism. Based on semiquantitative evaluation using the relative peak areas of the different metabolites, liver microsomes mainly generated metabolites based on oxidative degradation of the aliphatic 1-morpholinopropan-2-amine side chain, whereas, in vivo, predominantly oxidation of the aromatic backbone took place, leading to a very abundant metabolite <b>M1</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). <b>M1</b> was eliminated via bile and urine and was the most prevalent metabolite detected in blood.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Biotransformation of <b>30</b> in vitro in rat liver microsomes and in vivo in bile-duct cannulated rats, and relative peak areas of <b>30</b> and metabolites detected in the different matrices. <sup><i>a</i></sup>Incubation period. <sup><i>b</i></sup>Sampling time or period in hours post dose. <sup><i>c</i></sup>Sum of relative peak areas of metabolites modified only at the side chain. <sup><i>d</i></sup>Sum of relative peak areas of metabolites modified at the side chain and the aromatic core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Quantitative analysis of <b>30</b> in the in vivo samples showed that elimination of unchanged <b>30</b> occurred via bile (0.13% of applied dose) and urine (0.04% of applied dose). At 8 h post dose, kidney and liver together only contained 0.002% and feces 0.33% of the applied dose as unchanged <b>30</b>. These results indicated that metabolism was the predominant route of clearance.</div><div class="NLM_p">Biotransformation investigations for <b>31</b> also revealed a poor correlation between in vitro and in vivo metabolism (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Based on semiquantitative evaluation using relative peak areas, liver microsomes mainly generated metabolites from oxidative elimination of the morpholine or N-dealkylation at the secondary amino group. In vivo, the most prominent metabolites corresponded to glutathione-related adduct formation at the thiophene. <b>M2</b> was the most abundant metabolite in liver and kidney and was excreted in bile and urine as the corresponding glucuronic acid conjugate. Quantitative analysis of <b>31</b> in the in vivo samples showed that only 0.63% of the applied dose was detected as unchanged <b>31</b> in the excreta.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Biotransformation of <b>31</b> in vitro in rat liver microsomes and in vivo in bile-duct cannulated rats, and relative peak areas of <b>31</b> and metabolites detected in the different matrices. <sup><i>a</i></sup>Incubation period. <sup><i>b</i></sup>Sampling time or period in hours post dose. <sup><i>c</i></sup>Sum of relative peak areas of metabolites modified only at the side chain. <sup><i>d</i></sup>Sum of relative peak areas of GSH, cysteinylglycine, and cysteine adducts at thiophene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The most striking difference in the in vivo metabolic pattern between <b>30</b> and <b>31</b> is the much higher abundance of the oxidation product <b>M1</b> at the aromatic tricyclic backbone for <b>30</b> compared to <b>M2</b> for <b>31</b>. This was therefore hypothesized to be the main reason for the observed clearance discrepancy between the two compounds in vivo. In order to determine the precise position of oxidation at the imidazonaphthyridine tricycle, metabolite <b>M1</b> was isolated from the bile sample of the PK study that was collected 0–2 h post dose. Micropreparative HPLC/MS yielded a sufficient amount of metabolite <b>M1</b> (∼65 μg) with good purity (>90% determined by HPLC/MS). Subsequent structure elucidation by <sup>1</sup>H and <sup>13</sup>C NMR techniques revealed that oxidation occurred at position 4 of the 1,3,5,7-tetraazacyclopenta[<i>a</i>]naphthalen moiety (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of the isolated metabolite <b>M1</b> with key <sup>1</sup>H (red) and <sup>13</sup>C (blue) chemical shifts and important HMBC and ROESY correlations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As nitrogen-containing aromatic heterocycles are described in the literature as typical substrates for aldehyde oxidase (AO) mediated metabolism, we hypothesized that AO might also be the responsible enzyme causing the high clearance in this case.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> In order to test our hypothesis, <b>30</b> was incubated in vitro with rat and human S9 liver homogenate fractions without addition of the cofactor NADPH and screened for metabolite <b>M1</b>. The fast disappearance of <b>30</b> with concomitant formation of <b>M1</b> confirmed the independence of this conversion from cytochrome P450 isoenzymes, since these enzymes require NADPH. In order to further confirm whether the oxidation was AO-mediated, the AO specific inhibitor raloxifene was added to the incubation at two different concentrations. Raloxifene is described as a very potent inhibitor of human AO (IC<sub>50</sub> 0.003–0.008 μM) but a less potent inhibitor of rat aldehyde oxidases (IC<sub>50</sub> 1.1–2.8 μM).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, the formation of <b>M1</b> was only poorly inhibited in the rat liver S9 fraction at a raloxifene concentration of 10 μM (not shown), whereas its formation was dose-dependently inhibited in the human liver S9 fraction. This investigation unambiguously proved that oxidation by AO led to the formation of metabolite <b>M1</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Turnover of compound <b>30</b> (A) and formation of metabolite <b>M1</b> (B) after incubation with human S9 fractions (without NADPH) in the presence and absence of the aldehyde oxidase inhibitor raloxifene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the reported very low activity of AO in the liver of dog, we compared the pharmacokinetic profile of the more potent compound <b>32</b> in rats and dogs first in vitro in the liver S9 fraction and in liver microsomes, and subsequently in vivo after intravenous (i.v.) and oral (p.o.) compound administration (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo Pharmacokinetic Profiles of Compound <b>32</b> in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>Compound 32</b></th><th class="colsep0 rowsep0" align="center"><b>rat</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><b>dog</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><i><b>in vitro</b></i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (min), S9–NADPH</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">>120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (min), liver microsomes</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><i><b>in vivo</b></i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doses i.v./p.o., (mg/kg)</td><td class="colsep0 rowsep0" align="left">1.0/3.0</td><td class="colsep0 rowsep0" align="left">0.1/0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL·min<sup>–1</sup>kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">277 ± 46</td><td class="colsep0 rowsep0" align="left">25 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> terminal (h)</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.9</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>i.v.</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (nmol·h)</td><td class="colsep0 rowsep0" align="left">119 ± 20</td><td class="colsep0 rowsep0" align="left">1′570 ± 130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>p.o.</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (nmol·h)</td><td class="colsep0 rowsep0" align="left">31 ± 6</td><td class="colsep0 rowsep0" align="left">957 ± 310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (nM)</td><td class="colsep0 rowsep0" align="left">12 ± 4</td><td class="colsep0 rowsep0" align="left">61 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.3 ± 0.0</td><td class="colsep0 rowsep0" align="left">143 ± 97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F (%)</td><td class="colsep0 rowsep0" align="left">26 ± 5</td><td class="colsep0 rowsep0" align="left">61 ± 20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last"><i>n</i> = 3 Sprague–Dawley male rats/group.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last"><i>n</i> = 3 Beagle dogs/group.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Dose-normalized values.</p></div></div></div><div class="NLM_p">Whereas in rat a high clearance resulting in a very low exposure was confirmed also for derivative <b>32</b>, the pharmacokinetic profile in dog was significantly better. Clearance from blood was moderate, resulting in a prolonged mean residence time (MRT), terminal elimination half-life, and significant exposure after i.v. and p.o. dosing.</div><div class="NLM_p">Based on the promising PK profile in dog, the efficacy of <b>32</b> was evaluated in the dog uric acid-induced synovitis model.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Preceding in vitro assessment of <b>32</b>, in uric-acid, stimulated macrophages demonstrated potent inhibition of the formation of the pro-inflammatory cytokine interleukin-1β (IC<sub>50</sub>: 0.2 μM) by this compound. In the in vivo model, the test compound was examined for its ability to counteract lameness as a result of inflammation and pain induced by injection of 15 mg of uric acid crystals in suspension into one stifle joint (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Eight dogs were employed in a four-phase crossover study with a positive control (Meloxicam at 0.2 mg/kg), vehicle, and two doses of <b>32</b>: low dose at 5 mg/kg and high dose at 15 mg/kg. This lameness is acute and short-lived, and responsive to commercially available nonsteroidal anti-inflammatory drugs. The degree of lameness is measured on a Force Plate apparatus. The vertical force applied by the limb when trotting over the Force Plate is considered representative of the degree of lameness. The results are displayed in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>, wherein the time post-treatment required to reach 60% of the prelameness vertical peak force of the affected limb is shown.</div><figure id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0012.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Time needed for the z peak force of the affected limb to reach 60% of that measured prior to uric acid injection (time to recovery). (Short time to recovery reflects better efficacy.) Vehicle, 2 doses of <b>32</b>, and a positive control (meloxicam) were tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we show a clear and statistically significant (<i>p</i> < 0.5) benefit for the high dose of <b>32</b> (AUC<sub>0–10.5h</sub>: 4575 ± 2385 nmol·h) over vehicle. There is no statistical difference between the vehicle and the low dose of <b>32</b> (AUC<sub>0–10.5h</sub>: 2057 ± 625 nmol·h); neither is there a statistical difference between the high dose of <b>32</b> and the positive control meloxicam (AUC<sub>0–10.5h</sub>: 13975 ± 1941 nmol·h).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">4 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The discovery and chemical optimization of a novel series of selective imidazonaphthyridine COT kinase inhibitors has been described. Improvement of the physicochemical profile was absolutely crucial to achieve low nanomolar activity in the human whole blood assay. The X-ray cocrystal structure of an advanced candidate revealed an unusual binding mode, providing a rationale for the excellent kinase selectivity and enzymatic potency. Gained insights can serve as invaluable starting points for structure-based drug design of COT kinase inhibitors and facilitate future drug development. A lack of correlation between in vitro liver microsomal clearance and in vivo rat clearance could be attributed to a dominating aldehyde oxidase mediated metabolism in vivo. Moreover, pharmacodynamic evaluation of compound <b>32</b> in dogs showed a clear amelioration of inflammatory events in vivo, which further supports the notion that COT is an appropriate and attractive therapeutic target for inflammatory diseases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">5 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">5.1 Chemistry</h3><div class="NLM_p">All reagents and solvents were purchased from commercial suppliers and used without further purification or were prepared according to published procedures. All reactions were performed under inert conditions (argon) unless otherwise stated. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 MHz or a Bruker 600 MHz NMR spectrometer. Chemical shifts are reported in parts per million (ppm) relative to an internal solvent reference. Significant peaks are tabulated in the order multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; quintet; m, multiplet; br, broad), coupling constants, and number of protons. Final compounds were purified to ≥95% purity as assessed by analytical liquid chromatography with one of the following methods.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">5.1.1 Method A</h4><div class="NLM_p last">Waters Acquity UPLC–MS; column HSS T3 1.8 μm, 2.1 mm × 50 mm; A, water +0.05% formic acid +3.75 mM ammonium acetate; B, acetonitrile + 0.04% formic acid; 2–98% B in 1.4 min, 98% B 0.45 min, flow 1.2 mL/min; column temperature 50 °C.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">5.1.2 Method B</h4><div class="NLM_p">Waters Acquity UPLC–MS; column HSS T3 1.8 μm, 2.1 mm × 50 mm; A, water +0.05% formic acid + 3.75 mM ammonium acetate; B, acetonitrile + 0.04% formic acid; 5–98% B in 1.4 min, 98% B 0.45 min, flow 1.0 mL/min; column temperature 60 °C.</div><div class="NLM_p last">The accurate mass analyses were performed by using electrospray ionization in positive mode after separation by liquid chromatography. Enantiomerically enriched compounds were obtained by chiral preparative chromatography: Gilson PLC 2020; column Chiralcel OD-H 5 μm, 250 × 20 mm; <i>n</i>-heptane:EtOH:MeOH 75:15:10, flow 13 mL/min. Optical purity of the compounds was assessed by chiral analytical chromatography: Merck LaChrom HPLC system; Chiralcel OD-H 5 μm, 250 × 4.6 mm; <i>n</i>-heptane:EtOH:MeOH 70:20:10, flow 1 mL/min. LC-HRMS analyses were performed by using electrospray ionization in positive ion modus after separation by liquid chromatography (Nexera from Shimadzu). The elemental composition was derived from the mass spectra acquired at the high resolution of about 30′000 on an LTQ Orbitrap XL mass spectrometer (Thermo Scientific). The high mass accuracy below 1 ppm was obtained by using a lock mass.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">5.2 General Procedures</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">5.2.1 Chloro-Dehydroxylation of Phenols</h4><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18">5.2.1.1 Procedure 1</h5><div class="NLM_p last">A mixture of the naphthyridine 4-ol (1.0 equiv) and tripropylamine (2.0 equiv) in DMF (0.3 M) was heated to 75 °C. POCl<sub>3</sub> (1.0 equiv) was added and the mixture stirred for 1 min at 75 °C and then immediately cooled to 0 °C in an ice bath. Diethyl ether (2.5 mL) was added and the formed suspension stirred at 0 °C for 15 min. The solid was filtered and the filter cake washed with cold diethyl ether and dried.</div></div><div id="sec5_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19">5.2.1.2 Procedure 2</h5><div class="NLM_p last">Triethyl amine (5.0 equiv) was added dropwise to a suspension of the naphthyridine 4-ol (1.0 equiv) and POCl<sub>3</sub> (20 equiv) at −15 °C. The mixture was allowed to warm to rt and stirred at rt or until the reaction was complete (typically ca. 30 min). The reaction mixture was concentrated in vacuo and the residue taken up in CH<sub>2</sub>Cl<sub>2</sub> and diluted with H<sub>2</sub>O at 0 °C. The pH was adjusted to 8 with sat. aq. K<sub>2</sub>CO<sub>3</sub> soln., the layers were separated and the organic layer concentrated under reduced pressure to provide the crude chloride which was taken for the next step without further purification (typically ca. 90% pure).</div></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">5.2.2 Suzuki Reaction</h4><div id="sec5_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21">5.2.2.1 Procedure 1</h5><div class="NLM_p last">A microwave vial was charged with 6-chloro-3-nitro-1,7-naphthyridin-4-ol (<b>10</b>) (1.0 equiv), boronic acid (1.5 equiv) and K<sub>2</sub>CO<sub>3</sub> (2.1 equiv) in DMA/H<sub>2</sub>O 3:1 (0.1M) and the mixture was degassed with Argon. Pd(OAc)<sub>2</sub> (0.2 equiv) and S-Phos (0.4 equiv) were added, the vial sealed and the reaction mixture heated to 100–120 °C for the indicated time period. The mixture was cooled to rt, filtered through a pad of <i>Celite</i>, the filter cake washed with MeOH (2x) and the filtrate concentrated. Water was added and the pH adjusted to 5 by careful addition of acetic acid. The precipitated solid was filtered, the filter cake washed with H<sub>2</sub>O (3x) and dried. The solid was triturated with ethyl acetate, filtered and dried to provide the title compound.</div></div><div id="sec5_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22">5.2.2.2 Procedure 2</h5><div class="NLM_p last">A microwave vial was charged with 6-chloro-3-nitro-1,7-naphthyridin-4-ol (<b>10</b>) (1.0 equiv), boronic acid (1.2–1.3 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (1.6 equiv) in DME/H<sub>2</sub>O/EtOH 7:3:2 and the mixture was degassed with Argon. PdCl<sub>2</sub>(dppf)<sub>2</sub> (0.11 equiv) was added, the vial sealed and the reaction mixture heated to 140 °C for the indicated time period. The mixture was cooled to rt, filtered through a pad of <i>Celite</i>, the filter cake washed with EtOH (2x). The reaction mixture was concentrated in vacuo and the residue taken up in H<sub>2</sub>O, extracted twice with ethyl acetate, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. Title compound was obtained after purification by prep HPLC (Waters; column Sunfire C18 5 μm, 30 mm × 100 mm; A, water +0.1% TFA; B, acetonitrile +0.1% TFA; 15–35% B in 15 min.</div></div><div id="sec5_2_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23">5.2.2.2.1 6-chloro-3-nitro-1,7-naphthyridin-4-ol (<b>10</b>)</h5><div class="NLM_p last">A solution of 6-chloro-1,7-naphthyridin-4-ol <b>9</b> (360 g, 2.0 mol, 1.0 equiv) in propanoic acid (3.60 l) was heated to 130 °C. HNO<sub>3</sub> (236 mL, 2.4 mol, 1.2 equiv) was added dropwise at 130 °C. The reaction mixture was kept for 1 h at 130 °C and was then cooled to rt. The precipitated solid was separated by filtration, the filter cake washed with diethyl ether (3 × 2l) and dried to give the title compound <b>10</b> (252 g, 56%) as a pale yellow solid which was used without further purification. UPLC-MS <i>t</i><sub>R,B</sub>: 0.55 min, 225, 227 [M + H], UPLC-purity: 95%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.54 (br. s, 1H), 9.36 (s, 1H), 8.97 (s, 1H), 8.08 (s, 1H).</div></div><div id="sec5_2_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24">5.2.2.2.2 3-nitro-6-(thiophen-3-yl)-1,7-naphthyridin-4-ol (<b>12</b>)</h5><div class="NLM_p last">Title compound <b>12</b> was obtained as beige solid (1.08 g, 70%, ca. 90% pure) according to the <i>general Suzuki procedure 1</i> starting from <b>10</b> (1.13 g, 5.0 mmol) and thiophen-3-ylboronic acid (1.00 g, 7.5 mmol). UPLC-MS <i>t</i><sub>R,B</sub>: 0.73 min, 273 [M + H], UPLC-purity: 89%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.33 (br. s, 1H), 9.31 (s, 1H), 9.17 (s, 1H), 8.46 (s, 1H), 8.36 (dd, <i>J</i> = 3.0, 1.3 Hz, 1H), 7.87 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H), 7.71 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H).</div></div><div id="sec5_2_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25">5.2.2.2.3 2-(4-((3-nitro-6-(thiophen-3-yl)-1,7-naphthyridin-4-yl)amino)phenyl)acetonitrile (<b>15</b>)</h5><div class="NLM_p last">The chloride (270 mg, 0.93 mmol, 1.0 equiv), prepared from <b>12</b> in 90% yield according to <i>general chlorination procedure 2</i>, was dissolved in anhydrous DMF (6 mL). 4 M HCl in dioxane (28 μL, 0.11 mmol, 0.1 equiv), followed by 2-(4-aminophenyl)acetonitrile (185 mg, 1.3 mmol, 1.5 equiv) were added. The reaction mixture was stirred at rt overnight and was then quenched by addition of sat. aq. NaHCO<sub>3</sub> soln. to pH 8 and concentrated under reduced pressure. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide the title compound <b>15</b> (274 mg, 75%) as brown solid. UPLC-MS <i>t</i><sub>R,B</sub>: 1.08 min, 387 [M + H], UPLC-purity: 98%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1H), 9.37 (s, 1H), 9.10 (s, 1H), 8.73 (s, 1H), 8.21 (dd, <i>J</i> = 2.6, 1.4 Hz, 1H), 7.81–7.72 (m, 2H), 7.40 (d, <i>J</i> = 8.1 Hz, 2H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 4.09 (s, 2H).</div></div><div id="sec5_2_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26">5.2.2.2.4 2-(4-(8-(thiophen-3-yl)-1<i>H</i>-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)phenyl)acetonitrile (<b>24</b>)</h5><div class="NLM_p last">SnCl<sub>2</sub> (402 mg, 2.1 mmol, 3.0 equiv) was added to a solution of <b>15</b> (274 mg, 0.71 mmol) in conc. HCl/EtOH 3:2 (10 mL) and the mixture stirred for 1 h at rt. The mixture was cooled to 0 °C and the pH adjusted to 11 with 30% aq. NaOH. The mixture was partiotioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and H<sub>2</sub>O (20 mL), the layers separated and the organic phase concentrated <i>in vacuo</i> to provide the crude aniline as brown foam (218 mg). The crude material was taken up in triethyl orthoformate (4 mL) and the mixture heated in a sealed microwave vial to 150 °C for 25 min. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH), followed by a slurry of the chomatographed material in CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether 3:1 (2 mL) to provide <b>24</b> (39.0 mg, 14% over 2 steps) as beige solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.88 min, 367 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (d, <i>J</i> = 0.8 Hz, 1H), 9.45 (s, 1H), 8.82 (s, 1H), 7.94–7.90 (m, 2H), 7.89 (dd, <i>J</i> = 3.1, 1.3 Hz, 1H), 7.84–7.80 (m, 2H), 7.63 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.45–7.42 (m, 1H), 7.26 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H), 4.35 (s, 2H).</div></div><div id="sec5_2_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27">5.2.2.2.5 3-Nitro-<i>N</i>-(quinolin-6-yl)-6-(thiophen-3-yl)-1,7-naphthyridin-4-amine (<b>16</b>)</h5><div class="NLM_p last">The crude chloride (160 mg, 0.55 mmol, 1.0 equiv), prepared from <b>12</b> in 76% yield according to <i>general chlorination procedure 1</i>, was dissolved in anhydrous DMF (15 mL) and triethylamine (1.70 mL, 12 mmol, 10.0 equiv) and 6-aminoquinoline (138 mg, 0.96 mmol, 1.8 equiv) were added. The mixture was stirred at rt for 30 min and then poured onto a mixture of ice water and EtOAc/Et2O 1:1 (20 mL). The precipitated solid was filtered, washed with H<sub>2</sub>O (5 mL) and diethyl ether (2 × 5 mL) and dried under reduced pressure. The title compound <b>16</b> was obtained as brown solid (140 mg, 64%). UPLC-MS <i>t</i><sub>R,B</sub>: 1.04 min, 400 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>) δ 10.86 (s, 1H), 9.55 (s, 1H), 9.46 (s, 1H), 9.03 (dd, <i>J</i> = 4.3, 1.7 Hz, 1H), 8.27 (d, <i>J</i> = 8.9 Hz, 1H), 8.17–8.10 (m, 1H), 7.74 (d, <i>J</i> = 2.5 Hz, 1H), 7.65 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 7.57 (s, 1H), 7.52 (dd, <i>J</i> = 8.3, 4.3 Hz, 1H), 7.46 (dd, <i>J</i> = 3.1, 1.3 Hz, 1H), 7.14 (dd, <i>J</i> = 5.1, 3.0 Hz, 1H), 6.75 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H).</div></div><div id="sec5_2_2_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28">5.2.2.2.6 1-(quinolin-6-yl)-8-(thiophen-3-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>25</b>)</h5><div class="NLM_p">A mixture of <b>16</b> (110 mg, 0.28 mmol) and 10% Pd/C (15.0 mg) in THF/EtOH 1:1 (14 mL) was stirred under H<sub>2</sub> (1 atm.) for 1.5 h at rt. The reaction mixture was filtered over <i>Celite</i>, the filter cake washed with EtOH (3 × 2 mL) and the filtrate concentrated <i>in vacuo</i> to provide the aniline (106 mg) as brown solid which was used for the next step without further purification. The crude material was taken up in triethyl orthoformate (4 mL) and the mixture heated in a sealed microwave vial to 150 °C for 25 min. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide <b>25</b> (38.0 mg, 36% over 2 steps) as beige solid.</div><div class="NLM_p last">UPLC-MS <i>t</i><sub>R,B</sub>: 0.88 min, 380 [M + H], UPLC-purity: 98%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 9.49 (s, 1H), 9.16 (dd, <i>J</i> = 4.2, 1.7 Hz, 1H), 8.93 (s, 1H), 8.61–8.57 (m, 2H), 8.44 (d, <i>J</i> = 8.9 Hz, 1H), 8.27 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.86 (dd, <i>J</i> = 3.1, 1.3 Hz, 1H), 7.77 (dd, <i>J</i> = 8.3, 4.3 Hz, 1H), 7.59 (s, 1H), 7.56 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.01 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.0, 152.9, 148.0, 147.5, 147.0, 146.9, 141.5, 140.2, 138.7, 137.0, 134.0, 132.1, 131.4, 128.6, 128.5, 128.3, 126.8, 125.4, 124.6, 123.4, 122.3, 109.0; HRMS (ESI) for C22H14N5S [M + H], caluculated 380.0964, found 380.0962.</div></div><div id="sec5_2_2_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29">5.2.2.2.7 3-Nitro-6-phenyl-1,7-naphthyridin-4-ol (<b>13</b>)</h5><div class="NLM_p last">A mixture of 6-chloro-1,7-naphthyridin-4-ol (9.10 g, 40 mmol, 1.0 equiv), phenylboronic acid (6.53 g, 52 mmol, 1.3 equiv) and K<sub>2</sub>CO<sub>3</sub> (11.2 g, 80 mmol, 2.0 equiv) in acetonitrile/H<sub>2</sub>O 3:2 (185 mL) was degassed with argon. The mixture was warmed to 50 °C and Pd(OAc)<sub>2</sub> (362 mg, 1.6 mmol, 0.025 equiv) and S-Phos (1.34 g, 3.2 mmol, 0.05 equiv) were added. The reaction mixture was then stirred under reflux for 15 h. The mixture was cooled to 70 °C, filtered through a pad of activated charcoal and <i>Celite</i> and the filtrate concentrated to about 1/3 of its initial volume. The mixture was then warmed to 70 °C and the pH adjusted to 5 by careful addition of acetic acid. Ethyl acetate (20 mL) was added and the mixture left to cool to rt. The precipitated solid was filtered, the filter cake washed with ethyl acetate (2 × 10 mL) and H<sub>2</sub>O (3 × 20 mL) and dried to provide the title compound <b>13</b> (10.0 g, 94%) as gray solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.32 min, 268 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.42 (br. s, 1H), 9.31 (s, 1H), 9.21 (s, 1H), 8.51 (s, 1H), 8.19–8.11 (m, 2H), 7.57–7.50 (m, 2H), 7.49–7.43 (m, 1H).</div></div><div id="sec5_2_2_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30">5.2.2.2.8 3-Nitro-6-phenyl-<i>N</i>-(quinolin-6-yl)-1,7-naphthyridin-4-amine (<b>17</b>)</h5><div class="NLM_p last">The chloride (160 mg, 0.56 mmol, 1.0 equiv), prepared from <b>13</b> in 80% yield according to the <i>general chlorination procedure 1</i>, was dissolved in absolute DMF (6 mL) and triethylamine (0.78 mL, 5.6 mmol, 10 equiv) and 6-aminoquinoline (161 mg, 1.1 mmol, 2.0 equiv) were added. The mixture was stirred at rt for 30 min and was then quenched by addition of sat. aq. NaHCO<sub>3</sub> soln. (20 mL). The reaction mixture was extracted into CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL), the combined organics dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–20% MeOH) to provide <b>17</b> (90.0 mg, 41%) as a yellow solid. UPLC-MS <i>t</i><sub>R,A</sub>: 1.05 min, 394 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 9.45 (s, 1H), 9.13 (s, 1H), 9.00 (s, 1H), 8.85 (s, 1H), 8.42–8.25 (m, 1H), 8.24–8.14 (m, 2H), 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.71 (s, 1H), 7.63 (d, <i>J</i> = 8.6 Hz, 1H), 7.56–7.44 (m, 4H).</div></div><div id="sec5_2_2_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31">5.2.2.2.9 8-Phenyl-1-(quinolin-6-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>26</b>)</h5><div class="NLM_p last">A solution of Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> (159 mg, 0.92 mmol, 4.0 equiv) in H<sub>2</sub>O (0.9 mL) was added to a solution of <b>17</b> (90.0 mg, 0.23 mmol, 1.0 equiv) in anh. DMF (4 mL). The mixture was stirred at rt for 20 min and the solvent removed <i>in vacuo</i> at 60 °C. The residual yellow solid was taken up in EtOH (1 mL) and triethylorthoformate (5 mL) and the mixture heated in a sealed vial to 150 °C for 1 h. The reaction mixture was cooled to rt and partitioned between ethyl acetate (20 mL) and H<sub>2</sub>O (10 mL). The layers were separated and the organic layer was washed with brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The residue was triturated with H<sub>2</sub>O (2 mL), the solid filtered and the filter cake washed with diethyl ether (3 × 2 mL) and dried to provide <b>26</b> (25.0 mg, 29%) as a beige solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.89 min, 374 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.56 (d, <i>J</i> = 0.9 Hz, 1H), 9.50 (s, 1H), 9.14 (dd, <i>J</i> = 4.3, 1.7 Hz, 1H), 8.94 (s, 1H), 8.62 (d, <i>J</i> = 2.4 Hz, 1H), 8.62–8.55 (m, 1H), 8.42 (d, <i>J</i> = 8.9 Hz, 1H), 8.26 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.76 (dd, <i>J</i> = 8.3, 4.2 Hz, 1H), 7.69 (d, <i>J</i> = 0.9 Hz, 1H), 7.68–7.60 (m, 2H), 7.36–7.26 (m, 3H).</div></div><div id="sec5_2_2_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32">5.2.2.2.10 2-methyl-<i>N</i>-(3-nitro-6-phenyl-1,7-naphthyridin-4-yl)benzo[d]thiazol-6-amine (<b>18</b>)</h5><div class="NLM_p last">The chloride (295 mg, 1.0 mmol), prepared from <b>13</b> in 80% yield according to the <i>general chlorination procedure 2</i>, was dissolved in absolute DMF (6 mL) and 4 M HCl in dioxane (31 μL, 0.12 mmol, 0.1 equiv), followed by 2-methylbenzo[d]thiazol-6-amine (262 mg, 1.5 mmol, 1.5 equiv). The mixture was stirred at rt overnight and was then quenched by addition of sat. aq. NaHCO<sub>3</sub> soln. (2 mL) and concentrated under reduced pressure. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub> containing 3% AcOH and MeOH (0–10% MeOH) to provide <b>18</b> (451 mg, 79%, ca. 75% pure) as brown solid. UPLC-MS <i>t</i><sub>R,B</sub>: 1.15 min, 413 [M + H], UPLC-purity: 75%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.52 (s, 1H), 9.45 (s, 1H), 9.12 (s, 1H), 8.94 (s, 1H), 8.23–8.14 (m, 2H), 7.93 (dd, <i>J</i> = 5.4, 3.2 Hz, 2H), 7.59–7.48 (m, 2H), 7.36 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 5.78 (br. s, 1H), 2.83 (s, 3H).</div></div><div id="sec5_2_2_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33">5.2.2.2.11 2-methyl-6-(8-phenyl-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)benzo[d]thiazole (<b>27</b>)</h5><div class="NLM_p last">SnCl<sub>2</sub> (465 mg, 2.5 mmol, 3.0 equiv) was added to a solution of <b>18</b> (451 mg, 0.82 mmol, 75% pure) in conc. HCl/EtOH 3:2 (10 mL) and the mixture stirred for 1 h at rt. The mixture was cooled to 0 °C and the pH adjusted to 11 with 30% aq. NaOH. The mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and H<sub>2</sub>O (20 mL), the layers were separated and the organic phase was concentrated <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub> containing 3% AcOH and MeOH (0–10% MeOH) to provide the aniline as a yellow solid (213 mg). This material was taken up in triethyl orthoformate (4 mL) and the mixture heated in a sealed microwave vial to 150 °C for 25 min. The reaction mixture was cooled to rt and the volatiles were removed <i>in vacuo</i>. The residue was purified by a slurry in CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether 2:1 (4.5 mL) to provide <b>27</b> (65.0 mg, 20% over 2 steps) as a pale yellow solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.98 min, 394 [M + H], UPLC-purity: 99%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.58 (d, <i>J</i> = 0.9 Hz, 1H), 9.50 (s, 1H), 8.89 (s, 1H), 8.69 (d, <i>J</i> = 2.2 Hz, 1H), 8.32 (d, <i>J</i> = 8.5 Hz, 1H), 8.01 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.75–7.70 (m, 2H), 7.68 (d, <i>J</i> = 0.9 Hz, 1H), 7.43–7.38 (m, 3H), 2.97 (s, 3H).</div></div><div id="sec5_2_2_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34">5.2.2.2.12 <i>N</i><sup>2</sup>-(2-morpholinoethyl)-<i>N</i><sup>6</sup>-(3-nitro-6-phenyl-1,7-naphthyridin-4-yl)benzo[d]thiazole-2,6-diamine (<b>19</b>)</h5><div class="NLM_p last">A solution of <b>40</b> (177 mg, 0.64 mmol, 1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added at rt to a suspension of the chloride (200 mg, 0.64 mmol, 1.0 equiv), prepared from <b>13</b> in quantitative yield according to the <i>general chlorination procedure 2</i>) and triethylamine (0.35 mL, 2.5 mmol, 4.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL). The mixture was stirred for 6 h at rt and then partitioned between CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and H<sub>2</sub>O (10 mL). The layers were separated and the aq. phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL). The combined organics were washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filetered and concentrated <i>in vacuo</i>. The residue was triturated with CH<sub>2</sub>Cl<sub>2</sub> (5 mL) to provide <b>19</b> (257 mg, 76%) as a red solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.86 min, 528 [M + H], UPLC-purity: 93%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (s, 1H), 9.34 (s, 1H), 9.05 (s, 1H), 8.76 (s, 1H), 8.14–8.01 (m, 3H), 7.56 (s, 1H), 7.53–7.41 (m, 3H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 7.07 (d, <i>J</i> = 8.6 Hz, 1H), 3.58 (t, <i>J</i> = 4.6 Hz, 4H), 3.50 (q, <i>J</i> = 6.0 Hz, 2H), 2.60–2.51 (m, 2H), 2.42 (t, <i>J</i> = 4.5 Hz, 4H).</div></div><div id="sec5_2_2_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35">5.2.2.2.13 <i>N</i>-(2-morpholinoethyl)-6-(8-phenyl-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)benzo[d]thiazol-2-amine (<b>28</b>)</h5><div class="NLM_p last">Acetic acid (1.0 mL, 18 mmol, 37 equiv), H<sub>2</sub>O (1.0 mL, 58 mmol, 118 equiv) and Fe (272 mg, 4.9 mmol, 10 equiv) were added to a solution of <b>19</b> (84.0 mg, 0.14 mmol, 1.0 equiv) in THF (5 mL). The mixture was heated to 60 °C for 15 min, cooled to rt and partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and H<sub>2</sub>O (20 mL). The pH was adjusted to 11 with sat. aq. K<sub>2</sub>CO<sub>3</sub> soln. and the layers were separated. The aq. phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL) and the combined organics were washed with H<sub>2</sub>O (20 mL) and brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure to give the crude aniline as brown solid (142 mg). The solid was suspended in triethyl orthoformate (2.4 mL), and the mixture heated to 145 °C in a sealed vial for 18 h. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–5% MeOH) to provide the title compound <b>28</b> (24.0 mg, 16% over 2 steps) as red solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.70 min, 508 [M + H], UPLC-purity: 99%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.55 (s, 1H), 9.47 (s, 1H), 8.81 (s, 1H), 8.39 (t, <i>J</i> = 5.5 Hz, 1H), 8.25 (d, <i>J</i> = 1.83 Hz, 1H), 7.77–7.74 (m, 2H), 7.72–7.65 (m, 3H), 7.44–7.37 (m, 3H), 3.62 (t, <i>J</i> = 4.50 Hz, 6H), 2.61 (t, <i>J</i> = 6.5 Hz, 2H), 2.50–2.45 (m, 4H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.5, 154.4, 153.8, 150.7, 147.1, 147.0, 139.9, 138.9, 138.8, 132.6, 132.1, 129.5, 129.3, 128.8, 126.8, 125.2, 122.4, 120.6, 118.7, 109.4, 66.7, 57.5, 53.8, 41.8; HRMS (ESI) for C<sub>28</sub>H<sub>26</sub>ON<sub>7</sub>S [M + H], calculated 508.1914, found 508.1912.</div></div><div id="sec5_2_2_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36">5.2.2.2.14 N2-(1-morpholinopropan-2-yl)-N6-(3-nitro-6-phenyl-1,7-naphthyridin-4-yl)benzo[d]thiazole-2,6-diamine (<b>20</b>)</h5><div class="NLM_p last">A solution of <b>44</b> (221 mg, 0.76 mmol, 1.2 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and triethylamine (0.88 mL, 6.30 mmol, 10.0 equiv) were added to a suspension of the chloride (180 mg, 0.63 mmol, 1.0 eq, prepared from <b>13</b> in quantitative yield according to the <i>general chlorination procedure 2</i>) in CH<sub>2</sub>Cl<sub>2</sub> (2.7 mL) at rt. The reaction mixture was concentrated under reduced pressure and the residue purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide <b>20</b> as red solid (250 mg, 73%) as red solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.87 min, 542 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.45 (s, 1H), 9.33 (s, 1H), 9.05 (s, 1H), 8.75 (s, 1H), 8.07 (d, <i>J</i> = 7.0 Hz, 2H), 7.96 (s, 1H), 7.56 (s, 1H), 7.52–7.42 (m, 3H), 7.34 (d, <i>J</i> = 8.6 Hz, 1H), 7.14–6.95 (m, 1H), 4.17–3.94 (m, 1H), 3.61–3.44 (m, 4H), 2.42 (br. s, 4H), 2.30 (dd, <i>J</i> = 12.5, 6.7 Hz, 2H), 1.21 (d, <i>J</i> = 6.5 Hz, 3H).</div></div><div id="sec5_2_2_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37">5.2.2.2.15 N-(1-morpholinopropan-2-yl)-6-(8-phenyl-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)benzo[d]thiazol-2-amine (<b>29</b>)</h5><div class="NLM_p last">A mixture of <b>20</b> (250 mg, 0.46 mmol) and Raney-Ni in MeOH (4 mL) was stirred under H<sub>2</sub> (1 atm.) for 5 h at rt. The reaction mixture was filtered over <i>Celite</i>, the filter cake washed with MeOH (3 × 2 mL) and the filtrate concentrated <i>in vacuo</i> to provide the aniline (190 mg) as red solid which was used for the next step without further purification. The crude material was taken up in triethyl orthoformate (2.4 mL) and the mixture heated in a sealed microwave vial to 150 °C for 18 h. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–15% MeOH) to provide <b>29</b> (160 mg, 83% over 2 steps) as beige solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.73 min, 522 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.55 (s, 1H), 9.44 (s, 1H), 8.79 (s, 1H), 8.28 (d, <i>J</i> = 7.8 Hz, 1H), 8.22 (d, 1H), 7.80–7.68 (m, 2H), 7.69–7.59 (m, 3H), 7.39 (m, 3H), 4.30–4.13 (m, 1H) 3.58 (br. s, 4H), 2.60–2.50 (m, 4H), 2.41–2.30 (m, 2H), 1.26 (d, <i>J</i> = 6.0 Hz, 3H).</div></div><div id="sec5_2_2_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38">5.2.2.2.16 3-Nitro-6-(pyridin-4-yl)-1,7-naphthyridin-4-ol (<b>14</b>)</h5><div class="NLM_p last">The title compound <b>14</b> was obtained from a Suzuki reaction as a pale brown solid (2.18 g, 78%) according to the <i>general Suzuki procedure 1</i> starting from <b>10</b> (2.00 g, 8.9 mmol) and pyridine 4-boronic acid (1.64 g, 13 mmol) with stirring at 120 °C for 1 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.43 min, 269 [M + H], UPLC-purity: 85%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (br. s, 1H), 9.30 (s, 1H), 9.25 (s, 1H), 8.78–8.72 (m, 2H), 8.70 (s, 1H), 8.20–8.13 (m, 2H).</div></div><div id="sec5_2_2_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39">5.2.2.2.17 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)-<i>N</i><sup>6</sup>-(3-nitro-6-(pyridin-4-yl)-1,7-naphthyridin-4-yl)benzo[d]thiazole-2,6-diamine (<b>21</b>)</h5><div class="NLM_p last">A suspension of the chloride (125 mg, 0.41 mmol, 1.0 equiv) prepared from <b>14</b> in 55% yield according to <i>general chlorination procedure 2</i> and triethyl amine (0.23 mL, 1.6 mmol, 4.0 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was cooled to 0 °C and a solution of <b>44</b> (1.40 mg, 0.43 mmol, 1.05 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added dropwise. The layers were separated and the aq, phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL). The combined organics were washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated <i>in vacuo</i>. The residue was triturated with CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether 1.1 (10 mL) at rt. The solid was filtered and dried to provide <b>21</b> (153 mg, 68%) as an orange solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.75 min, 543 [M + H], UPLC-purity: 99%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (s, 1H), 9.44 (s, 1H), 9.12 (s, 1H), 9.02 (s, 1H), 8.74 (d, <i>J</i> = 5.1 Hz, 2H), 8.09–8.05 (m, 2H), 8.04 (d, <i>J</i> = 7.7 Hz, 1H), 7.61 (d, <i>J</i> = 2.3 Hz, 1H), 7.37 (d, <i>J</i> = 8.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 4.15–4.03 (m, 1H), 3.57 (t, <i>J</i> = 4.8 Hz, 4H), 2.55–2.48 (m, 1H), 2.44 (s, 4H), 2.31 (dd, <i>J</i> = 12.4, 6.7 Hz, 1H), 1.23 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec5_2_2_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40">5.2.2.2.18 <i>N</i>-(1-morpholinopropan-2-yl)-6-(8-(pyridin-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)benzo[d]thiazol-2-amine (<b>30</b>)</h5><div class="NLM_p last">Acetic acid (0.60 mL, 10 mmol, 37 equiv), H<sub>2</sub>O (0.60 mL, 33 mmol, 118 equiv) and Fe (157 mg, 2.8 mmol, 10 equiv) were added to a solution of <b>21</b> (153 mg, 0.28 mmol, 1.0 equiv) in THF (3 mL). The reaction mixture was heated to 60 °C for 20 min, cooled to rt and stirred for additional 2 h for the completion of the reaction. The mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and H<sub>2</sub>O (20 mL). The pH was adjusted to 11 with sat. aq. K<sub>2</sub>CO<sub>3</sub> soln. and the layers were separated. The aq. phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL) and the combined organics washed with H<sub>2</sub>O (20 mL) and brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure to give the crude aniline as a brown solid (155 mg). The solid was suspended in triethyl orthoformate (2.4 mL), and the mixture heated to 145 °C in a sealed vial for 30 min. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide <b>30</b> (84.0 mg, 51% over 2 steps) as a pale brown solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.61 min, 523 [M + H], UPLC-purity: 97%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.53 (s, 1H), 8.85 (s, 1H), 8.65–8.60 (m, 2H), 8.32 (d, <i>J</i> = 7.9 Hz, 1H), 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.84 (s, 1H), 7.71–7.63 (m, 4H), 4.22 (br. s, 1H), 3.58 (br. s, 4H), 2.60–2.41 (m, 4H), 2.41–2.35 (m, 2H), 1.32–1.25 (m, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.0, 154.6, 154.2, 150.8, 147.9, 147.8, 147.3, 145.8, 140.0, 139.6, 132.7, 131.9, 128.6, 125.2, 122.2, 120.9, 120.5, 118.7, 111.0, 66.7, 64.0, 54.2, 48.2, 19.5; HRMS (ESI) for C<sub>28</sub>H<sub>27</sub>ON<sub>8</sub>S [M + H] calculated 523.2023, found 523.2025.</div></div><div id="sec5_2_2_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41">5.2.2.2.19 3-nitro-6-(thiophen-2-yl)-1,7-naphthyridin-4-ol (<b>11</b>)</h5><div class="NLM_p last">Title compound <b>11</b> was obtained as a yellow solid (283 mg, 78%) by Suzuki reaction according to the <i>general Suzuki procedure 1</i> starting from <b>10</b> (400 mg, 1.8 mmol) and thiophen-2-ylboronic acid (340 mg, 2.7 mmol) with stirring at 120 °C for 1 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.71 min, 274 [M + H], UPLC-purity: 90%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.48 (br. s, 1H), 9.27 (s, 1H), 9.09 (s, 1H), 8.46 (s, 1H), 7.97 (d, <i>J</i> = 3.7 Hz, 1H), 7.70 (d, <i>J</i> = 4.9 Hz, 1H), 7.21 (dd, <i>J</i> = 5.0, 3.7 Hz, 1H).</div></div><div id="sec5_2_2_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42">5.2.2.2.20 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)-<i>N</i><sup>6</sup>-(3-nitro-6-(thiophen-2-yl)-1,7-naphthyridin-4-yl)benzo[d]thiazole-2,6-diamine (<b>22</b>)</h5><div class="NLM_p last">A suspension of the chloride 85.0 mg (0.26 mmol, 1.0 eq., 90% pure), prepared from <b>11</b> in 76% yield according to the <i>general chlorination procedure 2</i>, and triethyl amine (147 μL, 2.3 mmol, 4.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was cooled to 0 °C. A solution of <b>44</b> (85.0 mg, 0.26 mmol) was added and the resulting red solution was stirred for 1 h at rt. The reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and H<sub>2</sub>O (15 mL), the layers were separated and the organic layer washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–5% MeOH) to provide the title compound <b>22</b> as an orange solid (84.0 mg, 54%). UPLC-MS <i>t</i><sub>R,B</sub>: 0.89 min, 548 [M+H, UPLC-purity: 93%]; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.35 (s, 1H), 9.25 (s, 1H), 9.02 (s, 1H), 8.72 (s, 1H), 8.00 (s, 1H), 7.70 (d, <i>J</i> = 5.0 Hz, 1H), 7.66 (d, <i>J</i> = 3.6 Hz, 1H), 7.58 (s, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 7.21 (dd, <i>J</i> = 5.0, 3.7 Hz, 1H), 7.12–7.05 (m, 1H), 4.15–4.03 (m, 1H), 3.56 (t, <i>J</i> = 4.6 Hz, 4H), 2.47–2.37 (m, 5H), 2.31 (dd, <i>J</i> = 12.4, 6.6 Hz, 1H), 1.22 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec5_2_2_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43">5.2.2.2.21 <i>N</i>-(1-morpholinopropan-2-yl)-6-(8-(thiophen-2-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)benzo[d]thiazol-2-amine (<b>31</b>)</h5><div class="NLM_p last">Acetic acid (0.30 mL, 5.3 mmol, 37 equiv), H<sub>2</sub>O (0.30 mL, 16 mmol, 118 equiv) and Fe (80.0 mg, 1.4 mmol, 10 equiv) were added to a solution of <b>22</b> (84.0 mg, 0.14 mmol, 1.0 equiv) in THF (1.5 mL). The mixture was heated to 60 °C for 30 min, cooled to rt and partitioned between CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and H<sub>2</sub>O (10 mL). The pH was adjusted to 11 with sat. aq. K<sub>2</sub>CO<sub>3</sub> soln. and the layers were separated. The aq. phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL) and the combined organics washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure to give the crude aniline as brown solid (72 mg). The solid was suspended in triethyl orthoformate (1.5 mL), and the mixture heated to 145 °C in a sealed vial. The reaction mixture was cooled to rt and the volatiles were removed <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> to provide the title compound <b>31</b> (22.0 mg, 29% over 2 steps) as a beige solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.73 min, 528 [M + H], UPLC-purity: 99%; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.43 (d, <i>J</i> = 0.9 Hz, 1H), 9.42 (s, 1H), 8.79 (s, 1H), 8.28 (s, 1H), 8.19 (d, <i>J</i> = 2.1 Hz, 1H), 7.70–7.64 (m, 2H), 7.63 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 7.58 (s, 1H), 7.12–7.08 (m, 2H), 4.29–4.14 (m, 1H), 3.58 (s, 4H), 2.58–2.42 (m, 5H), 2.42–2.35 (m, 1H), 1.33–1.22 (m, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.03, 154.6, 153.8, 147.1, 146.8, 146.4, 144.4, 140.0, 138.8, 132.4, 131.9, 129.1, 128.9, 128.6, 125.1, 124.5, 122.4, 120.4, 118.5, 107.4, 66.8, 64.04, 54.2, 48.2, 19.5. HRMS (ESI) for C<sub>27</sub>H<sub>26</sub>ON<sub>7</sub>S<sub>2</sub> [M + H] calculated 528.1635, found 528.1636.</div></div><div id="sec5_2_2_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44">5.2.2.2.22 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)-<i>N</i><sup>6</sup>-(3-nitro-6-(pyridin-4-yl)-1,7-naphthyridin-4-yl)quinoline-2,6-diamine (<b>23</b>)</h5><div class="NLM_p last">To a solution of the chloride 134 mg (0.77 mmol, 1.0 eq., 94% pure), prepared from <b>14</b> according to the <i>general chlorination procedure 2</i>, in DMF (6 mL), were added <b>47</b> (219 mg, 0.99 mmol) and 4 M HCl in dioxane (23 μL, 0.090 mmol). The reaction mixture was stirred overnight at rt, quenched with aq. sat NaHCO<sub>3</sub> and concentrated <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide the title compound <b>23</b> as an orange solid (163 mg, 40%). UPLC-MS <i>t</i><sub>R,B</sub>: 0.68 min, 537 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, 1H), 9.47 (s, 1H), 9.15 (s, 1H), 9.08 (d, <i>J</i> = 1.5 Hz, 1H), 8.74 (d, <i>J</i> = 5.2 Hz, 2H), 8.09 (d, <i>J</i> = 5.7 Hz, 2H), 7.81 (d, <i>J</i> = 8.9 Hz, 1H), 7.58–7.45 (m, 2H), 7.37 (d, <i>J</i> = 8.9 Hz, 1H), 6.94 (br. s, 1H), 6.81 (d, <i>J</i> = 8.9 Hz, 1H), 4.49–4.27 (m, 1H), 3.59 (br. s, 4H), 2.53–2.44 (m, 5H), 2.36–2.22 (m, 1H), 1.24 (d, <i>J</i> = 6.5 Hz, 3H).</div></div><div id="sec5_2_2_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45">5.2.2.2.23 <i>N</i>-(1-morpholinopropan-2-yl)-6-(8-(pyridin-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)quinolin-2-amine (<b>32</b>)</h5><div class="NLM_p last">SnCl<sub>2</sub> dihydrate (210 mg, 0.91 mmol, 3.0 equiv) was added to a solution of <b>23</b> (163 mg, 0.30 mmol) in conc. HCl (5 mL) and the mixture was stirred for 2.5 h at rt. The mixture was cooled to 0 °C and the pH adjusted to 11 with 30% aq. NaOH. The mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and H<sub>2</sub>O (20 mL), the layers were separated and the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub> containing 1% NH<sub>4</sub>OH and MeOH (0–15% MeOH) to provide the aniline as yellow solid (111 mg). This material was suspended in triethyl orthoformate (4 mL) and the mixture was heated in a sealed microwave vial to 150 °C for 1.5 h. The reaction mixture was cooled to rt and the volatiles were removed <i>in vacuo</i>. The residue was slurried in CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether 2:3 (12.5 mL) for 1 h at rt, the solid was filtered and the filter cake was washed with CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether 2:3 (2 × 2 mL). This material was further purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–20% MeOH) to provide <b>32</b> (49.0 mg, 42% over 2 steps) as a pale yellow solid. UPLC-MS <i>t</i><sub>R,B</sub>: 0.56 min, 517 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.62 (d, <i>J</i> = 1.4 Hz, 1H), 9.56 (s, 1H), 8.90 (s, 1H), 8.60–8.54 (m, 2H), 8.17 (d, <i>J</i> = 2.5 Hz, 1H), 8.01 (d, <i>J</i> = 9.0 Hz, 1H), 7.89 (d, <i>J</i> = 2.5 Hz, 1H), 7.86–7.79 (m, 2H), 7.64–7.55 (m, 2H), 7.26 (d, <i>J</i> = 7.7 Hz, 1H), 6.97 (d, <i>J</i> = 9.0 Hz, 1H), 4.51 (d, <i>J</i> = 9.4 Hz, 1H), 3.66–3.56 (m, 4H), 2.63–2.53 (m, 5H), 2.36 (dd, <i>J</i> = 11.8, 6.7 Hz, 1H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.1, 154.2, 150.7, 149.1, 148.0, 147.3, 145.7, 140.1, 139.6, 136.6, 132.6, 128.6, 127.9, 127.4, 126.3, 123.2, 122.2, 120.8 × 2, 115.4, 111.0, 66.7, 64.5, 54.3, 43.4, 19.6; HRMS (ESI) for C<sub>30</sub>H<sub>29</sub>ON<sub>8</sub> [M + H] calculated 517.2459, found 517.2458.</div></div><div id="sec5_2_2_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46">5.2.2.2.24 (<i>R</i>)-<i>N</i>-(1-morpholinopropan-2-yl)-6-(8-(pyridin-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)quinolin-2-amine (<b>33</b>)</h5><div class="NLM_p">The title compound (47.0 mg, 93%, 99.5% ee) was obtained as a colorless solid by chiral preparative HPLC of racemic <b>32</b> (100 mg). <i>t</i><sub>R, chiral</sub>: 18.7 min; UPLC-MS <i>t</i><sub>R,B</sub>: 0.59 min, 517 [M + H], UPLC-purity: 99%; <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>) δ 9.64 (s, 1H), 9.51 (s, 1H), 8.58–8.51 (m, 2H), 8.27 (s, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.86 (d, <i>J</i> = 9.0 Hz, 1H), 7.81 (d, <i>J</i> = 2.6 Hz, 2H), 7.69 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.61–7.55 (m, 2H), 6.83 (d, <i>J</i> = 8.9 Hz, 1H), 5.55 (br. s, 1H), 4.35 (br. s, 1H), 3.79–3.63 (m, 4H), 2.68–2.57 (m, 3H), 2.56–2.44 (m, 3H), 1.43 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p last">The absolute configuration of <b>33</b> was unambiguously assigned by independent synthesis starting from (<i>R</i>)-1-morpholinopropan-2-amine (prepared in 3 steps from commercially available (<i>R</i>)-<i>tert</i>-butyl (1-hydroxypropan-2-yl)carbamate according to literature procedure and comparing the chiral HPLC retention times.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_2_2_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47">5.2.2.2.25 (S)-N-(1-morpholinopropan-2-yl)-6-(8-(pyridin-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-1-yl)quinolin-2-amine (<b>34</b>)</h5><div class="NLM_p last">The title compound (48 mg, 94%, 99.7% ee) was obtained as colorless solid by chiral preparative HPLC of racemic <b>32</b> (100 mg). <i>t</i><sub>R, chiral</sub>: 23.9 min; UPLC-MS <i>t</i><sub>R,B</sub>: 0.59 min, 517 [M + H], UPLC-purity: 98%; <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>) δ 9.68 (d, <i>J</i> = 0.7 Hz, 1H), 9.53 (s, 1H), 8.60–8.52 (m, 2H), 8.28 (s, 1H), 7.97 (d, <i>J</i> = 8.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.83 (d, <i>J</i> = 2.4 Hz, 2H), 7.70 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.61 (dd, <i>J</i> = 4.6, 1.5 Hz 2H), 6.85 (d, <i>J</i> = 8.9 Hz, 1H), 5.69 (br. s, 1H), 4.41 (br. s, 1H), 3.85–3.60 (m, 4H), 2.69 (br. s, 3H), 2.63–2.45 (m, 3H), 1.44 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec5_2_2_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48">5.2.2.2.26 <i>N</i><sup>2</sup>-(2-morpholinoethyl)benzo[d]thiazole-2,6-diamine (<b>40</b>)</h5><div class="NLM_p last">A solution of 2-chlorobenzo[d]thiazol-6-amine (250 mg, 1.35 mmol), 2-morpholinoethanamine (881 mg, 6.8 mmol, 5 equiv) and triethylamine (0.94 mL, 6.8 mmol) in abs. dioxane (2.4 mL) was heated in a sealed microwave vial for 24 h at 130 °C. The reaction mixture was cooled to rt, concentrated under reduced pressure and the residue partitioned between H<sub>2</sub>O (20 mL) and ethyl acetate (20 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated <i>in vacuo</i>. The crude product was purified by flash chromatography on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0–10% MeOH) to provide the title compound (300 mg, 80%) as a pale yellow solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.32 min, 279 [M + H], UPLC-purity 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41 (t, <i>J</i> = 5.5 Hz, 1H), 7.06 (d, <i>J</i> = 8.5 Hz, 1H), 6.80 (d, <i>J</i> = 2.2 Hz, 1H), 6.48 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 4.76 (s, 2H), 3.56 (t, <i>J</i> = 4.6 Hz, 4H), 3.39 (q, <i>J</i> = 6.4 Hz, 2H), 2.55–2.44 (m, 2H), 2.39 (t, <i>J</i> = 4.7 Hz, 4H).</div></div><div id="sec5_2_2_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49">5.2.2.2.27 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)-6-nitrobenzo[d]thiazol-2-amine (<b>43</b>)</h5><div class="NLM_p last">1-Morpholinopropan-2-amine (5.38 g, 37 mmol) were added to a mixture of 2-chloro-6-nitrobenzo[d]thiazole (4.00 g, 19 mmol) and K<sub>2</sub>CO<sub>3</sub> (5.15 g, 37 mmol, 2.0 equiv) in abs. DMF (130 mL). The mixture was stirred at rt for 1h. The reaction mixture was filtered through a pad of <i>Celite</i> and the filtrate was concentrated under reduced pressure. The residue was purified by FC on SiO<sub>2</sub> eluting with ethyl acetate/cyclohexane 1:1 to provide <b>40</b> (5.65 g, 94%) as yellow solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.63 min, 323 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 2.7 Hz, 1H), 8.08 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.42 (d, <i>J</i> = 8.9 Hz, 1H), 4.14 (br. s, 1H), 3.51 (t, <i>J</i> = 4.7 Hz, 4H), 2.50–2.35 (m, 6H), 2.31 (dd, <i>J</i> = 12.4, 6.3 Hz, 1H), 1.20 (d, <i>J</i> = 6.5 Hz, 3H).</div></div><div id="sec5_2_2_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50">5.2.2.2.28 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)benzo[d]thiazole-2,6-diamine (<b>44</b>)</h5><div class="NLM_p last">Raney-Ni (399 mg) was added to a suspension of <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)-6-nitrobenzo[d]thiazol-2-amine <b>40</b> (1.50 g, 4.6 mmol) in MeOH (8 mL) and the mixture was stirred under H<sub>2</sub> (1 atm.) at rt for 18 h. The reaction mixture was filtered through a pad of <i>Celite</i>, the filter cake washed with MeOH (2 × 3 mL) and the filtrate concentrated <i>in vacuo</i>. The residue was purified by FC on SiO<sub>2</sub> eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0 to 10% MeOH) to give <b>41</b> (1.04 g, 76%) as an orange solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.35 min, 293 [M + H], UPLC-purity: 98%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.33 (d, <i>J</i> = 7.7 Hz, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 2.2 Hz, 1H), 6.48 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 4.77 (s, 1H), 4.02–3.90 (m, 1H), 3.53 (t, <i>J</i> = 4.5 Hz, 4H), 2.47–2.33 (m, 6H), 2.24 (dd, <i>J</i> = 12.3, 6.9 Hz, 1H), 1.15 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec5_2_2_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51">5.2.2.2.29 <i>N</i>-(1-morpholinopropan-2-yl)-6-nitroquinolin-2-amine (<b>46</b>)</h5><div class="NLM_p last">A mixture of 2-chloro-6-nitro-quinoline (10.0 g, 48 mmol), 1-morpholinopropan-2-amine (9.33 g, 65 mmol, 1.3 equiv) and K<sub>2</sub>CO<sub>3</sub> (16.6 g, 0.12 mol, 2.5 equiv) in anhydrous dioxane (120 mL) was stirred under reflux for 20 h. The reaction mixture was cooled to rt and partitioned between ethyl acetate (200 mL) and H<sub>2</sub>O (200 mL) and the layers were separated. The aq. phase was extracted with ethyl acetate (1 × 200 mL) and the combined organics were washed with sat. aq. NaHCO<sub>3</sub> soln. (1 × 200 mL) and brine (1 × 200 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The crude material was recrystallized from ethyl acetate/diethyl ether/petrolether to give the title compound (11.9 g, 78%) as a pale yellow solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.64 min, 317 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (d, <i>J</i> = 2.7 Hz, 1H), 8.20 (dd, <i>J</i> = 9.2, 2.7 Hz, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.51 (d, <i>J</i> = 9.2 Hz, 1H), 6.90 (d, <i>J</i> = 9.0 Hz, 1H), 4.48–4.38 (m, 1H), 3.53 (t, <i>J</i> = 4.6 Hz, 4H), 2.53–2.41 (m, 5H), 2.28 (dd, <i>J</i> = 12.2, 6.9 Hz, 1H), 1.21 (d, <i>J</i> = 6.5 Hz, 3H).</div></div><div id="sec5_2_2_2_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52">5.2.2.2.30 <i>N</i><sup>2</sup>-(1-morpholinopropan-2-yl)quinoline-2,6-diamine (<b>47</b>)</h5><div class="NLM_p last">10% Pd/C (801 mg, 0.02 equiv) was added to a solution of <i>N</i>-(1-morpholinopropan-2-yl)-6-nitroquinolin-2-amine (<b>46</b>) (11.9 g, 4.6 mmol) in MeOH/THF 1:1 (250 mL) and the mixture was stirred under H<sub>2</sub> (1 atm.) at rt for 2.5 h. The reaction mixture was filtered through a pad of <i>Celite</i>, the filter cake washed with MeOH (2 × 20 mL) and the filtrate concentrated <i>in vacuo</i> to give the title compound as a yellow foam which was used without further purification. UPLC-MS <i>t</i><sub>R,A</sub>: 0.35 min, 287 [M + H], UPLC-purity: 97%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.64 (d, <i>J</i> = 2.5 Hz, 1H), 6.60 (d, <i>J</i> = 8.9 Hz, 1H), 6.21 (d, <i>J</i> = 7.5 Hz, 1H), 4.88 (s, 2H), 4.22 (p, <i>J</i> = 6.8 Hz, 1H), 3.55 (t, <i>J</i> = 4.7 Hz, 4H), 2.53–2.34 (m, 5H), 2.21 (dd, <i>J</i> = 12.0, 7.4 Hz, 1H), 1.16 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec5_2_2_2_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53">5.2.2.2.31 <i>N</i>-(1H-benzo[d]imidazol-6-yl)-6-chloro-3-nitro-1,7-naphthyridin-4-amine (<b>48</b>)</h5><div class="NLM_p last">The crude chloride (5.50 g, 24.4 mmol, 1.0 equiv), prepared from <b>10</b> in 76% yield according to <i>general chlorination procedure 1</i>, was dissolved in anhydrous DMF (275 mL) and 4 N HCl in dioxanes (0.64 μL, 24.4 mmol, 1.0 equiv) and 5-aminobenzimidazole (4.96 g, 37.2 mmol, 1.5 equiv) were added. The mixture was stirred at rt for 2.5 h and then poured onto a mixture of ice water and EtOAc/Et<sub>2</sub>O 1:1 (200 mL). The precipitated solid was filtered, washed with H<sub>2</sub>O (50 mL) and diethyl ether (2 × 50 mL) and dried under reduced pressure. The title compound <b>48</b> was obtained as brown solid (4.19 g, 50%). UPLC-MS <i>t</i><sub>R,B</sub>: 0.66 min, 341 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.46 (br, s, 1H), 10.39 (s, 1H), 9.15 (s, 1H), 9.07 (s, 1H), 8.46 (br, s, 1H), 8.22 (s, 1H), 7.56 (br, s, 1H), 7.36 (br, s, 1H), 7.01 (s, 1H).</div></div><div id="sec5_2_2_2_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54">5.2.2.2.32 1-(1H-benzo[d]imidazol-6-yl)-8-chloro-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>49</b>)</h5><div class="NLM_p last">Raney-Ni (1.0 g) was added to a suspension of <i>N</i>-(1H-benzo[d]imidazol-6-yl)-6-chloro-3-nitro-1,7-naphthyridin-4-amine (<b>48</b>) (3.92 g, 11.5 mmol) in MeOH (250 mL) and the mixture was stirred under H<sub>2</sub> (1 atm.) at rt for 18 h. The reaction mixture was filtered through a pad of <i>Celite</i>, the filter cake washed with MeOH (2 × 60 mL) and the filtrate concentrated <i>in vacuo</i> to provide the aniline (3.13 g) as brown solid which was used for the next step without further purification. The crude material was taken up in EtOH (60 mL) and triethyl orthoformate (16.1 mL, 97 mmol, 10 equiv) and conc. HCl (0.83 mL, 1.0 equiv) were added before the mixture was heated in a sealed microwave vial to 145 °C for 1 h. The reaction mixture was cooled to rt and the volatiles removed <i>in vacuo</i>. Resulting solid was taken up in MeOH (20 mL) and pH adjusted to 12 using ammonia. Resulting solution was evaporated under reduced pressure to provide title compound <b>49</b> (1.71 g, 46% over 2 steps) as beige solid. UPLC-MS <i>t</i><sub>R,A</sub>: 0.58 min, 321 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.91 (br, s, 1H), 9.49 (s, 1H), 9.31 (s, 1H), 8.79 (s, 1H), 8.48 (s, 1H), 8.05 (s, 1H), 7.89 (d, <i>J</i> = 1.6, 1H), 7.56 (d, <i>J</i> = 2.0 Hz, 1H), 7.08 (s, 1H).</div></div><div id="sec5_2_2_2_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55">5.2.2.2.33 1-(1H-benzo[d]imidazol-6-yl)-8-(thiophen-3-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>50</b>)</h5><div class="NLM_p last">Title compound <b>50</b> was obtained as a yellow solid (51.0 mg, 30%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (150 mg, 0.47 mmol) and thiophen-2-ylboronic acid (78.0 mg, 0.61 mmol) with stirring for 1.5 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.77 min, 369 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (s, 1H), 9.43 (s, 1H), 9.08 (s, 1H), 8.80 (s, 1H), 8.26 (s, 1H), 8.09 (d, <i>J</i> = 8.6 Hz, 1H), 7.82 (m, 2H), 7.55 (m, 1H), 7.44 (s, 1H), 7.06 (d, <i>J</i> = 6.3 Hz, 1H).</div></div><div id="sec5_2_2_2_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56">5.2.2.2.34 1-(1H-benzo[d]imidazol-6-yl)-8-phenyl-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>51</b>)</h5><div class="NLM_p last">Title compound <b>51</b> was obtained as a yellow solid (4.60 mg, 31%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (13.0 mg, 0.041 mmol) and phenylboronic acid (5.90 mg, 0.049 mmol) with stirring for 40 min. UPLC-MS <i>t</i><sub>R,B</sub>: 0.72 min, 363 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (br, 1H), 9.52 (s, 1H), 9.45 (s, 1H), 8.80 (s, 1H), 8.50 (s, 1H), 8.16–7.84 (m, 3H), 7.61–7.50 (m, 4H), 7.33 (ss, 2H).</div></div><div id="sec5_2_2_2_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57">5.2.2.2.35 1-(1H-benzo[d]imidazol-6-yl)-8-(p-tolyl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>52</b>)</h5><div class="NLM_p last">Title compound <b>52</b> was obtained as a yellow solid (27.0 mg, 30%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (80.0 mg, 0.249 mmol) and 3-methyl-phenylboronic acid (44.1 mg, 0.324 mmol) with stirring for 1.5 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.76 min, 377 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 9.45 (s, 1H), 9.03 (s, 1H), 8.81 (s, 1H), 8.26 (s, 1H), 8.08 (d, <i>J</i> = 8.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.6 Hz, 1H), 7.54–7.51 (m, 3H), 7.15 (d, <i>J</i> = 8.2 Hz, 2H).</div></div><div id="sec5_2_2_2_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58">5.2.2.2.36 1-(1H-benzo[d]imidazol-6-yl)-8-(m-tolyl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>53</b>)</h5><div class="NLM_p last">Title compound <b>53</b> was obtained as a yellow solid (20.0 mg, 21%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (80.0 mg, 0.249 mmol) and 2-methyl-phenylboronic acid (44.1 mg, 0.324 mmol) with stirring for 2 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.76 min, 377 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 9.46 (s, 1H), 8.88 (s, 1H), 8.83 (s, 1H), 8.24 (s, 1H), 8.06 (d, <i>J</i> = 8.2 Hz, 1H), 7.76 (d, <i>J</i> = 6.6 Hz, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.48 (s, 1H), 7.30 (s, 1H), 7.24 (t, <i>J</i> = 6.8 Hz, 1H), 7.15 (d, <i>J</i> = 7.8 Hz, 1H).</div></div><div id="sec5_2_2_2_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59">5.2.2.2.37 1-(1H-benzo[d]imidazol-6-yl)-8-(pyridin-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>54</b>)</h5><div class="NLM_p last">Title compound <b>54</b> was obtained as a yellow solid (19.0 mg, 21%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (80.0 mg, 0.249 mmol) and 4-pyridinylboronic acid (44.0 mg, 0.324 mmol) with stirring for 2 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.55 min, 364 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 10.11 (s, 1H), 9.96 (s, 1H), 9.78 (s, 1H), 9.19 (s 1H), 8.97 (d, <i>J</i> = 6.3 Hz, 2H), 8.61 (s, 1H), 8.52 (d, <i>J</i> = 6.3 Hz, 2H), 8.37 (d, <i>J</i> = 8.2 Hz, 1H), 8.30 (s, 1H), 8.20 (d, <i>J</i> = 8.2 Hz, 1H).</div></div><div id="sec5_2_2_2_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60">5.2.2.2.38 1-(1H-benzo[d]imidazol-6-yl)-8-(pyridin-3-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>55</b>)</h5><div class="NLM_p last">Title compound <b>55</b> was obtained as a yellow solid (11.0 mg, 12%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (80.0 mg, 0.249 mmol) and 3-pyridinylboronic acid (43.0 mg, 0.324 mmol) with stirring for 2 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.56 min, 364 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.56 (s, 1H), 9.48 (s, 1H), 8.82 (s, 1H), 8.68 (s 1H), 8.52 (d, <i>J</i> = 6.3 Hz, 1H), 8.49 (s, 1H), 8.11 (s, 1H), 7.95 (d, <i>J</i> = 8.6 Hz, 1H), 7.65–7.63 (m, 3H), 7.42 (s, 1H).</div></div><div id="sec5_2_2_2_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61">5.2.2.2.39 4-(1-(1H-benzo[d]imidazol-6-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridin-8-yl)isothiazole (<b>56</b>)</h5><div class="NLM_p last">Title compound <b>56</b> was obtained as a yellow solid (4.60 mg, 4%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (100 mg, 0.312 mmol) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isothiazole (114 mg, 0.405 mmol) with stirring for 1.5 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.61 min, 370 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.93 (br, s, 1H), 9.49 (s, 1H), 9.45 (s, 1H), 9.12 (s, 1H), 8.80 (s, 1H), 8.49 (s 1H), 8.46 (s, 1H), 8.13–7.92 (m, 2H), 7.62 (d, <i>J</i> = 8.6 Hz, 1H), 7.52 (s, 1H).</div></div><div id="sec5_2_2_2_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62">5.2.2.2.40 1-(1H-benzo[d]imidazol-6-yl)-8-(1H-pyrazol-4-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>57</b>)</h5><div class="NLM_p last">Title compound <b>57</b> was obtained as a yellow solid (15.0 mg, 35%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (40.0 mg, 0.125 mmol) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (34.0 mg, 0.175 mmol) with stirring for 1 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.51 min, 353 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.40 (s, 1H), 9.37 (s, 1H), 8.80 (s, 1H), 8.77 (s, 1H), 8.16 (s 1H), 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 8.6 Hz, 1H), 7.68 (br, s, 2H), 7.22 (s, 1H).</div></div><div id="sec5_2_2_2_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63">5.2.2.2.41 1-(1H-benzo[d]imidazol-6-yl)-8-(cyclohex-1-en-1-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>58</b>)</h5><div class="NLM_p last">Title compound <b>58</b> was obtained as a yellow solid (45.0 mg, 49%) according to the <i>general Suzuki procedure 2</i> starting from <b>49</b> (80.0 mg, 0.249 mmol) and cyclohexenyl-1-boronic acid (41.0 mg, 0.324 mmol) with stirring for 1 h. UPLC-MS <i>t</i><sub>R,B</sub>: 0.74 min, 367 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 1H), 9.37 (s, 1H), 8.95 (s, 1H), 8.76 (s, 1H), 8.19 (s 1H), 8.02 (d, <i>J</i> = 8.6 Hz, 1H), 7.72 (d, <i>J</i> = 8.6 Hz, 1H), 7.03 (s, 1H), 6.80 (s, 1H), 2.12 (s, 2H), 2.48 (br, s, 2H), 1.51 (br, s, 4H).</div></div><div id="sec5_2_2_2_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64">5.2.2.2.42 1-(1H-benzo[d]imidazol-6-yl)-8-(piperidin-1-yl)-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>59</b>)</h5><div class="NLM_p last">1-(1H-benzo[d]imidazol-6-yl)-8-chloro-1H-imidazo[4,5-<i>c</i>][1,7]naphthyridine (<b>49</b>) (80.0 mg, 0.249 mmol) and piperidine (7 mL) were stirred at 160 °C for 6 h. The mixture was cooled to rt, filtered through a pad of <i>Celite</i>, the filter cake washed with EtOH (2x). The reaction mixture cooled to rt and concentrated in vacuo. Title compound <b>59</b> was obtained as a beige solid (61.9 mg, 67%) after purification by prep HPLC (Waters; column Sunfire C18 5 μm, 30 mm × 100 mm; A, water +0.1% TFA; B, acetonitrile +0.1% TFA; 5–25% B in 16 min. UPLC-MS <i>t</i><sub>R,B</sub>: 0.70 min, 370 [M + H], UPLC-purity: 100%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.85 (br, s, 1H), 9.03 (s, 2H), 8.62 (s, 1H), 8.44 (s, 1H), 7.98 (s, 1H), 7.85 (s 1H), 7.51 (d, <i>J</i> = 8.6 Hz, 1H), 6.03 (s, 1H), 3.13 (s, 4H), 1.47 (s, 2H), 1.29 (s, 4H).</div></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65">5.3 Biology</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">5.3.1 Protein Production, Crystallization, and Structure Elucidation</h4><div class="NLM_p">All chemicals, unless stated otherwise, were bought from Sigma-Aldrich. The kinase domain of human COT encompassing amino acids 66 to 395 was overexpressed in Sf21 cells and purified according to procedures described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">COT.<b>28</b> complex was concentrated to 3.5 mg/mL using an Amicon Ultra centrifugal filter with 10K molecular weight cutoff (Millipore) before crystallization by vapor diffusion. Hanging drops consisting of an equal ratio of complex to reservoir solution (1 μL) were set up and equilibrated against 500 μL reservoir solution containing 0.1 M Bis-Tris pH 7, 1.7 M ammonium sulfate, 0.01 M proline in a 24-well VDX plate (Hampton Research) at room temperature. Crystals grew within 2 days and were quickly dipped into a reservoir solution containing 10% glycerol before flash-freezing them in liquid nitrogen.</div><div class="NLM_p last">Diffraction data were collected at 100 K at the Swiss Light Source beamline X10SA at 1.0 Å wavelength. Diffraction images were recorded on a Pilatus 6 M pixel detector (Dectris) and processed and scaled with XDS and XSCALE respectively (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Table 1 in the Supporting Information</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The structure was solved by molecular replacement with Phaser using 4y85.pdb as search model.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The structure was built using COOT and refined with BUSTER to Rwork =23.3% and Rfree =25.8%. 96.6% of all the residues in the structure are in the favored and 0.3% in the outlier regions of the Ramachandran plot.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> PyMOL was used for structural visualization and figure preparation.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">5.3.2 Biotransformation and Pharmacokinetic Investigations</h4><div class="NLM_p">The origin of the chemical and reagents used as well as the experimental conditions used for the analyses of the samples for the investigation of the biotransformation, the isolation of a metabolite as well as for the pharmacokinetic parameters are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec5_3_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68">5.3.2.1 Animals</h5><div class="NLM_p last">Male wild-type Sprague–Dawley rats (Iffa Credo, France) were kept under standard cages and conditions according to Swiss Animal Welfare guidelines (12h light/dark cycles, room temperature at 22–24 °C, humidity at least 45% but <70%) with free access to Ringer solution (glucose 5%, NaCl 0.9% and KCl 0.5%) and pelleted rodent chow. Adult male beagle dogs (originating from Marshall Farms at Montichiari, Italy) from the permanent MAP/DMPK stock were kept under standard conditions in dog pens according to Swiss Animal Welfare guidelines (standard dog chow once daily, free access to tap water throughout the study).</div></div><div id="sec5_3_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69">5.3.2.1.1 In vivo pharmacokinetic studies in rats</h5><div class="NLM_p last">96–120 h before administration of the test substance, the animals were anesthetized with isoflurane and catheters were surgically implanted under aseptic precautions (use of sterile instruments and surgical material in combination with local antibiotic prophylaxis) into the femoral artery and vein. The catheters were exteriorized in the neck region, connected to a Harvard swivel system (Harvard Instruments) and filled with 0.9% saline containing 100 U·mL<sup>–1</sup> heparin. After recovery from anesthesia the animals were housed individually in special cages with free access to food and tap water until and throughout the experiment. Analgesic treatment with Temgesic (10 μg/kg s.c., application volume 1 mL/kg) was performed in the evening following surgery and in the next morning. Compound administration was in the morning (6–8 AM). Blood samples were collected at various time points from the femoral artery catheter into Eppendorf tubes coated with sodium EDTA. Blood samples were immediately frozen at −20 °C until final processing (maximum storage was 8 days). Intravenous and oral dosing was performed in the same animals after a 48 h wash-out interval between the single dose applications. The test substance was administered intravenously as a solution in 1-methyl-2-pyrrolidone and polyethylene glycol 200 (30:70, v/v) at a dose of 1 mg/kg and orally as a homogeneous aqueous suspension in Tween 80 and carboxy methyl cellulose sodium 0.5/0.5/99 (w/w) at a dose of 3 mg/kg.</div></div><div id="sec5_3_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70">5.3.2.1.2 In vivo pharmacokinetic studies in dogs</h5><div class="NLM_p last">The dogs were fasted 12 h before dosing and then fed 2 h post dose. Compound administration was done in a cassette dosing format of five compounds and in the morning (7–8 AM). Intravenous and oral dosing was performed in different animals. The test substance were administered intravenously as a solution in 1-methyl-2-pyrrolidone and polyethylene glycol 200 (10:90, v/v) at a dose of 0.1 mg/kg and orally as a homogeneous aqueous suspension in Tween 80 and carboxy methyl cellulose sodium 0.5/0.5/99 (w/w) at a dose of 0.3 mg/kg.</div></div><div id="sec5_3_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71">5.3.2.1.3 In vivo metabolism investigation in bile-duct cannulated rat</h5><div class="NLM_p">The cannulation of the bile duct as well as of the blood vessels were performed under general anesthesia and aseptic conditions (sterile foil covering the animal, sterile instruments and material, and with gloves, coat and mask for the surgeon). After shaving, washing and disinfecting its neck, abdomen and inguinal areas, the anaesthetized rat was placed under the binocular microscope on a heating pad. For cannulation of the bile duct, a middle abdominal incision of 2–3 cm was made posterior to the xiphoid cartilage. The bile duct was then dissected and exposed. For collection of the bile, a disinfected indwelling catheter (polyethylene tubing 0.28 mm i.d., 0.61 mm o.d.) was inserted into the duct near the hilum of the liver and then pushed toward the liver. The catheter was secured with 2 ligatures. For cannulation of the blood vessels (femoral artery and vein), a small incision (about 1 cm) was made in the inguinal region and the vessels were dissected, exposed and isolated. Then disinfected indwelling catheters (polyethylene tubing 0.28 mm i.d., 0.61 mm o.d.) were inserted over 10–20 mm and secured with silk threads. Patency was verified by withdrawal of a small amount of blood and flushing with saline. All catheters were passed under the skin using a stainless steel trocar needle to emerge at the dorsal neck region. For recovery (24 h only, as bile loss and bile salt depletion start at cannulation), the animal was placed in a metabolic cage and was connected to the freely moving system (a balanced arm and a tether connected to mesh sutured to the skin or to a special harness to lead the catheters to the liquid swivel through the inner ring of a metal spring). Bile collection started immediately after the surgery (as the bile flow is continuous). The end of the catheter was below the level of the animal during bile collection to aid flow by gravity. About 24 h after surgery, the test substance was administered intravenously via the femoral vein catheter.</div><div class="NLM_p">During 8 h after drug administration, bile and urine were collected quantitatively (i.e., volumes are recorded) at predefined intervals, without disturbing the animal. Moreover 1, 4, and 8 h postdose, blood samples were collected via the catheter implanted into the femoral artery. Tissues, liver and kidney were collected at the necropsy 8 h post dose.</div><div class="NLM_p last">Intravenous administration of the test substance was performed in a solution in 1-methyl-2-pyrrolidone (NMP)/polyethylene glycol 200 (30/70, v/v) at a dose of 3 mg/kg.</div></div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">5.3.3 In vitro pharmacological assays</h4><div id="sec5_3_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73">5.3.3.1 In vitro COT kinase assay</h5><div class="NLM_p last">The assay was performed in 384 well microtiter plates using automated liquid dispensing. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 μL per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 10 mM beta-glycerophosphate, and 10 μM sodium orthovanadate, 14 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, 306 μM ATP, 4 μM peptide (5-Fluo-Ahx-AGAGSGQLIDSNleANSFVGTR-NH2, Biosyntan GmbH) and 4.5 μL per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 10 mM beta-glycerophosphate, and 10 μM sodium orthovanadate, 14 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, 17 nM MAP3K8/COT (MAP3K8 (30-404), produced in-house). Kinase reactions were incubated at 30 °C for 60 min and subsequently terminated by addition of 16 μL per well of stop solution (100 mM HEPES pH 7.5, 5%DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Plates with terminated kinase reactions were transferred to the Caliper LC3000 workstations for reading. Phosphorylated and unphosphorylated peptides were separated and quantified using the Caliper microfluidic mobility shift technology.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec5_3_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74">5.3.3.2 Analysis of pERK in A431 cells</h5><div class="NLM_p last">The human epidermoid carcinoma cell line A431 (ATCC No.: CRL-1555) was cultivated in DMEM high glucose supplemented with 10% heat inactivated fetal FCS and of 1% sodium pyruvate. For RPA experiments 200 μL cell suspension of 450.000 A431 cells/mL were seeded in 96well plates and grown in full medium for 24 h. Then cells were starved for 16 h in 50 μL serum free culture medium containing 0.1% (w/v) BSA (starvation medium). The starved cells were treated with serial dilutions of compounds for 60 min (37 °C, 5% CO<sub>2</sub>) followed by stimulation with EGF or TNFα (100 ng/mL) for 10 min at 37 °C. Phosphorylation of ERK1/2 was detected using reverse phase protein arrays as described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec5_3_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75">5.3.3.3 LPS-induced pERK, p-p65 production in human PBMCs</h5><div class="NLM_p">All compounds were dissolved in 100% (v/v) DMSO as 10 mM stock solutions and stored at 4 °C. Serial predilutions were made from 10 mM compound solutions in 100% DMSO using a nanospotting device (Hamilton nanodispenser). Compound DMSO stock solutions resulting in the desired final concentrations per well for a full IC<sub>50</sub> curve were dispensed as 60 nl droplets into 384-well plates (8 points per IC<sub>50</sub> curve). Cells were added in a volume of 20 μL RPMI+0.5% FCS. The final concentration of DMSO was 0.3% (v/v). Plates were sealed and incubated at 37 °C for 60 min in a humidified incubator with 5% (v/v) CO<sub>2</sub>.</div><div class="NLM_p">Fresh blood from healthy individuals was obtained from the Novartis Health center. PBMCs were purified from human heparinized (100 U/mL) blood by Ficoll gradient centrifugation and resuspended in PBS containing 1% (v/v) heat-inactivated FBS (PBS/FBS). Cell number was determined by CASI (particles 5.5–40 μm) and adjusted to 7.5 × 10<sup>6</sup> cells/mL with PBS/1% FBS. Twenty μL aliquots of this cell suspension were seeded in 384-well-plate (150′000 cells/well final).</div><div class="NLM_p last">Lipopolysacharide was dissolved in RPMI at 1 mg/mL. Cells were stimulated by the addition of 5 ng/mL LPS diluted in PBS/1% FBS (5 μL/well; 1 ng/well final concentration). Plates were gently mixed, sealed and incubated at 37 °C for 12 min in a humidified incubator. Cells were fixed by addition of 25 μL/well para-formaldehyde (5% w/v final concentration) for 10 min at 37 °C (μ-Fill, BioTek Inc.). After fixation, plates were centrifuged (500<i>g</i>, 5 min) and the supernatant was removed by aspiration using a 384-well plate washer (Skatron/Embla). Plates were incubated for up to 20 h at 4 °C following addition of 85 μL/well of PBS/1% FCS. Cells were permeabilized following aspiration of buffer with the addition of 20 μL/well 1x PERM buffer (Becton Dickinson #642435) for 30 min at room temperature. Plates with permeabilized cells were centrifuged (500<i>g</i>, 5 min) followed by two washes with PBS containing 0.5% w/v BSA (PBS/BSA). Phosphorylated signaling proteins were detected with Alexa-Fluor 647-conjugated antiphospho-p65(Ser529, BD 558422) specific antibodies (1.2 μL/well) diluted in PBS/FBS. Monocytes were identified by coimmunostaining cells with a PE-conjugated anti-CD14 antibody (0.1 μL/well, Immunotools cat# 21270144X2). The two antibodies were added to the cells in a total volume of 5 μL. The cells were incubated at RT for 60 min. Plates were washed twice with PBS/BSA followed by centrifugation steps (500<i>g</i>, 5 min). Cell pellets were resuspended in 25 μL PBS/BSA and analyzed by flow cytometry within 3 h. For the detection of p-Erk, mouse αpERK1/2- Alexa647 (pT202/pY204) (BD cat# 612593) was used instead of the NFκB antibody.</div></div><div id="sec5_3_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76">5.3.3.4 LPS-induced TNFα production in human PBMCs</h5><div class="NLM_p last">The PBMC cell suspension (see above) was diluted 1:2 (3 mL cells +6 mL PBS 1%FCS) and 20 μL per well were dispensed in a 384 well plate, shaken for 10 s and incubated 1h at 37 °C. For stimulation, 5 μL of LPS 0.5 ng/mL (0.1 ng/mL fc) were added and the plate was shaken and incubated for 4 h at 37 °C. After the 4 h incubation, 10 μL of cell supernatant were transferred to a black low volume plate and mixed with 10 μL of the HTRF detection antibody mix from Cisbio (#62TNFPEC). Plates were covered with viewseal, stored overnight at 4 °C and measured the next day.</div></div><div id="sec5_3_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77">5.3.3.5 LPS-induced TNFα production in human whole blood</h5><div class="NLM_p last">Heparinized blood (25000l.E., 5 mL) was diluted 1:5 with assay medium (RPMI, 10 mM Hepes, 50 μM β-mercaptoethanol, 5% FCS) and hirudin was added in a final concentration of 1 μg/mL. 180 μL of the diluted blood was seeded into the wells of the 96-well plate, shaken for 5 s. and incubated for 30 min at 37 °C. LPS stock (1 mg/mL stock in assay medium) was diluted 1:100 in assay medium and 20 μL of LPS were added to each well to reach a final concentration of 1 μg/mL. After gentle mixing with a pipet, the plate was incubated for 3 h at 37 °C/5% CO<sub>2</sub>, the plate was centrifuged at 200 g for 2 min and 70 μL of the supernatant were transferred to a 384 V-bottom plate. Ten μL of the supernatant were transferred to a black low volume plate and mixed with 10 μL of HTRF TNFα detection mix (Cisbio assays). Plates were sealed and stored overnight at 4C and measured in a PheraStar the day after.</div></div><div id="sec5_3_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78">5.3.3.6 Uric acid-induced IL-1β production in human PBMCs</h5><div class="NLM_p last">Frozen PBMCs from one donor were thawed and seeded at a density of 2 × 10<sup>4</sup> cells/well into 384-well plates in RPMI 1640, 25 mM HEPES, 5% FCS, 2 mM Glutamine. After overnight incubation, cells were primed with 0.2 ng/mL LPS ultrapure (#TLRL-PELPS Invivogen) for 2 h and then cells were washed in medium before addition of compound in DMSO or DMSO without compound. Stimulation of cells was done by addition of ATP (2 mM final conc.) and MSU crystals (200 μg/mL final conc.). After 3 h of incubation, the plate was centrifuged for 5 min and supernatant was taken off. Il-1β was measured with the kit Cat#62IL1PEC (CisBio) according to the vendor’s instructions.</div></div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">5.3.4 In vivo pharmacology</h4><div id="sec5_3_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80">5.3.4.1 Uric acid-induced synovitis model in dog: see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a></h5></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00598">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00598" class="ext-link">10.1021/acs.jmedchem.6b00598</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structures of intermediates <b>11</b>–<b>23</b> with yields of corresponding synthetic steps; siRNA knockdown data demonstrating the COT-dependency of the TNF-pathway in A431 cells; experimental details for the determinations of the high-throughput equilibrium solubility, the human plasma protein binding, the kinase selectivity, the analyses of the samples for the investigation of the biotransformation, and the isolation of a metabolite as well as for the determination of the pharmacokinetic parameters; X-ray data collection and refinement statistics; and kinase selectivity profiles of compounds <b>32</b> and <b>33</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data for compounds <b>1</b>–<b>48</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf">jm6b00598_si_001.pdf (450.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_002.csv">jm6b00598_si_002.csv (2.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00598" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Glatthar</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84f6e5e8e2aae3e8e5f0f0ece5f6c4eaebf2e5f6f0edf7aae7ebe9"><span class="__cf_email__" data-cfemail="6715060b0149000b0613130f0615270908110615130e144904080a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleksandar Stojanovic</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Troxler</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henri Mattes</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henrik Möbitz</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rene Beerli</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joachim Blanz</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernst Gassmann</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Drückes</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriele Fendrich</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sascha Gutmann</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georg Martiny-Baron</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fiona Spence</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Hornfeld</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Edmonson Peel</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helmut Sparrer</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Analytical Sciences, §Center for Proteomic
Chemistry, ∥Preclinical Safety, and ⊥Autoimmunity
Transplantation Inflammation, Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>∇</sup>(J.H.) Previous address: Novartis Animal Health, Research and Development, CH-1566 St-Aubin, Switzerland.<br /></br></div></li></ul></div><div class="ack" id="ACK-d44e5356-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Christian Boesch, Patrick Seitzer, Sandrine Liverneaux, Thomas Gut, Peter Kipfer, Carole Bordes, Marjorie Bourrel, Celine Dubois, and Michael Wright for synthetic support; Heinz Niggli, Helene Marlot, Erika Loetscher, Karolina Schulz, and Wolfgang Seewald for statistical analysis; Alexandra Hinniger for crystallization; Jean-Michel Florent for complex protein purification; members of the MX group at the Swiss Light Source at Paul Scherrer Institute and the team at Expose GmbH for assistance in X-ray data collection; Philippe Ramstein, Werner Gertsch, Thierry Délémonté, Reiner Aichholz, Michael Kiffe, Jerome Dayer, Sandrine Desrayaud, Roland Feifel, Francesca Blasco, Valerie Cordier, Elisabeth Braun, Sabrina Widmer, Sabine Kauffmann, Melih Altin, Jean-Claude Hengy, Irene Mueller, Philip Arabin, Marc Fischer, Francis Risser, Francisco Cordoba Castro, Alexander Cattini, Reto Baumgartner, Nathalie Stuber, Claude Hager, Daniel Lehmann, Christian Elsaesser, Andreas Gertsch, Grit Laue, Ralf Endres, Peter Wipfli, Claudia Textor, Laurent Hoffmann, Caroline Rynn, Yannick Friche, Cornelia Schluep, and Gareth Williams for in vitro and in vivo studies; Rita Ramos for compound formulation support; Christian Guenat and Corinne Marx for analytical support; and Jürgen Wagner and Gisbert Weckbecker for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> Abbreviations Used</h2><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">CID</td><td class="NLM_def"><p class="first last">collison-induced dissociation</p></td></tr><tr><td class="NLM_term">COT</td><td class="NLM_def"><p class="first last">cancer Osaka thyroid kinase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular-signal regulated kinases</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple bond correlation</p></td></tr><tr><td class="NLM_term">HPLC/MS</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography/mass spectrometry</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">IκB kinase</p></td></tr><tr><td class="NLM_term">IL-1</td><td class="NLM_def"><p class="first last">interleukin-1</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminale dinase</p></td></tr><tr><td class="NLM_term">LMW</td><td class="NLM_def"><p class="first last">low molecular weight</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MAP3K8</td><td class="NLM_def"><p class="first last">mitogen activated protein kinase kinase 8</p></td></tr><tr><td class="NLM_term">MKK4</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase 4</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">Nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">ROESY</td><td class="NLM_def"><p class="first last">rotating-frame nuclear Overhauser effect correlation spectroscopy</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TLR4</td><td class="NLM_def"><p class="first last">Toll-like receptor 4</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gantke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriskantharajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. C.</span><span> </span><span class="NLM_article-title">IκB kinase regulation of the TPL-2/ERK MAPK pathway</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1111/j.1600-065X.2012.01104.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1111%2Fj.1600-065X.2012.01104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=22435554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyku73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=168-182&issue=1&author=T.+Gantkeauthor=S.+Sriskantharajahauthor=M.+Sadowskiauthor=S.+C.+Ley&title=I%CE%BAB+kinase+regulation+of+the+TPL-2%2FERK+MAPK+pathway&doi=10.1111%2Fj.1600-065X.2012.01104.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">IκB kinase regulation of the TPL-2/ERK MAPK pathway</span></div><div class="casAuthors">Gantke, Thorsten; Sriskantharajah, Srividya; Sadowski, Michael; Ley, Steven C.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-182, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) activation play central roles in the induction of gene expression in innate immune cells following pathogen recognition.  TPL-2 (tumor progression locus 2) is the MAP 3-kinase component of an ERK-1/2 (extracellular signal-regulated kinase 1/2) MAPK pathway activated by Toll-like receptor and tumor necrosis factor receptor family stimulation.  In this review, we discuss results obtained from our lab. and others that show that TPL-2 signaling function is directly controlled by the inhibitor of NF-κB (IκB) kinase (IKK) complex.  Significantly, this means that IKK controls both NF-κB and ERK activation.  TPL-2 is stoichiometrically complexed with the NF-κB inhibitory protein, NF-κB1 p105, and the ubiquitin-binding protein ABIN-2, both of which are required to maintain TPL-2 protein stability.  Binding to p105 also prevents TPL-2 from phosphorylating MEK (MAPK/ERK kinase), its downstream target.  Agonist stimulation releases TPL-2 from p105-inhibition by IKK-mediated phosphorylation of p105, which triggers degrdn. of p105 by the proteasome.  This facilitates TPL-2 phosphorylation of MEK, in addn. to liberating p105-assocd. Rel subunits to translocate into the nucleus.  We also examine evidence that TPL-2 is crit. for the induction of inflammation and may play a role in development and/or progression of certain types of cancer.  Finally, we consider the potential of TPL-2 as an anti-inflammatory drug target for treatment of certain types of inflammatory disease and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJBKYwzwU8UbVg90H21EOLACvtfcHk0lhz-O9i1Wno5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyku73F&md5=23185e836a6c7579a48c8c4e62448d8b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2012.01104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2012.01104.x%26sid%3Dliteratum%253Aachs%26aulast%3DGantke%26aufirst%3DT.%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DSadowski%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DS.%2BC.%26atitle%3DI%25CE%25BAB%2520kinase%2520regulation%2520of%2520the%2520TPL-2%252FERK%2520MAPK%2520pathway%26jtitle%3DImmunol%2520Rev.%26date%3D2012%26volume%3D246%26issue%3D1%26spage%3D168%26epage%3D182%26doi%3D10.1111%2Fj.1600-065X.2012.01104.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dumitru, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsatsanis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontoyiannis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamatakis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patriotis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">TNF-alpha induction by LPS is regulated post-transcriptionally via a Tpl2/ERK-dependent pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1071</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)00210-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2FS0092-8674%2800%2900210-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=1071-1083&issue=7&author=C.+D.+Dumitruauthor=J.+D.+Ceciauthor=C.+Tsatsanisauthor=D.+Kontoyiannisauthor=K.+Stamatakisauthor=J.+H.+Linauthor=C.+Patriotisauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=G.+Kolliasauthor=P.+N.+Tsichlis&title=TNF-alpha+induction+by+LPS+is+regulated+post-transcriptionally+via+a+Tpl2%2FERK-dependent+pathway&doi=10.1016%2FS0092-8674%2800%2900210-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900210-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900210-5%26sid%3Dliteratum%253Aachs%26aulast%3DDumitru%26aufirst%3DC.%2BD.%26aulast%3DCeci%26aufirst%3DJ.%2BD.%26aulast%3DTsatsanis%26aufirst%3DC.%26aulast%3DKontoyiannis%26aufirst%3DD.%26aulast%3DStamatakis%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DPatriotis%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DTNF-alpha%2520induction%2520by%2520LPS%2520is%2520regulated%2520post-transcriptionally%2520via%2520a%2520Tpl2%252FERK-dependent%2520pathway%26jtitle%3DCell%26date%3D2000%26volume%3D103%26issue%3D7%26spage%3D1071%26epage%3D1083%26doi%3D10.1016%2FS0092-8674%2800%2900210-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mielke, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watford, W. T.</span><span> </span><span class="NLM_article-title">Tumor progression locus 2 (Map3k8) is critical for host defense against listeria monocytogenes and IL-1 beta production</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">7984</span><span class="NLM_x">–</span> <span class="NLM_lpage">7993</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.4049%2Fjimmunol.0901336" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7984-7993&issue=12&author=L.+A.+Mielkeauthor=K.+L.+Elkinsauthor=L.+Weiauthor=R.+Starrauthor=P.+N.+Tsichlisauthor=J.+J.+O%E2%80%99Sheaauthor=W.+T.+Watford&title=Tumor+progression+locus+2+%28Map3k8%29+is+critical+for+host+defense+against+listeria+monocytogenes+and+IL-1+beta+production&doi=10.4049%2Fjimmunol.0901336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901336%26sid%3Dliteratum%253Aachs%26aulast%3DMielke%26aufirst%3DL.%2BA.%26aulast%3DElkins%26aufirst%3DK.%2BL.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DStarr%26aufirst%3DR.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DWatford%26aufirst%3DW.%2BT.%26atitle%3DTumor%2520progression%2520locus%25202%2520%2528Map3k8%2529%2520is%2520critical%2520for%2520host%2520defense%2520against%2520listeria%2520monocytogenes%2520and%2520IL-1%2520beta%2520production%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26issue%3D12%26spage%3D7984%26epage%3D7993%26doi%3D10.4049%2Fjimmunol.0901336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. C.</span><span> </span><span class="NLM_article-title">ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5235</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1128/MCB.24.12.5235-5248.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1128%2FMCB.24.12.5235-5248.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=15169888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5235-5248&issue=12&author=V.+Langauthor=A.+Symonsauthor=S.+J.+Wattonauthor=J.+Janzenauthor=Y.+Sonejiauthor=S.+Beinkeauthor=S.+Howellauthor=S.+C.+Ley&title=ABIN-2+forms+a+ternary+complex+with+TPL-2+and+NF-kappa+B1+p105+and+is+essential+for+TPL-2+protein+stability&doi=10.1128%2FMCB.24.12.5235-5248.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability</span></div><div class="casAuthors">Lang, V.; Symons, A.; Watton, S. J.; Janzen, J.; Soneji, Y.; Beinke, S.; Howell, S.; Ley, S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5235-5248</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">NF-κB1 p105 forms a high-affinity, stoichiometric interaction with TPL-2, a MEK kinase essential for TLR4 activation of the ERK mitogen-activated protein kinase cascade in lipopolysaccharide (LPS)-stimulated macrophages.  Interaction with p105 is required to maintain TPL-2 metabolic stability and also neg. regulates TPL-2 MEK kinase activity.  Here, affinity purifn. identified A20-binding inhibitor of NF-κB 2 (ABIN-2) as a novel p105-assocd. protein.  Cotransfection expts. demonstrated that ABIN-2 could interact with TPL-2 in addn. to p105 but preferentially formed a ternary complex with both proteins.  Consistently, in unstimulated bone marrow-derived macrophages (BMDMs), a substantial fraction of endogenous ABIN-2 was assocd. with both p105 and TPL-2.  Although the majority of TPL-2 in these cells was complexed with ABIN-2, the pool of TPL-2 which could activate MEK after LPS stimulation was not, and LPS activation of TPL-2 was found to correlate with its release from ABIN-2.  Depletion of ABIN-2 by RNA interference dramatically reduced steady-state levels of TPL-2 protein without affecting levels of TPL-2 mRNA or p105 protein.  In addn., ABIN-2 increased the half-life of cotransfected TPL-2.  Thus, optimal TPL-2 stability in vivo requires interaction with ABIN-2 as well as p105.  Together, these data raise the possibility that ABIN-2 functions in the TLR4 signaling pathway which regulates TPL-2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr96_p3xYpa5LVg90H21EOLACvtfcHk0lhz-O9i1Wno5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFOqt74%253D&md5=02421d8f2d15e6a62b746dd91146c0d9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.12.5235-5248.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.12.5235-5248.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DV.%26aulast%3DSymons%26aufirst%3DA.%26aulast%3DWatton%26aufirst%3DS.%2BJ.%26aulast%3DJanzen%26aufirst%3DJ.%26aulast%3DSoneji%26aufirst%3DY.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DHowell%26aufirst%3DS.%26aulast%3DLey%26aufirst%3DS.%2BC.%26atitle%3DABIN-2%2520forms%2520a%2520ternary%2520complex%2520with%2520TPL-2%2520and%2520NF-kappa%2520B1%2520p105%2520and%2520is%2520essential%2520for%2520TPL-2%2520protein%2520stability%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26issue%3D12%26spage%3D5235%26epage%3D5248%26doi%3D10.1128%2FMCB.24.12.5235-5248.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Waterfield, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. C.</span><span> </span><span class="NLM_article-title">NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00070-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2FS1097-2765%2803%2900070-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=685-694&issue=3&author=M.+R.+Waterfieldauthor=M.+Zhangauthor=L.+P.+Normanauthor=S.+C.+Sun&title=NF-kappaB1%2Fp105+regulates+lipopolysaccharide-stimulated+MAP+kinase+signaling+by+governing+the+stability+and+function+of+the+Tpl2+kinase&doi=10.1016%2FS1097-2765%2803%2900070-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900070-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900070-4%26sid%3Dliteratum%253Aachs%26aulast%3DWaterfield%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DL.%2BP.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNF-kappaB1%252Fp105%2520regulates%2520lipopolysaccharide-stimulated%2520MAP%2520kinase%2520signaling%2520by%2520governing%2520the%2520stability%2520and%2520function%2520of%2520the%2520Tpl2%2520kinase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26issue%3D3%26spage%3D685%26epage%3D694%26doi%3D10.1016%2FS1097-2765%2803%2900070-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelliher, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliopoulos, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">Tpl2/COT signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">23748</span><span class="NLM_x">–</span> <span class="NLM_lpage">23757</span><span class="refDoi"> DOI: 10.1074/jbc.M412837200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1074%2Fjbc.M412837200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23748-23757&issue=25&author=S.+Dasauthor=J.+Choauthor=I.+Lambertzauthor=M.+A.+Kelliherauthor=A.+G.+Eliopoulosauthor=K.+Duauthor=P.+N.+Tsichlis&title=Tpl2%2FCOT+signals+activate+ERK%2C+JNK%2C+and+NF-kappaB+in+a+cell-type+and+stimulus-specific+manner&doi=10.1074%2Fjbc.M412837200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412837200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412837200%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%26aulast%3DLambertz%26aufirst%3DI.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DEliopoulos%26aufirst%3DA.%2BG.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DTpl2%252FCOT%2520signals%2520activate%2520ERK%252C%2520JNK%252C%2520and%2520NF-kappaB%2520in%2520a%2520cell-type%2520and%2520stimulus-specific%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D23748%26epage%3D23757%26doi%3D10.1074%2Fjbc.M412837200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Channavajhala, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutsatsos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1794</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bbapap.2009.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19563921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2rsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=1485-1495&issue=10&author=L.+Liuauthor=P.+L.+Channavajhalaauthor=V.+R.+Raoauthor=I.+Moutsatsosauthor=L.+Wuauthor=Y.+Zhangauthor=L.+L.+Linauthor=Y.+Qiu&title=Proteomic+characterization+of+the+dynamic+KSR-2+interactome%2C+a+signaling+scaffold+complex+in+MAPK+pathway&doi=10.1016%2Fj.bbapap.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway</span></div><div class="casAuthors">Liu, Lin; Channavajhala, Padma L.; Rao, Vikram R.; Moutsatsos, Ioannis; Wu, Leeying; Zhang, Yuhua; Lin, Lih-ling; Qiu, Yongchang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1794</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1485-1495</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">KSR-1 is a scaffolding protein that is essential for the Ras-induced activation of the highly conserved RAF-MEK-ERK kinase module.  Previously, we identified a close homolog of KSR-1, called KSR-2, through structural homol.-based data mining.  In order to further understand the role of KSR-2 in MAPK signaling, we undertook a functional proteomics approach to elucidate the dynamic compn. of the KSR-2 functional complex in HEK-293 cells under conditions with and without TNF-α stimulation.  We found nearly 100 proteins that were potentially assocd. with the KSR-2 complex and 43 proteins that were likely recruited to the supramol. complex after TNF-α treatment.  Our results indicate that KSR-2 may act as a scaffolding protein similar to KSR-1 to mediate MAPK core (RAF-MEK-ERK) signaling but with a distinct RAF isoform specificity; namely, KSR-2 may only mediate A-RAF signaling, while KSR-1 is responsible for transducing signals only from c-RAF.  In addn., KSR-2 may be involved in the activation of many MAPK downstream signaling mols. such as p38 MAPK, IKAP, AIF, and proteins involved in ubiquitin-proteasome, apoptosis, cell cycle control, and DNA synthesis and repair pathways, as well as in mediating crosstalk between MAPK and several other signaling pathways, including the PI3K and insulin pathways.  While interactions with these mols. are not known for KSR-1, it's reasonable to hypothesize that KSR-1 may also play a similar role in mediating these downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2MiOdFMKe7Vg90H21EOLACvtfcHk0lhxTfyze4YTCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2rsb%252FN&md5=7f8f97aeb352e68178607c219aff1ddf</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChannavajhala%26aufirst%3DP.%2BL.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DMoutsatsos%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DProteomic%2520characterization%2520of%2520the%2520dynamic%2520KSR-2%2520interactome%252C%2520a%2520signaling%2520scaffold%2520complex%2520in%2520MAPK%2520pathway%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2009%26volume%3D1794%26issue%3D10%26spage%3D1485%26epage%3D1495%26doi%3D10.1016%2Fj.bbapap.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Channavajhala, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. G.</span><span> </span><span class="NLM_article-title">hKSR-2 inhibits MEKK3</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2005.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bbrc.2005.07.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2005&pages=1214-1218&issue=4&author=P.+L.+Channavajhalaauthor=V.+R.+Raoauthor=V.+Spauldingauthor=L.+L.+Linauthor=Y.+G.+Zhang&title=hKSR-2+inhibits+MEKK3&doi=10.1016%2Fj.bbrc.2005.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DChannavajhala%26aufirst%3DP.%2BL.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSpaulding%26aufirst%3DV.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DZhang%26aufirst%3DY.%2BG.%26atitle%3DhKSR-2%2520inhibits%2520MEKK3%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D334%26issue%3D4%26spage%3D1214%26epage%3D1218%26doi%3D10.1016%2Fj.bbrc.2005.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. C.</span><span> </span><span class="NLM_article-title">TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1689</span><span class="NLM_x">–</span> <span class="NLM_lpage">1702</span><span class="refDoi"> DOI: 10.1084/jem.20132640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1084%2Fjem.20132640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=1689-1702&issue=8&author=Y.+Xiaoauthor=J.+Jinauthor=M.+Changauthor=M.+Nakayaauthor=H.+Huauthor=Q.+Zouauthor=X.+Zhouauthor=G.+C.+Brittainauthor=X.+Chengauthor=S.+C.+Sun&title=TPL2+mediates+autoimmune+inflammation+through+activation+of+the+TAK1+axis+of+IL-17+signaling&doi=10.1084%2Fjem.20132640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1084%2Fjem.20132640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20132640%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DBrittain%26aufirst%3DG.%2BC.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DTPL2%2520mediates%2520autoimmune%2520inflammation%2520through%2520activation%2520of%2520the%2520TAK1%2520axis%2520of%2520IL-17%2520signaling%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D8%26spage%3D1689%26epage%3D1702%26doi%3D10.1084%2Fjem.20132640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kim, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ki, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. S.</span><span> </span><span class="NLM_article-title">Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1093/carcin/bgs342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1093%2Fcarcin%2Fbgs342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=341-350&issue=2&author=G.+Kimauthor=P.+Khanalauthor=S.+C.+Limauthor=H.+J.+Yunauthor=S.+G.+Ahnauthor=S.+H.+Kiauthor=H.+S.+Choi&title=Interleukin-17+induces+AP-1+activity+and+cellular+transformation+via+upregulation+of+tumor+progression+locus+2+activity&doi=10.1093%2Fcarcin%2Fbgs342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgs342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgs342%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DG.%26aulast%3DKhanal%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DS.%2BC.%26aulast%3DYun%26aufirst%3DH.%2BJ.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26aulast%3DKi%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DInterleukin-17%2520induces%2520AP-1%2520activity%2520and%2520cellular%2520transformation%2520via%2520upregulation%2520of%2520tumor%2520progression%2520locus%25202%2520activity%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D341%26epage%3D350%26doi%3D10.1093%2Fcarcin%2Fbgs342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Alghasham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, Z.</span><span> </span><span class="NLM_article-title">Therapeutic targets for rheumatoid arthritis: Progress and promises</span> <span class="citation_source-journal">Autoimmunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.3109/08916934.2013.873413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.3109%2F08916934.2013.873413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=77-94&issue=2&author=A.+Alghashamauthor=Z.+Rasheed&title=Therapeutic+targets+for+rheumatoid+arthritis%3A+Progress+and+promises&doi=10.3109%2F08916934.2013.873413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F08916934.2013.873413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08916934.2013.873413%26sid%3Dliteratum%253Aachs%26aulast%3DAlghasham%26aufirst%3DA.%26aulast%3DRasheed%26aufirst%3DZ.%26atitle%3DTherapeutic%2520targets%2520for%2520rheumatoid%2520arthritis%253A%2520Progress%2520and%2520promises%26jtitle%3DAutoimmunity%26date%3D2014%26volume%3D47%26issue%3D2%26spage%3D77%26epage%3D94%26doi%3D10.3109%2F08916934.2013.873413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span> </span><span class="NLM_article-title">Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.2174/156802609789007345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2174%2F156802609789007345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19689369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=611-622&author=D.+Georgeauthor=A.+Salmeron&title=Cot%2FTpl-2+protein+kinase+as+a+target+for+the+treatment+of+inflammatory+disease&doi=10.2174%2F156802609789007345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease</span></div><div class="casAuthors">George, D.; Salmeron, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">611-622</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cot/Tpl-2/MAP3K8 is a serine/threonine protein kinase that is essential for lipopolysaccharide (LPS)-induced activation of the MEK/ERK pathway in macrophages as demonstrated in Cot/Tpl-2-deficient mice.  Cot/Tpl-2 kinase activation plays an integral role in the prodn. of pro-inflammatory cytokines such as TNF and IL-1β in this immune cell type.  Elevated levels of these cytokines have been clin. implicated as mediators of a no. of autoimmune diseases, in particular, the pain and joint destruction of rheumatoid arthritis.  By inference, pharmaceutical agents that inhibit Cot/Tpl-2 kinase have the potential to be novel and effective therapies for the treatment of these diseases.  This review will describe the physiol. regulation and importance of Cot/Tpl-2 in inflammation as well as the landscape of small mols. that have been reported as Cot/Tpl-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlIsbz7T4_urVg90H21EOLACvtfcHk0lifEPyXWtxldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjP&md5=57c1e5ec2c57a19bce4f2811fe89d201</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802609789007345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007345%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DSalmeron%26aufirst%3DA.%26atitle%3DCot%252FTpl-2%2520protein%2520kinase%2520as%2520a%2520target%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D611%26epage%3D622%26doi%3D10.2174%2F156802609789007345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J.</span><span> </span><span class="NLM_article-title">Identification of a novel class of selective Tpl2 kinase inhibitors: 4-alkylamino-[1,7]naphthyridine-3-carbonitriles</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6425</span><span class="NLM_x">–</span> <span class="NLM_lpage">6442</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmc.2007.06.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6425-6442&issue=19&author=N.+Kailaauthor=N.+Greenauthor=H.-Q.+Liauthor=Y.+Huauthor=K.+Janzauthor=L.+K.+Gavrinauthor=J.+Thomasonauthor=S.+Tamauthor=D.+Powellauthor=J.+Cuozzo&title=Identification+of+a+novel+class+of+selective+Tpl2+kinase+inhibitors%3A+4-alkylamino-%5B1%2C7%5Dnaphthyridine-3-carbonitriles&doi=10.1016%2Fj.bmc.2007.06.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DCuozzo%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520novel%2520class%2520of%2520selective%2520Tpl2%2520kinase%2520inhibitors%253A%25204-alkylamino-%255B1%252C7%255Dnaphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26issue%3D19%26spage%3D6425%26epage%3D6442%26doi%3D10.1016%2Fj.bmc.2007.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, S.</span><span> </span><span class="NLM_article-title">Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">6067</span><span class="NLM_x">–</span> <span class="NLM_lpage">6072</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2006.08.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6067-6072&issue=23&author=Y.+Huauthor=N.+Greenauthor=L.+K.+Gavrinauthor=K.+Janzauthor=N.+Kailaauthor=H.-Q.+Liauthor=J.+R.+Thomasonauthor=J.+W.+Cuozzoauthor=J.+P.+Hallauthor=S.+Hsu&title=Inhibition+of+Tpl2+kinase+and+TNF%CE%B1+production+with+quinoline-3-carbonitriles+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2006.08.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.102%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26aulast%3DHsu%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520Tpl2%2520kinase%2520and%2520TNF%25CE%25B1%2520production%2520with%2520quinoline-3-carbonitriles%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D23%26spage%3D6067%26epage%3D6072%26doi%3D10.1016%2Fj.bmcl.2006.08.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszewski, G.</span><span> </span><span class="NLM_article-title">Inhibition of Tpl2 kinase and TNFα production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure-activity relationships</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">5288</span><span class="NLM_x">–</span> <span class="NLM_lpage">5292</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2005.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5288-5292&issue=23&author=L.+K.+Gavrinauthor=N.+Greenauthor=Y.+Huauthor=K.+Janzauthor=N.+Kailaauthor=H.-Q.+Liauthor=S.+Y.+Tamauthor=J.+R.+Thomasonauthor=A.+Gopalsamyauthor=G.+Ciszewski&title=Inhibition+of+Tpl2+kinase+and+TNF%CE%B1+production+with+1%2C7-naphthyridine-3-carbonitriles%3A+Synthesis+and+structure-activity+relationships&doi=10.1016%2Fj.bmcl.2005.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DTam%26aufirst%3DS.%2BY.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DCiszewski%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Tpl2%2520kinase%2520and%2520TNF%25CE%25B1%2520production%2520with%25201%252C7-naphthyridine-3-carbonitriles%253A%2520Synthesis%2520and%2520structure-activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D23%26spage%3D5288%26epage%3D5292%26doi%3D10.1016%2Fj.bmcl.2005.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchandani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span> </span><span class="NLM_article-title">Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-α production in human whole blood</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3485</span><span class="NLM_x">–</span> <span class="NLM_lpage">3488</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2009.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3485-3488&issue=13&author=J.+Wuauthor=N.+Greenauthor=R.+Hotchandaniauthor=Y.+Huauthor=J.+Condonauthor=A.+Huangauthor=N.+Kailaauthor=H.-Q.+Liauthor=S.+Gulerauthor=W.+Li&title=Selective+inhibitors+of+tumor+progression+loci-2+%28Tpl2%29+kinase+with+potent+inhibition+of+TNF-%CE%B1+production+in+human+whole+blood&doi=10.1016%2Fj.bmcl.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHotchandani%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCondon%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DGuler%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DSelective%2520inhibitors%2520of%2520tumor%2520progression%2520loci-2%2520%2528Tpl2%2529%2520kinase%2520with%2520potent%2520inhibition%2520of%2520TNF-%25CE%25B1%2520production%2520in%2520human%2520whole%2520blood%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3485%26epage%3D3488%26doi%3D10.1016%2Fj.bmcl.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph-McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchandani, R.</span><span> </span><span class="NLM_article-title">Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor α (TNFα) production: Selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4728</span><span class="NLM_x">–</span> <span class="NLM_lpage">4745</span><span class="refDoi"> DOI: 10.1021/jm070436q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070436q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4728-4745&issue=19&author=N.+Greenauthor=Y.+Huauthor=K.+Janzauthor=H.-Q.+Liauthor=N.+Kailaauthor=S.+Gulerauthor=J.+Thomasonauthor=D.+Joseph-McCarthyauthor=S.+Y.+Tamauthor=R.+Hotchandani&title=Inhibitors+of+tumor+progression+loci-2+%28Tpl2%29+kinase+and+tumor+necrosis+factor+%CE%B1+%28TNF%CE%B1%29+production%3A+Selectivity+and+in+vivo+antiinflammatory+activity+of+novel+8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles&doi=10.1021%2Fjm070436q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm070436q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070436q%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DGuler%26aufirst%3DS.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DJoseph-McCarthy%26aufirst%3DD.%26aulast%3DTam%26aufirst%3DS.%2BY.%26aulast%3DHotchandani%26aufirst%3DR.%26atitle%3DInhibitors%2520of%2520tumor%2520progression%2520loci-2%2520%2528Tpl2%2529%2520kinase%2520and%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520%2528TNF%25CE%25B1%2529%2520production%253A%2520Selectivity%2520and%2520in%2520vivo%2520antiinflammatory%2520activity%2520of%2520novel%25208-substituted-4-anilino-6-aminoquinoline-3-carbonitriles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4728%26epage%3D4745%26doi%3D10.1021%2Fjm070436q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaisrivongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span> </span><span class="NLM_article-title">Discovery of indazoles as inhibitors of Tpl2 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4758</span><span class="NLM_x">–</span> <span class="NLM_lpage">4761</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2011.06.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4758-4761&issue=16&author=Y.+Huauthor=D.+Coleauthor=R.+A.+Dennyauthor=D.+R.+Andersonauthor=M.+Ipekauthor=Y.+Niauthor=X.+Wangauthor=S.+Thaisrivongsauthor=T.+Chamberlainauthor=J.+P.+Hall&title=Discovery+of+indazoles+as+inhibitors+of+Tpl2+kinase&doi=10.1016%2Fj.bmcl.2011.06.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DThaisrivongs%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DT.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520indazoles%2520as%2520inhibitors%2520of%2520Tpl2%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4758%26epage%3D4761%26doi%3D10.1016%2Fj.bmcl.2011.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiriadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fix-Stenzel, S.</span><span> </span><span class="NLM_article-title">Discovery of thieno[2,3-<i>c</i>]pyridines as potent COT inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4952</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2008.08.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4952-4955&issue=18&author=D.+Georgeauthor=M.+Friedmanauthor=H.+Allenauthor=M.+Argiriadiauthor=C.+Barberisauthor=A.+Bischoffauthor=A.+Clabbersauthor=K.+Cusackauthor=R.+Dixonauthor=S.+Fix-Stenzel&title=Discovery+of+thieno%5B2%2C3-c%5Dpyridines+as+potent+COT+inhibitors&doi=10.1016%2Fj.bmcl.2008.08.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DH.%26aulast%3DArgiriadi%26aufirst%3DM.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBischoff%26aufirst%3DA.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DCusack%26aufirst%3DK.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DFix-Stenzel%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520thieno%255B2%252C3-c%255Dpyridines%2520as%2520potent%2520COT%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D18%26spage%3D4952%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2008.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cusack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fix-Stenzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaumont, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, T.</span><span> </span><span class="NLM_article-title">Identification of a selective thieno[2,3-<i>c</i>]pyridine inhibitor of COT kinase and TNF-α production</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2009.01.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1722-1725&issue=6&author=K.+Cusackauthor=H.+Allenauthor=A.+Bischoffauthor=A.+Clabbersauthor=R.+Dixonauthor=S.+Fix-Stenzelauthor=M.+Friedmanauthor=Y.+Gaumontauthor=D.+Georgeauthor=T.+Gordon&title=Identification+of+a+selective+thieno%5B2%2C3-c%5Dpyridine+inhibitor+of+COT+kinase+and+TNF-%CE%B1+production&doi=10.1016%2Fj.bmcl.2009.01.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.088%26sid%3Dliteratum%253Aachs%26aulast%3DCusack%26aufirst%3DK.%26aulast%3DAllen%26aufirst%3DH.%26aulast%3DBischoff%26aufirst%3DA.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DFix-Stenzel%26aufirst%3DS.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DGaumont%26aufirst%3DY.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520selective%2520thieno%255B2%252C3-c%255Dpyridine%2520inhibitor%2520of%2520COT%2520kinase%2520and%2520TNF-%25CE%25B1%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D1722%26epage%3D1725%26doi%3D10.1016%2Fj.bmcl.2009.01.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, M.</span><span> </span><span class="NLM_article-title">Identification and SAR of a new series of thieno[3,2-<i>d</i>]pyrimidines as Tpl2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5952</span><span class="NLM_x">–</span> <span class="NLM_lpage">5956</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2011.07.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5952-5956&issue=19&author=Y.+Niauthor=A.+Gopalsamyauthor=D.+Coleauthor=Y.+Huauthor=R.+Dennyauthor=M.+Ipekauthor=J.+Liuauthor=J.+Leeauthor=J.+P.+Hallauthor=M.+Luong&title=Identification+and+SAR+of+a+new+series+of+thieno%5B3%2C2-d%5Dpyrimidines+as+Tpl2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.07.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DY.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDenny%26aufirst%3DR.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26aulast%3DLuong%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520SAR%2520of%2520a%2520new%2520series%2520of%2520thieno%255B3%252C2-d%255Dpyrimidines%2520as%2520Tpl2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D19%26spage%3D5952%26epage%3D5956%26doi%3D10.1016%2Fj.bmcl.2011.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span> </span><span class="NLM_article-title">Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-κB1 p105</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.abb.2005.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.abb.2005.06.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2005&pages=64-74&author=Y.+Jiaauthor=C.+M.+Quinnauthor=N.+J.+Bumpauthor=K.+M.+Clarkauthor=A.+Clabbersauthor=J.+Hardmanauthor=A.+Gagnonauthor=J.+Kamensauthor=M.+J.+Tomlinsonauthor=N.+Wishartauthor=H.+Allen&title=Purification+and+kinetic+characterization+of+recombinant+human+mitogen-activated+protein+kinase+kinase+kinase+COT+and+the+complexes+with+its+cellular+partner+NF-%CE%BAB1+p105&doi=10.1016%2Fj.abb.2005.06.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2005.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2005.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DClark%26aufirst%3DK.%2BM.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DKamens%26aufirst%3DJ.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DAllen%26aufirst%3DH.%26atitle%3DPurification%2520and%2520kinetic%2520characterization%2520of%2520recombinant%2520human%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520kinase%2520COT%2520and%2520the%2520complexes%2520with%2520its%2520cellular%2520partner%2520NF-%25CE%25BAB1%2520p105%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2005%26volume%3D441%26spage%3D64%26epage%3D74%26doi%3D10.1016%2Fj.abb.2005.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gutmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinniger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmiedeberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieffel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatthar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparrer, H.</span><span> </span><span class="NLM_article-title">The crystal structure of cancer osaka thyroid kinase reveals an unexpected kinase domain fold</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">15210</span><span class="NLM_x">–</span> <span class="NLM_lpage">15218</span><span class="refDoi"> DOI: 10.1074/jbc.M115.648097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1074%2Fjbc.M115.648097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=15210-15218&issue=24&author=S.+Gutmannauthor=A.+Hinnigerauthor=G.+Fendrichauthor=P.+Drueckesauthor=S.+Antzauthor=H.+Mattesauthor=H.+Moebitzauthor=S.+Ofnerauthor=N.+Schmiedebergauthor=A.+Stojanovicauthor=S.+Rieffelauthor=A.+Straussauthor=T.+Troxlerauthor=R.+Glattharauthor=H.+Sparrer&title=The+crystal+structure+of+cancer+osaka+thyroid+kinase+reveals+an+unexpected+kinase+domain+fold&doi=10.1074%2Fjbc.M115.648097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.648097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.648097%26sid%3Dliteratum%253Aachs%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DHinniger%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DAntz%26aufirst%3DS.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DSchmiedeberg%26aufirst%3DN.%26aulast%3DStojanovic%26aufirst%3DA.%26aulast%3DRieffel%26aufirst%3DS.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGlatthar%26aufirst%3DR.%26aulast%3DSparrer%26aufirst%3DH.%26atitle%3DThe%2520crystal%2520structure%2520of%2520cancer%2520osaka%2520thyroid%2520kinase%2520reveals%2520an%2520unexpected%2520kinase%2520domain%2520fold%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D24%26spage%3D15210%26epage%3D15218%26doi%3D10.1074%2Fjbc.M115.648097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Capraro, H.-G.; Furet, P.; Garcia-Echeverria, C.; Stauffer, F.</span><span> </span><span class="NLM_article-title">Preparation of 1H-imidazo[4,5-c]quinolines for the treatment of protein kinase dependent diseases</span>. WO 2005054238 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=H.-G.+Capraro&author=P.+Furet&author=C.+Garcia-Echeverria&author=F.+Stauffer&title=Preparation+of+1H-imidazo%5B4%2C5-c%5Dquinolines+for+the+treatment+of+protein+kinase+dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCapraro%26aufirst%3DH.-G.%26atitle%3DPreparation%2520of%25201H-imidazo%255B4%252C5-c%255Dquinolines%2520for%2520the%2520treatment%2520of%2520protein%2520kinase%2520dependent%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeuillet-Ritzler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, X.</span><span> </span><span class="NLM_article-title">High-throughput lipophilicity measurement with immobilized artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span><span class="refDoi"> DOI: 10.1021/jm049377w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049377w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2571-2576&issue=7&author=B.+Fallerauthor=H.+P.+Grimmauthor=F.+Loeuillet-Ritzlerauthor=S.+Arnoldauthor=X.+Briand&title=High-throughput+lipophilicity+measurement+with+immobilized+artificial+membranes&doi=10.1021%2Fjm049377w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049377w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049377w%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DGrimm%26aufirst%3DH.%2BP.%26aulast%3DLoeuillet-Ritzler%26aufirst%3DF.%26aulast%3DArnold%26aufirst%3DS.%26aulast%3DBriand%26aufirst%3DX.%26atitle%3DHigh-throughput%2520lipophilicity%2520measurement%2520with%2520immobilized%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D7%26spage%3D2571%26epage%3D2576%26doi%3D10.1021%2Fjm049377w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haasen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Dorazio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Characterization of kinase inhibitors using reverse phase protein arrays</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">785</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1007/978-1-61779-286-1_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1007%2F978-1-61779-286-1_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=21901595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls12rsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=785&publication_year=2011&pages=79-107&author=G.+Martiny-Baronauthor=D.+Haasenauthor=D.+D%E2%80%99Dorazioauthor=J.+Vosholauthor=D.+Fabbro&title=Characterization+of+kinase+inhibitors+using+reverse+phase+protein+arrays&doi=10.1007%2F978-1-61779-286-1_7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of kinase inhibitors using reverse phase protein arrays</span></div><div class="casAuthors">Martiny-Baron, Georg; Haasen, Dorothea; D'Dorazio, Daniel; Voshol, Johannes; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">785</span>
        (<span class="NLM_cas:issue">Protein Microarrays</span>),
    <span class="NLM_cas:pages">79-107</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Using the reverse protein array platform in combination with planar waveguide technol., which allows detection of proteins in spotted cell lysates with high sensitivity in a 96-well microtiter-plate format for growing, treating, and lysing cells was shown to be suitable for this approach and indicates the usefulness of the technol. as a screening tool for characterization of large nos. of kinase inhibitors.  In this study, we have used reverse protein arrays to profile kinase inhibitors in various cellular pathways in order to unravel their MoA.  Multiplexing and simultaneous anal. of several phospho-proteins within the same lysate allows (1) the estn. of inhibitor concns. needed to shut down an entire pathway, (2) the estn. of inhibitor selectivity, and (3) the comparison of inhibitors of different kinases within one assay.  For example, parallel anal. of p-InsR, p-PKB, p-GSK-3, p-MEK, p-ERK, and p-S6rp in insulin treated A14 cells allows profiling for inhibitors of the InsR, PI3K, PKB, mTor, RAF, and MEK.  Selective kinase inhibitors revealed different specific inhibitory pattern of the analyzed phospho-read outs.  Altogether, multiplexed anal. of reverse (phase) protein arrays is a powerful tool to characterize kinase inhibitors in a semi-automated low to medium throughput assay format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3rYjntFLlLbVg90H21EOLACvtfcHk0ljOxY39IcgtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls12rsLw%253D&md5=a8fdf4164f6c66c6baad923c1b14eba8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-286-1_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-286-1_7%26sid%3Dliteratum%253Aachs%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Dorazio%26aufirst%3DD.%26aulast%3DVoshol%26aufirst%3DJ.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520kinase%2520inhibitors%2520using%2520reverse%2520phase%2520protein%2520arrays%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D785%26spage%3D79%26epage%3D107%26doi%3D10.1007%2F978-1-61779-286-1_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dreiem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonnum, F.</span><span> </span><span class="NLM_article-title">Thiophene is toxic to cerebellar granule cells in culture after bioactivation by rat liver enzymes</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.neuro.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.neuro.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=15474614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlCnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=959-66&issue=6&author=A.+Dreiemauthor=F.+Fonnum&title=Thiophene+is+toxic+to+cerebellar+granule+cells+in+culture+after+bioactivation+by+rat+liver+enzymes&doi=10.1016%2Fj.neuro.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Thiophene is Toxic to Cerebellar Granule Cells in Culture After Bioactivation by Rat Liver Enzymes</span></div><div class="casAuthors">Dreiem, Anne; Fonnum, Frode</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-966</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several compds. that are not neurotoxic by themselves can cause toxic effects in vivo after enzymic bioactivation.  Thiophene is an industrial solvent known to produce degeneration primarily of the granule cells in the cerebellum when administered to animals in vivo.  The mechanism for thiophene toxicity is not known, although it was suggested that thiophene metab. may lead to formation of oxidative intermediates that could function as the ultimate toxicants.  In the present work the authors have used rat cerebellar granule cells (CGCs) in culture combined with rat liver postmitochondrial (S9) fraction as a source of biotransformation enzymes to test the toxicity of thiophene in vitro.  The results demonstrate that thiophene is toxic to rat cerebellar granule cells in culture only after biotransformation.  Furthermore, the toxic effects were reduced by cytochrome P 450 (CYP) inhibitors and by scavengers of reactive mols. (α-tocopherol, reduced glutathione, and phenyl-N-tert-butylnitrone).  These findings support the hypothesis that thiophene requires metab. to produce the ultimate toxicant, and that the cytochrome P 450 enzyme system is involved in the metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyIPxFRH5kLVg90H21EOLACvtfcHk0ljOxY39IcgtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlCnsbY%253D&md5=c9a3d1817a07439502259258434c676f</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuro.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuro.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDreiem%26aufirst%3DA.%26aulast%3DFonnum%26aufirst%3DF.%26atitle%3DThiophene%2520is%2520toxic%2520to%2520cerebellar%2520granule%2520cells%2520in%2520culture%2520after%2520bioactivation%2520by%2520rat%2520liver%2520enzymes%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26issue%3D6%26spage%3D959%26epage%3D66%26doi%3D10.1016%2Fj.neuro.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, K.</span><span> </span><span class="NLM_article-title">Thiophene, a sulfur-containing heterocyclic hydrocarbon, causes widespread neuronal degeneration in rats</span> <span class="citation_source-journal">Neuropathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1046/j.1440-1789.2000.00348.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1046%2Fj.1440-1789.2000.00348.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=283-288&author=F.+Moriauthor=K.+Tanjiauthor=K.+Wakabayashi&title=Thiophene%2C+a+sulfur-containing+heterocyclic+hydrocarbon%2C+causes+widespread+neuronal+degeneration+in+rats&doi=10.1046%2Fj.1440-1789.2000.00348.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1789.2000.00348.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1789.2000.00348.x%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DF.%26aulast%3DTanji%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3DThiophene%252C%2520a%2520sulfur-containing%2520heterocyclic%2520hydrocarbon%252C%2520causes%2520widespread%2520neuronal%2520degeneration%2520in%2520rats%26jtitle%3DNeuropathology%26date%3D2000%26volume%3D20%26spage%3D283%26epage%3D288%26doi%3D10.1046%2Fj.1440-1789.2000.00348.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Albrechtsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H.</span><span> </span><span class="NLM_article-title">Histochemical investigation of thiophen necrosis in the cerebellum of rats</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1007/BF00684431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1007%2FBF00684431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=4769151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADyaE2cXht1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1973&pages=217-223&author=R.+Albrechtsenauthor=H.+Jensen&title=Histochemical+investigation+of+thiophen+necrosis+in+the+cerebellum+of+rats&doi=10.1007%2FBF00684431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Histochemical investigation of thiophen necrosis in the cerebellum of rats</span></div><div class="casAuthors">Albrechtsen, R.; Jensen, H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-23</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Selective necrosis of the granular layer of the cerebellum was induced in 14 of 25 rats by s.c. injection of thiophen (I) [110-02-1].  Pyknosis of the granular cell nuclei was seen before any alteration in enzymes in the cytoplasm.  After the termination of I injections there was a tempory fall in the NADH-tetrazolium reductase [37219-67-3] in the Purkinje cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g14s9KqBW7Vg90H21EOLACvtfcHk0lhZJ7JuqiRe-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXht1ygs7w%253D&md5=4acd93f2dcf8383f0ac8a203e8c5c5e3</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1007%2FBF00684431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00684431%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrechtsen%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DH.%26atitle%3DHistochemical%2520investigation%2520of%2520thiophen%2520necrosis%2520in%2520the%2520cerebellum%2520of%2520rats%26jtitle%3DActa%2520Neuropathol.%26date%3D1973%26volume%3D26%26spage%3D217%26epage%3D223%26doi%3D10.1007%2FBF00684431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span> </span><span class="NLM_article-title">Drug-metabolizing ability of molybdenum hydroxylases</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.2133/dmpk.21.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2133%2Fdmpk.21.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=16702728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=83-98&author=S.+Kitamuraauthor=K.+Sugiharaauthor=S.+Ohta&title=Drug-metabolizing+ability+of+molybdenum+hydroxylases&doi=10.2133%2Fdmpk.21.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing ability of molybdenum hydroxylases</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-98</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Molybdenum hydroxylases, which include aldehyde oxidase and xanthine oxidoreductase, are involved in the metab. of some medicines in humans.  They exhibit oxidase activity toward various heterocyclic compds. and aldehydes.  The liver cytosol of various mammals also exhibits a significant reductase activity toward nitro, sulfoxide, N-oxide, and other moieties, catalyzed by aldehyde oxidase.  There is considerable variability of aldehyde oxidase activity in liver cytosol of mammals: humans show the highest activity, rats and mice show low activity, and dogs have no detectable activity.  On the other hand, xanthine oxidoreductase activity is present widely among species.  Interindividual variation of aldehyde oxidase activity is present in humans.  Drug-drug interactions assocd. with aldehyde oxidase and xanthine oxidoreductase are of potential clin. significance.  The drug-metabolizing ability of molybdenum hydroxylases and variation of the activity are described here by the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIDBvL67GcbVg90H21EOLACvtfcHk0lhZJ7JuqiRe-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D&md5=0698f203efaf5b2cf20f373af3cd4f28</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.83%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DDrug-metabolizing%2520ability%2520of%2520molybdenum%2520hydroxylases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D83%26epage%3D98%26doi%3D10.2133%2Fdmpk.21.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: An enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span><span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+An+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lhZJ7JuqiRe-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520An%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Potent inhibition of human liver aldehyde oxidase by raloxifene</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1124/dmd.32.1.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1124%2Fdmd.32.1.89" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=89-97&author=R.+S.+Obach&title=Potent+inhibition+of+human+liver+aldehyde+oxidase+by+raloxifene&doi=10.1124%2Fdmd.32.1.89"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.1.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.1.89%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPotent%2520inhibition%2520of%2520human%2520liver%2520aldehyde%2520oxidase%2520by%2520raloxifene%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D89%26epage%3D97%26doi%3D10.1124%2Fdmd.32.1.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Borer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seewald, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schawalder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreng, D. E.</span><span> </span><span class="NLM_article-title">Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis</span> <span class="citation_source-journal">Am. J. Vet. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.2460/ajvr.2003.64.1429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2460%2Fajvr.2003.64.1429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=14620781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1429-1437&author=L.+R.+Borerauthor=J.+E.+Peelauthor=W.+Seewaldauthor=P.+Schawalderauthor=D.+E.+Spreng&title=Effect+of+carprofen%2C+etodolac%2C+meloxicam%2C+or+butorphanol+in+dogs+with+induced+acute+synovitis&doi=10.2460%2Fajvr.2003.64.1429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis</span></div><div class="casAuthors">Borer, Luc R.; Peel, John E.; Seewald, Wolfgang; Schawalder, Peter; Spreng, David E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Veterinary Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1437</span>CODEN:
                <span class="NLM_cas:coden">AJVRAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    
            (<span class="NLM_cas:orgname">American Veterinary Medical Association</span>)
        </div><div class="casAbstract">Objective-To compare the analgesic and anti-inflammatory effect of single doses of carprofen, etodolac, meloxicam, and butorphanol in dogs with induced acute synovitis (acute pain model) via kinetic gait anal. and orthopedic evaluation and examine measurement of serum C-reactive protein (CRP) concn. as an indicator of treatment efficacy.  Animals-12 Beagles and 6 addnl. Beagles that were used only in serum CRP analyses.  Procedure-Acute synovitis was induced in right stifle joints of dogs via intra-articular injection of monosodium urate soln.  Treatments included butorphanol (0.2 mg/kg, IV), carprofen (4 mg/kg, PO), etodolac (17 mg/kg, PO), or meloxicam (0.2 mg/kg, PO); control dogs received no treatment.  The procedure was repeated (3-wk intervals) until all dogs received all treatments including control treatment.  Lameness was assessed on a biomech. force platform and via orthopedic evaluations of the stifle joints; blood was collected to monitor serum CRP concn.  Results-Compared with control dogs, treated dogs had significantly different vertical ground reaction forces and wt.-bearing scores.  Greatest improvement in lameness was obsd. in carprofen-treated dogs.  Etodolac had the fastest onset of action.  Compared with butorphanol treatment, only carprofen and etodolac were assocd. with significantly lower pain scores.  An increase in serum CRP concn. was detected after intra-articular injection in all dogs; this change was similar among groups.  Conclusions and Clin. Relevance-Carprofen, etodolac, and meloxicam had greater efficacy than butorphanol in relief of acute pain.  Carprofen was most effective overall.  In this acute pain model, serum CRP anal. was not useful to assess drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzzOwixde-s7Vg90H21EOLACvtfcHk0liOMHnhLWq3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eiurk%253D&md5=c510cbfe1cd7963e2b4ab7b4708945c4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2460%2Fajvr.2003.64.1429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2460%252Fajvr.2003.64.1429%26sid%3Dliteratum%253Aachs%26aulast%3DBorer%26aufirst%3DL.%2BR.%26aulast%3DPeel%26aufirst%3DJ.%2BE.%26aulast%3DSeewald%26aufirst%3DW.%26aulast%3DSchawalder%26aufirst%3DP.%26aulast%3DSpreng%26aufirst%3DD.%2BE.%26atitle%3DEffect%2520of%2520carprofen%252C%2520etodolac%252C%2520meloxicam%252C%2520or%2520butorphanol%2520in%2520dogs%2520with%2520induced%2520acute%2520synovitis%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D2003%26volume%3D64%26spage%3D1429%26epage%3D1437%26doi%3D10.2460%2Fajvr.2003.64.1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, L.; Dillon, M. P.; Feng, L.; Hawley, R. C.; Yang, M.</span><span> </span><span class="NLM_article-title">Novel pyrazole-substituted arylamides</span>. WO 2009077367 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Chen&author=M.+P.+Dillon&author=L.+Feng&author=R.+C.+Hawley&author=M.+Yang&title=Novel+pyrazole-substituted+arylamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DNovel%2520pyrazole-substituted%2520arylamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liOMHnhLWq3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0liOMHnhLWq3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liOMHnhLWq3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER version 2.11.5; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>The PyMOL Molecular Graphics System, Version 1.5.0.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+Version+1.5.0.4%3B+Schr%C3%B6dinger%2C+LLC%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frémaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span> </span><span class="NLM_article-title">Assay development and screening of a serine/threonine kinase in an on-chip mode using Caliper nanofluidics technology</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1177/1087057106286653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1177%2F1087057106286653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=16751332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2gsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=359-368&author=D.+Perrinauthor=C.+Fr%C3%A9mauxauthor=A.+Scheer&title=Assay+development+and+screening+of+a+serine%2Fthreonine+kinase+in+an+on-chip+mode+using+Caliper+nanofluidics+technology&doi=10.1177%2F1087057106286653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology</span></div><div class="casAuthors">Perrin, Dominique; Fremaux, Christele; Scheer, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Kinases are key targets for drug discovery.  In the field of screening in general and esp. in the kinase area, because of considerations of efficiency and cost, radioactivity-based assays tend to be replaced by alternative, mostly fluorescence-based, assays.  Today, the limiting factor is rarely the no. of data points that can be obtained but rather the quality of the data, enzyme availability, and cost.  In this article, the authors describe the development of an assay for a kinase screen based on the electrophoretic sepn. of fluorescent product and substrate using a Caliper-based nanofluidics environment in on-chip incubation mode.  The authors present the results of screening a focused set of 32,000 compds. together with confirmation data obtained in a filtration assay.  In addn., they have made a small-scale comparison between the on-chip and off-chip nanofluidics screening modes.  In their hands, the screen in on-chip mode is characterized by high precision most likely due to the absence of liq. pipetting; an excellent confirmation rate (62%) in an independent assay format, namely, filtration; and good sensitivity.  This study led to the identification of 4 novel chem. series of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoxLYDe_xvrVg90H21EOLACvtfcHk0lhjhuebMWGMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2gsL8%253D&md5=fb2ba529cbf74f0a8a863cee2bf793fb</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1177%2F1087057106286653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106286653%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DFr%25C3%25A9maux%26aufirst%3DC.%26aulast%3DScheer%26aufirst%3DA.%26atitle%3DAssay%2520development%2520and%2520screening%2520of%2520a%2520serine%252Fthreonine%2520kinase%2520in%2520an%2520on-chip%2520mode%2520using%2520Caliper%2520nanofluidics%2520technology%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D359%26epage%3D368%26doi%3D10.1177%2F1087057106286653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dunne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, J.</span><span> </span><span class="NLM_article-title">Comparison of on-chip and off-chip microfluidic kinase assay formats</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1089/154065804323056468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1089%2F154065804323056468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=121-129&author=J.+Dunneauthor=H.+Reardonauthor=V.+Trinhauthor=E.+Liauthor=J.+Farinas&title=Comparison+of+on-chip+and+off-chip+microfluidic+kinase+assay+formats&doi=10.1089%2F154065804323056468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1089%2F154065804323056468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065804323056468%26sid%3Dliteratum%253Aachs%26aulast%3DDunne%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DH.%26aulast%3DTrinh%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DFarinas%26aufirst%3DJ.%26atitle%3DComparison%2520of%2520on-chip%2520and%2520off-chip%2520microfluidic%2520kinase%2520assay%2520formats%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2004%26volume%3D2%26spage%3D121%26epage%3D129%26doi%3D10.1089%2F154065804323056468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cohen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin-Dixon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforov, T. T.</span><span> </span><span class="NLM_article-title">A microchip-based enzyme assay for protein kinase A</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1006/abio.1999.4204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1006%2Fabio.1999.4204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10452803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Wktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=89-97&author=C.+B.+Cohenauthor=E.+Chin-Dixonauthor=S.+Jeongauthor=T.+T.+Nikiforov&title=A+microchip-based+enzyme+assay+for+protein+kinase+A&doi=10.1006%2Fabio.1999.4204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">A microchip-based enzyme assay for protein kinase A</span></div><div class="casAuthors">Cohen, Claudia B.; Chin-Dixon, Emily; Jeong, Sang; Nikiforov, Theo T.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A microchip-based enzyme assay for protein kinase A (PKA) is described.  The microchips were prepd. by std. photolithog. techniques.  The assay reagents were placed in wells on the microchips, and electro-osmosis was used to transport aliquots of these reagents into the network of etched channels, where the enzymic reaction takes place.  PKA catalyzes the transfer of a phosphate group from ATP to the Ser residue of the heptapeptide, LRRASLG (Kemptide).  The outcome of the enzymic reaction was assessed by performing an on-chip electrophoretic sepn. of the fluorescently labeled peptide substrate and product.  All liq.-handling steps were performed by controlling the electro-osmotically driven flow from reagent and buffer wells using elec. current.  On-chip dilns. of the peptide substrate, ATP, and H-89, a known PKA inhibitor, were performed, and the kinetic consts. (Km, Ki) of these compds. were detd.  This prototype assay demonstrates the usefulness of microchips for performing enzymic assays for which fluorogenic substrates cannot easily be designed.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgeuQtBqd6bVg90H21EOLACvtfcHk0lhjhuebMWGMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Wktbk%253D&md5=341a9838daa1fd47d84d72f9f09479f7</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4204%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DC.%2BB.%26aulast%3DChin-Dixon%26aufirst%3DE.%26aulast%3DJeong%26aufirst%3DS.%26aulast%3DNikiforov%26aufirst%3DT.%2BT.%26atitle%3DA%2520microchip-based%2520enzyme%2520assay%2520for%2520protein%2520kinase%2520A%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D89%26epage%3D97%26doi%3D10.1006%2Fabio.1999.4204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nenad Manevski, Lloyd King, William R. Pitt, Fabien Lecomte, <span class="NLM_string-name hlFld-ContribAuthor">Francesca Toselli</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10955-10994. <a href="https://doi.org/10.1021/acs.jmedchem.9b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolism%252Bby%252BAldehyde%252BOxidase%25253A%252BDrug%252BDesign%252Band%252BComplementary%252BApproaches%252Bto%252BChallenges%252Bin%252BDrug%252BDiscovery%26aulast%3DManevski%26aufirst%3DNenad%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30052019%26date%3D20082019%26date%3D06082019%26volume%3D62%26issue%3D24%26spage%3D10955%26epage%3D10994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Zheng  Sun</span>, <span class="hlFld-ContribAuthor ">Gui-Feng  Lin</span>, <span class="hlFld-ContribAuthor ">Lin-Li  Li</span>, <span class="hlFld-ContribAuthor ">Xi-Ting  Jin</span>, <span class="hlFld-ContribAuthor ">Lu-Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Kai  Chen</span>, <span class="hlFld-ContribAuthor ">Rong  Xiang</span>, <span class="hlFld-ContribAuthor ">Chong  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>, <span class="hlFld-ContribAuthor ">Guang-Wen  Lu</span>, and <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6337-6352. <a href="https://doi.org/10.1021/acs.jmedchem.7b00665" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00665%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BCdc2-Like%252BKinase%252B1%252B%252528CLK1%252529%252Bas%252Ba%252BNew%252BClass%252Bof%252BAutophagy%252BInducers%26aulast%3DSun%26aufirst%3DQi-Zheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D17072017%26date%3D27072017%26date%3D10072017%26volume%3D60%26issue%3D14%26spage%3D6337%26epage%3D6352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erickson M.  Paragas</span>, <span class="hlFld-ContribAuthor ">Kanika  Choughule</span>, <span class="hlFld-ContribAuthor ">Jeffrey P.  Jones</span>, <span class="hlFld-ContribAuthor ">John T.  Barr</span>. </span><span class="cited-content_cbyCitation_article-title">Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 257-284. <a href="https://doi.org/10.1007/978-1-0716-1554-6_10" title="DOI URL">https://doi.org/10.1007/978-1-0716-1554-6_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-1554-6_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-1554-6_10%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BKinetics%25252C%252BPharmacokinetics%25252C%252Band%252BInhibition%252Bof%252BAldehyde%252BOxidase%26aulast%3DParagas%26aufirst%3DErickson%2BM.%26date%3D2021%26date%3D2021%26spage%3D257%26epage%3D284%26pub%3DSpringer%2520US%26atitle%3DEnzyme%252BKinetics%252Bin%252BDrug%252BMetabolism%26aulast%3DNagar%26aufirst%3DSwati%26date%3D2021%26volume%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maaged  Abdullah</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (1)
                                     , 213-226. <a href="https://doi.org/10.1007/s11224-018-1176-3" title="DOI URL">https://doi.org/10.1007/s11224-018-1176-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-018-1176-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-018-1176-3%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Bfragment-based%252Bdesign%252Bof%252BWee1%252Bkinase%252Binhibitors%252Bwith%252Btricyclic%252Bcore%252Bscaffolds%26aulast%3DAbdullah%26aufirst%3DMaaged%26date%3D2019%26date%3D2018%26volume%3D30%26issue%3D1%26spage%3D213%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhen Ting  Gao</span>, <span class="hlFld-ContribAuthor ">Zheng Tian  Yu</span>, <span class="hlFld-ContribAuthor ">Ji Yue (Jeff)  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of c-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating, and Steric Hindrance Effect. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2018,</strong> <em>46 </em>
                                    (12)
                                     , 1847-1855. <a href="https://doi.org/10.1124/dmd.118.081919" title="DOI URL">https://doi.org/10.1124/dmd.118.081919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.118.081919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.118.081919%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Bof%252Bc-Met%252BKinase%252BInhibitors%252BContaining%252BQuinoline%252Bby%252BAldehyde%252BOxidase%25252C%252BElectron%252BDonating%25252C%252Band%252BSteric%252BHindrance%252BEffect%26aulast%3DZhang%26aufirst%3DJiang%2BWei%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D12%26spage%3D1847%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hélène G.  Bazin</span>, <span class="hlFld-ContribAuthor ">Laura S.  Bess</span>, <span class="hlFld-ContribAuthor ">Mark T.  Livesay</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Applications of Imidazoquinolines: A Review. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2018,</strong> <em>50 </em>
                                    (2)
                                     , 109-244. <a href="https://doi.org/10.1080/00304948.2018.1433427" title="DOI URL">https://doi.org/10.1080/00304948.2018.1433427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2018.1433427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2018.1433427%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DSynthesis%252Band%252BApplications%252Bof%252BImidazoquinolines%25253A%252BA%252BReview%26aulast%3DBazin%26aufirst%3DH%25C3%25A9l%25C3%25A8ne%2BG.%26date%3D2018%26date%3D2018%26volume%3D50%26issue%3D2%26spage%3D109%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daqi  Xu</span>, <span class="hlFld-ContribAuthor ">Marissa L.  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Brent S.  McKenzie</span>, <span class="hlFld-ContribAuthor ">Ali A.  Zarrin</span>. </span><span class="cited-content_cbyCitation_article-title">TPL2 kinase action and control of inflammation. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2018,</strong> <em>129 </em>, 188-193. <a href="https://doi.org/10.1016/j.phrs.2017.11.031" title="DOI URL">https://doi.org/10.1016/j.phrs.2017.11.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2017.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2017.11.031%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTPL2%252Bkinase%252Baction%252Band%252Bcontrol%252Bof%252Binflammation%26aulast%3DXu%26aufirst%3DDaqi%26date%3D2018%26volume%3D129%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad-Reza  Rashidi</span>, <span class="hlFld-ContribAuthor ">Somaieh  Soltani</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2017,</strong> <em>12 </em>
                                    (3)
                                     , 305-316. <a href="https://doi.org/10.1080/17460441.2017.1284198" title="DOI URL">https://doi.org/10.1080/17460441.2017.1284198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2017.1284198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2017.1284198%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252Baldehyde%252Boxidase%25253A%252Ban%252Benzyme%252Bof%252Bemerging%252Bimportance%252Bin%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DRashidi%26aufirst%3DMohammad-Reza%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D305%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COT kinase signaling pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative compounds of COT kinase inhibitor scaffolds reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. COT kinase inhibitors: pyrrolopyridine (<b>7</b>), aminopyridine (<b>8</b>), and imidazonaphthyridine scaffold <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds of Type <b>A</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) HNO<sub>3</sub>, propanoic acid, 130 °C, 56%; (b) (hetero-)arylboronic acid, Pd(OAc)<sub>2</sub>, SPhos, K<sub>2</sub>CO<sub>3</sub>, solvent, 100–130 °C, 65–94%; (c) 1. POCl<sub>3</sub>, N(n-Pr)<sub>3</sub>, DMF, 75 °C, 1 min or POCl<sub>3</sub>, Et<sub>3</sub>N, −15 °C to rt. 2. Y-NH<sub>2</sub>, Et<sub>3</sub>N, solvent, rt or Y-NH<sub>2</sub>, HCl, solvent, rt, 18–76%; (d) 1. H<sub>2</sub>, Pd/C, MeOH, rt or SnCl<sub>2</sub>, conc. HCl, EtOH, rt or Fe, AcOH, H<sub>2</sub>O/THF, 60 °C or aq. Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMF, rt. 2. CH(OEt)<sub>3</sub>, EtOH 120–150 °C or 1. H<sub>2</sub>/Pd/C, EtOH, rt. 2. CH(OEt)<sub>3</sub>, EtOH 120–150 °C, 15–30%. For structures of intermediates <b>11</b>–<b>23</b>; see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf" class="ext-link">Supporting Information</a>.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Aniline Building Blocks Y-NH<sub>2</sub>: (I) Commercial Compounds <b>35–37</b> and (II) Synthesis of the Noncommericial Compounds <b>40</b>, <b>44</b>, and <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 5 equiv Et<sub>3</sub>N, dioxane 130 °C, 80%; (b) 2 equiv K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 94%; (c) Ra–Ni, H<sub>2</sub> (1 atm), THF, rt 82%; (d) 2 equiv K<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 78%; (e) 10% Pd/C, H<sub>2</sub> (1 atm), MeOH, rt, 97%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Benzimidazole Substituted Derivatives <b>50–-59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 1. POCl<sub>3</sub>, N(n-Pr)<sub>3</sub>, DMF, 75 °C; 2. 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine, HCl-dioxane, DMF, rt, 50%; (b) 1. H<sub>2</sub>, Raney-Ni, MeOH, rt; 2. CH(OEt)<sub>3</sub>, EtOH, HCl, 145 °C, 55%. (c) (hetero-) arylboronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O/EtOH, 140 °C, 4–49% or piperidine, 160 °C, 67%.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacologic profile of compound <b>25</b> in PBMCs after LPS stimulation (graph and table) and in A431 after EGF- and TNF-stimulation (table).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Top (a) and side (b) views of the crystal structure of imidazonaphthyridine (<b>28</b>) (blue sticks) in complex with human COT kinase protein (66–395) at 2.7 Å resolution. Key residues are shown as sticks. The unique P-loop inset (residues 133–144) is colored in red, and polar interactions of <b>28</b> with the protein and selected water molecules are shown as red dashed lines. The inset in part b shows a comparison of the P-loop conformations in COT·<b>28</b> versus a indazole cocrystal structure (green, only β1−β2 and ligand shown, pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4y85">4y85</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overlay of the X-ray structure of imidazonaphthyridine (<b>28</b>) (blue) with human COT kinase protein (66–395, white) and with the closest related kinase, NIK (MAP3K14, magenta (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dn5">4dn5</a>)). Key residues are shown as sticks. The hinge in COT is distorted, enabling the typical hydrogen bond pattern with a shifted core of <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Biotransformation of <b>30</b> in vitro in rat liver microsomes and in vivo in bile-duct cannulated rats, and relative peak areas of <b>30</b> and metabolites detected in the different matrices. <sup><i>a</i></sup>Incubation period. <sup><i>b</i></sup>Sampling time or period in hours post dose. <sup><i>c</i></sup>Sum of relative peak areas of metabolites modified only at the side chain. <sup><i>d</i></sup>Sum of relative peak areas of metabolites modified at the side chain and the aromatic core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Biotransformation of <b>31</b> in vitro in rat liver microsomes and in vivo in bile-duct cannulated rats, and relative peak areas of <b>31</b> and metabolites detected in the different matrices. <sup><i>a</i></sup>Incubation period. <sup><i>b</i></sup>Sampling time or period in hours post dose. <sup><i>c</i></sup>Sum of relative peak areas of metabolites modified only at the side chain. <sup><i>d</i></sup>Sum of relative peak areas of GSH, cysteinylglycine, and cysteine adducts at thiophene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of the isolated metabolite <b>M1</b> with key <sup>1</sup>H (red) and <sup>13</sup>C (blue) chemical shifts and important HMBC and ROESY correlations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Turnover of compound <b>30</b> (A) and formation of metabolite <b>M1</b> (B) after incubation with human S9 fractions (without NADPH) in the presence and absence of the aldehyde oxidase inhibitor raloxifene.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/medium/jm-2016-00598r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0012.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Time needed for the z peak force of the affected limb to reach 60% of that measured prior to uric acid injection (time to recovery). (Short time to recovery reflects better efficacy.) Vehicle, 2 doses of <b>32</b>, and a positive control (meloxicam) were tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00598/20160819/images/large/jm-2016-00598r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00598&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gantke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriskantharajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. C.</span><span> </span><span class="NLM_article-title">IκB kinase regulation of the TPL-2/ERK MAPK pathway</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1111/j.1600-065X.2012.01104.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1111%2Fj.1600-065X.2012.01104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=22435554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyku73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=168-182&issue=1&author=T.+Gantkeauthor=S.+Sriskantharajahauthor=M.+Sadowskiauthor=S.+C.+Ley&title=I%CE%BAB+kinase+regulation+of+the+TPL-2%2FERK+MAPK+pathway&doi=10.1111%2Fj.1600-065X.2012.01104.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">IκB kinase regulation of the TPL-2/ERK MAPK pathway</span></div><div class="casAuthors">Gantke, Thorsten; Sriskantharajah, Srividya; Sadowski, Michael; Ley, Steven C.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-182, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) activation play central roles in the induction of gene expression in innate immune cells following pathogen recognition.  TPL-2 (tumor progression locus 2) is the MAP 3-kinase component of an ERK-1/2 (extracellular signal-regulated kinase 1/2) MAPK pathway activated by Toll-like receptor and tumor necrosis factor receptor family stimulation.  In this review, we discuss results obtained from our lab. and others that show that TPL-2 signaling function is directly controlled by the inhibitor of NF-κB (IκB) kinase (IKK) complex.  Significantly, this means that IKK controls both NF-κB and ERK activation.  TPL-2 is stoichiometrically complexed with the NF-κB inhibitory protein, NF-κB1 p105, and the ubiquitin-binding protein ABIN-2, both of which are required to maintain TPL-2 protein stability.  Binding to p105 also prevents TPL-2 from phosphorylating MEK (MAPK/ERK kinase), its downstream target.  Agonist stimulation releases TPL-2 from p105-inhibition by IKK-mediated phosphorylation of p105, which triggers degrdn. of p105 by the proteasome.  This facilitates TPL-2 phosphorylation of MEK, in addn. to liberating p105-assocd. Rel subunits to translocate into the nucleus.  We also examine evidence that TPL-2 is crit. for the induction of inflammation and may play a role in development and/or progression of certain types of cancer.  Finally, we consider the potential of TPL-2 as an anti-inflammatory drug target for treatment of certain types of inflammatory disease and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJBKYwzwU8UbVg90H21EOLACvtfcHk0lgCcKfkAQ_DQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyku73F&md5=23185e836a6c7579a48c8c4e62448d8b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2012.01104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2012.01104.x%26sid%3Dliteratum%253Aachs%26aulast%3DGantke%26aufirst%3DT.%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DSadowski%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DS.%2BC.%26atitle%3DI%25CE%25BAB%2520kinase%2520regulation%2520of%2520the%2520TPL-2%252FERK%2520MAPK%2520pathway%26jtitle%3DImmunol%2520Rev.%26date%3D2012%26volume%3D246%26issue%3D1%26spage%3D168%26epage%3D182%26doi%3D10.1111%2Fj.1600-065X.2012.01104.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dumitru, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsatsanis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontoyiannis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamatakis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patriotis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">TNF-alpha induction by LPS is regulated post-transcriptionally via a Tpl2/ERK-dependent pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1071</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)00210-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2FS0092-8674%2800%2900210-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=1071-1083&issue=7&author=C.+D.+Dumitruauthor=J.+D.+Ceciauthor=C.+Tsatsanisauthor=D.+Kontoyiannisauthor=K.+Stamatakisauthor=J.+H.+Linauthor=C.+Patriotisauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=G.+Kolliasauthor=P.+N.+Tsichlis&title=TNF-alpha+induction+by+LPS+is+regulated+post-transcriptionally+via+a+Tpl2%2FERK-dependent+pathway&doi=10.1016%2FS0092-8674%2800%2900210-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900210-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900210-5%26sid%3Dliteratum%253Aachs%26aulast%3DDumitru%26aufirst%3DC.%2BD.%26aulast%3DCeci%26aufirst%3DJ.%2BD.%26aulast%3DTsatsanis%26aufirst%3DC.%26aulast%3DKontoyiannis%26aufirst%3DD.%26aulast%3DStamatakis%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DPatriotis%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DTNF-alpha%2520induction%2520by%2520LPS%2520is%2520regulated%2520post-transcriptionally%2520via%2520a%2520Tpl2%252FERK-dependent%2520pathway%26jtitle%3DCell%26date%3D2000%26volume%3D103%26issue%3D7%26spage%3D1071%26epage%3D1083%26doi%3D10.1016%2FS0092-8674%2800%2900210-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mielke, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watford, W. T.</span><span> </span><span class="NLM_article-title">Tumor progression locus 2 (Map3k8) is critical for host defense against listeria monocytogenes and IL-1 beta production</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">7984</span><span class="NLM_x">–</span> <span class="NLM_lpage">7993</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.4049%2Fjimmunol.0901336" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7984-7993&issue=12&author=L.+A.+Mielkeauthor=K.+L.+Elkinsauthor=L.+Weiauthor=R.+Starrauthor=P.+N.+Tsichlisauthor=J.+J.+O%E2%80%99Sheaauthor=W.+T.+Watford&title=Tumor+progression+locus+2+%28Map3k8%29+is+critical+for+host+defense+against+listeria+monocytogenes+and+IL-1+beta+production&doi=10.4049%2Fjimmunol.0901336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901336%26sid%3Dliteratum%253Aachs%26aulast%3DMielke%26aufirst%3DL.%2BA.%26aulast%3DElkins%26aufirst%3DK.%2BL.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DStarr%26aufirst%3DR.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DWatford%26aufirst%3DW.%2BT.%26atitle%3DTumor%2520progression%2520locus%25202%2520%2528Map3k8%2529%2520is%2520critical%2520for%2520host%2520defense%2520against%2520listeria%2520monocytogenes%2520and%2520IL-1%2520beta%2520production%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26issue%3D12%26spage%3D7984%26epage%3D7993%26doi%3D10.4049%2Fjimmunol.0901336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. C.</span><span> </span><span class="NLM_article-title">ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5235</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1128/MCB.24.12.5235-5248.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1128%2FMCB.24.12.5235-5248.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=15169888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5235-5248&issue=12&author=V.+Langauthor=A.+Symonsauthor=S.+J.+Wattonauthor=J.+Janzenauthor=Y.+Sonejiauthor=S.+Beinkeauthor=S.+Howellauthor=S.+C.+Ley&title=ABIN-2+forms+a+ternary+complex+with+TPL-2+and+NF-kappa+B1+p105+and+is+essential+for+TPL-2+protein+stability&doi=10.1128%2FMCB.24.12.5235-5248.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability</span></div><div class="casAuthors">Lang, V.; Symons, A.; Watton, S. J.; Janzen, J.; Soneji, Y.; Beinke, S.; Howell, S.; Ley, S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5235-5248</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">NF-κB1 p105 forms a high-affinity, stoichiometric interaction with TPL-2, a MEK kinase essential for TLR4 activation of the ERK mitogen-activated protein kinase cascade in lipopolysaccharide (LPS)-stimulated macrophages.  Interaction with p105 is required to maintain TPL-2 metabolic stability and also neg. regulates TPL-2 MEK kinase activity.  Here, affinity purifn. identified A20-binding inhibitor of NF-κB 2 (ABIN-2) as a novel p105-assocd. protein.  Cotransfection expts. demonstrated that ABIN-2 could interact with TPL-2 in addn. to p105 but preferentially formed a ternary complex with both proteins.  Consistently, in unstimulated bone marrow-derived macrophages (BMDMs), a substantial fraction of endogenous ABIN-2 was assocd. with both p105 and TPL-2.  Although the majority of TPL-2 in these cells was complexed with ABIN-2, the pool of TPL-2 which could activate MEK after LPS stimulation was not, and LPS activation of TPL-2 was found to correlate with its release from ABIN-2.  Depletion of ABIN-2 by RNA interference dramatically reduced steady-state levels of TPL-2 protein without affecting levels of TPL-2 mRNA or p105 protein.  In addn., ABIN-2 increased the half-life of cotransfected TPL-2.  Thus, optimal TPL-2 stability in vivo requires interaction with ABIN-2 as well as p105.  Together, these data raise the possibility that ABIN-2 functions in the TLR4 signaling pathway which regulates TPL-2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr96_p3xYpa5LVg90H21EOLACvtfcHk0lgCcKfkAQ_DQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFOqt74%253D&md5=02421d8f2d15e6a62b746dd91146c0d9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.12.5235-5248.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.12.5235-5248.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DV.%26aulast%3DSymons%26aufirst%3DA.%26aulast%3DWatton%26aufirst%3DS.%2BJ.%26aulast%3DJanzen%26aufirst%3DJ.%26aulast%3DSoneji%26aufirst%3DY.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DHowell%26aufirst%3DS.%26aulast%3DLey%26aufirst%3DS.%2BC.%26atitle%3DABIN-2%2520forms%2520a%2520ternary%2520complex%2520with%2520TPL-2%2520and%2520NF-kappa%2520B1%2520p105%2520and%2520is%2520essential%2520for%2520TPL-2%2520protein%2520stability%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26issue%3D12%26spage%3D5235%26epage%3D5248%26doi%3D10.1128%2FMCB.24.12.5235-5248.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Waterfield, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. C.</span><span> </span><span class="NLM_article-title">NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00070-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2FS1097-2765%2803%2900070-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=685-694&issue=3&author=M.+R.+Waterfieldauthor=M.+Zhangauthor=L.+P.+Normanauthor=S.+C.+Sun&title=NF-kappaB1%2Fp105+regulates+lipopolysaccharide-stimulated+MAP+kinase+signaling+by+governing+the+stability+and+function+of+the+Tpl2+kinase&doi=10.1016%2FS1097-2765%2803%2900070-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900070-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900070-4%26sid%3Dliteratum%253Aachs%26aulast%3DWaterfield%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNorman%26aufirst%3DL.%2BP.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNF-kappaB1%252Fp105%2520regulates%2520lipopolysaccharide-stimulated%2520MAP%2520kinase%2520signaling%2520by%2520governing%2520the%2520stability%2520and%2520function%2520of%2520the%2520Tpl2%2520kinase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26issue%3D3%26spage%3D685%26epage%3D694%26doi%3D10.1016%2FS1097-2765%2803%2900070-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelliher, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliopoulos, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">Tpl2/COT signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">23748</span><span class="NLM_x">–</span> <span class="NLM_lpage">23757</span><span class="refDoi"> DOI: 10.1074/jbc.M412837200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1074%2Fjbc.M412837200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23748-23757&issue=25&author=S.+Dasauthor=J.+Choauthor=I.+Lambertzauthor=M.+A.+Kelliherauthor=A.+G.+Eliopoulosauthor=K.+Duauthor=P.+N.+Tsichlis&title=Tpl2%2FCOT+signals+activate+ERK%2C+JNK%2C+and+NF-kappaB+in+a+cell-type+and+stimulus-specific+manner&doi=10.1074%2Fjbc.M412837200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412837200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412837200%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%26aulast%3DLambertz%26aufirst%3DI.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DEliopoulos%26aufirst%3DA.%2BG.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DTpl2%252FCOT%2520signals%2520activate%2520ERK%252C%2520JNK%252C%2520and%2520NF-kappaB%2520in%2520a%2520cell-type%2520and%2520stimulus-specific%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D23748%26epage%3D23757%26doi%3D10.1074%2Fjbc.M412837200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Channavajhala, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moutsatsos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1794</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bbapap.2009.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19563921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2rsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=1485-1495&issue=10&author=L.+Liuauthor=P.+L.+Channavajhalaauthor=V.+R.+Raoauthor=I.+Moutsatsosauthor=L.+Wuauthor=Y.+Zhangauthor=L.+L.+Linauthor=Y.+Qiu&title=Proteomic+characterization+of+the+dynamic+KSR-2+interactome%2C+a+signaling+scaffold+complex+in+MAPK+pathway&doi=10.1016%2Fj.bbapap.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway</span></div><div class="casAuthors">Liu, Lin; Channavajhala, Padma L.; Rao, Vikram R.; Moutsatsos, Ioannis; Wu, Leeying; Zhang, Yuhua; Lin, Lih-ling; Qiu, Yongchang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1794</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1485-1495</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">KSR-1 is a scaffolding protein that is essential for the Ras-induced activation of the highly conserved RAF-MEK-ERK kinase module.  Previously, we identified a close homolog of KSR-1, called KSR-2, through structural homol.-based data mining.  In order to further understand the role of KSR-2 in MAPK signaling, we undertook a functional proteomics approach to elucidate the dynamic compn. of the KSR-2 functional complex in HEK-293 cells under conditions with and without TNF-α stimulation.  We found nearly 100 proteins that were potentially assocd. with the KSR-2 complex and 43 proteins that were likely recruited to the supramol. complex after TNF-α treatment.  Our results indicate that KSR-2 may act as a scaffolding protein similar to KSR-1 to mediate MAPK core (RAF-MEK-ERK) signaling but with a distinct RAF isoform specificity; namely, KSR-2 may only mediate A-RAF signaling, while KSR-1 is responsible for transducing signals only from c-RAF.  In addn., KSR-2 may be involved in the activation of many MAPK downstream signaling mols. such as p38 MAPK, IKAP, AIF, and proteins involved in ubiquitin-proteasome, apoptosis, cell cycle control, and DNA synthesis and repair pathways, as well as in mediating crosstalk between MAPK and several other signaling pathways, including the PI3K and insulin pathways.  While interactions with these mols. are not known for KSR-1, it's reasonable to hypothesize that KSR-1 may also play a similar role in mediating these downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2MiOdFMKe7Vg90H21EOLACvtfcHk0lglzJKsKQJAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2rsb%252FN&md5=7f8f97aeb352e68178607c219aff1ddf</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChannavajhala%26aufirst%3DP.%2BL.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DMoutsatsos%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DProteomic%2520characterization%2520of%2520the%2520dynamic%2520KSR-2%2520interactome%252C%2520a%2520signaling%2520scaffold%2520complex%2520in%2520MAPK%2520pathway%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2009%26volume%3D1794%26issue%3D10%26spage%3D1485%26epage%3D1495%26doi%3D10.1016%2Fj.bbapap.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Channavajhala, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. G.</span><span> </span><span class="NLM_article-title">hKSR-2 inhibits MEKK3</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2005.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bbrc.2005.07.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2005&pages=1214-1218&issue=4&author=P.+L.+Channavajhalaauthor=V.+R.+Raoauthor=V.+Spauldingauthor=L.+L.+Linauthor=Y.+G.+Zhang&title=hKSR-2+inhibits+MEKK3&doi=10.1016%2Fj.bbrc.2005.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DChannavajhala%26aufirst%3DP.%2BL.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSpaulding%26aufirst%3DV.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DZhang%26aufirst%3DY.%2BG.%26atitle%3DhKSR-2%2520inhibits%2520MEKK3%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D334%26issue%3D4%26spage%3D1214%26epage%3D1218%26doi%3D10.1016%2Fj.bbrc.2005.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. C.</span><span> </span><span class="NLM_article-title">TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1689</span><span class="NLM_x">–</span> <span class="NLM_lpage">1702</span><span class="refDoi"> DOI: 10.1084/jem.20132640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1084%2Fjem.20132640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=1689-1702&issue=8&author=Y.+Xiaoauthor=J.+Jinauthor=M.+Changauthor=M.+Nakayaauthor=H.+Huauthor=Q.+Zouauthor=X.+Zhouauthor=G.+C.+Brittainauthor=X.+Chengauthor=S.+C.+Sun&title=TPL2+mediates+autoimmune+inflammation+through+activation+of+the+TAK1+axis+of+IL-17+signaling&doi=10.1084%2Fjem.20132640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1084%2Fjem.20132640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20132640%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DBrittain%26aufirst%3DG.%2BC.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DTPL2%2520mediates%2520autoimmune%2520inflammation%2520through%2520activation%2520of%2520the%2520TAK1%2520axis%2520of%2520IL-17%2520signaling%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D8%26spage%3D1689%26epage%3D1702%26doi%3D10.1084%2Fjem.20132640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kim, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ki, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. S.</span><span> </span><span class="NLM_article-title">Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1093/carcin/bgs342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1093%2Fcarcin%2Fbgs342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=341-350&issue=2&author=G.+Kimauthor=P.+Khanalauthor=S.+C.+Limauthor=H.+J.+Yunauthor=S.+G.+Ahnauthor=S.+H.+Kiauthor=H.+S.+Choi&title=Interleukin-17+induces+AP-1+activity+and+cellular+transformation+via+upregulation+of+tumor+progression+locus+2+activity&doi=10.1093%2Fcarcin%2Fbgs342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgs342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgs342%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DG.%26aulast%3DKhanal%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DS.%2BC.%26aulast%3DYun%26aufirst%3DH.%2BJ.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26aulast%3DKi%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DInterleukin-17%2520induces%2520AP-1%2520activity%2520and%2520cellular%2520transformation%2520via%2520upregulation%2520of%2520tumor%2520progression%2520locus%25202%2520activity%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D341%26epage%3D350%26doi%3D10.1093%2Fcarcin%2Fbgs342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Alghasham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, Z.</span><span> </span><span class="NLM_article-title">Therapeutic targets for rheumatoid arthritis: Progress and promises</span> <span class="citation_source-journal">Autoimmunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.3109/08916934.2013.873413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.3109%2F08916934.2013.873413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=77-94&issue=2&author=A.+Alghashamauthor=Z.+Rasheed&title=Therapeutic+targets+for+rheumatoid+arthritis%3A+Progress+and+promises&doi=10.3109%2F08916934.2013.873413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F08916934.2013.873413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08916934.2013.873413%26sid%3Dliteratum%253Aachs%26aulast%3DAlghasham%26aufirst%3DA.%26aulast%3DRasheed%26aufirst%3DZ.%26atitle%3DTherapeutic%2520targets%2520for%2520rheumatoid%2520arthritis%253A%2520Progress%2520and%2520promises%26jtitle%3DAutoimmunity%26date%3D2014%26volume%3D47%26issue%3D2%26spage%3D77%26epage%3D94%26doi%3D10.3109%2F08916934.2013.873413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span> </span><span class="NLM_article-title">Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.2174/156802609789007345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2174%2F156802609789007345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19689369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=611-622&author=D.+Georgeauthor=A.+Salmeron&title=Cot%2FTpl-2+protein+kinase+as+a+target+for+the+treatment+of+inflammatory+disease&doi=10.2174%2F156802609789007345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease</span></div><div class="casAuthors">George, D.; Salmeron, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">611-622</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cot/Tpl-2/MAP3K8 is a serine/threonine protein kinase that is essential for lipopolysaccharide (LPS)-induced activation of the MEK/ERK pathway in macrophages as demonstrated in Cot/Tpl-2-deficient mice.  Cot/Tpl-2 kinase activation plays an integral role in the prodn. of pro-inflammatory cytokines such as TNF and IL-1β in this immune cell type.  Elevated levels of these cytokines have been clin. implicated as mediators of a no. of autoimmune diseases, in particular, the pain and joint destruction of rheumatoid arthritis.  By inference, pharmaceutical agents that inhibit Cot/Tpl-2 kinase have the potential to be novel and effective therapies for the treatment of these diseases.  This review will describe the physiol. regulation and importance of Cot/Tpl-2 in inflammation as well as the landscape of small mols. that have been reported as Cot/Tpl-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlIsbz7T4_urVg90H21EOLACvtfcHk0lg2ku1tBv7K3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjP&md5=57c1e5ec2c57a19bce4f2811fe89d201</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802609789007345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007345%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DSalmeron%26aufirst%3DA.%26atitle%3DCot%252FTpl-2%2520protein%2520kinase%2520as%2520a%2520target%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D611%26epage%3D622%26doi%3D10.2174%2F156802609789007345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J.</span><span> </span><span class="NLM_article-title">Identification of a novel class of selective Tpl2 kinase inhibitors: 4-alkylamino-[1,7]naphthyridine-3-carbonitriles</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6425</span><span class="NLM_x">–</span> <span class="NLM_lpage">6442</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmc.2007.06.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6425-6442&issue=19&author=N.+Kailaauthor=N.+Greenauthor=H.-Q.+Liauthor=Y.+Huauthor=K.+Janzauthor=L.+K.+Gavrinauthor=J.+Thomasonauthor=S.+Tamauthor=D.+Powellauthor=J.+Cuozzo&title=Identification+of+a+novel+class+of+selective+Tpl2+kinase+inhibitors%3A+4-alkylamino-%5B1%2C7%5Dnaphthyridine-3-carbonitriles&doi=10.1016%2Fj.bmc.2007.06.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DCuozzo%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520novel%2520class%2520of%2520selective%2520Tpl2%2520kinase%2520inhibitors%253A%25204-alkylamino-%255B1%252C7%255Dnaphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26issue%3D19%26spage%3D6425%26epage%3D6442%26doi%3D10.1016%2Fj.bmc.2007.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, S.</span><span> </span><span class="NLM_article-title">Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">6067</span><span class="NLM_x">–</span> <span class="NLM_lpage">6072</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2006.08.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6067-6072&issue=23&author=Y.+Huauthor=N.+Greenauthor=L.+K.+Gavrinauthor=K.+Janzauthor=N.+Kailaauthor=H.-Q.+Liauthor=J.+R.+Thomasonauthor=J.+W.+Cuozzoauthor=J.+P.+Hallauthor=S.+Hsu&title=Inhibition+of+Tpl2+kinase+and+TNF%CE%B1+production+with+quinoline-3-carbonitriles+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2006.08.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.102%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26aulast%3DHsu%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520Tpl2%2520kinase%2520and%2520TNF%25CE%25B1%2520production%2520with%2520quinoline-3-carbonitriles%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D23%26spage%3D6067%26epage%3D6072%26doi%3D10.1016%2Fj.bmcl.2006.08.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszewski, G.</span><span> </span><span class="NLM_article-title">Inhibition of Tpl2 kinase and TNFα production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure-activity relationships</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">5288</span><span class="NLM_x">–</span> <span class="NLM_lpage">5292</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2005.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5288-5292&issue=23&author=L.+K.+Gavrinauthor=N.+Greenauthor=Y.+Huauthor=K.+Janzauthor=N.+Kailaauthor=H.-Q.+Liauthor=S.+Y.+Tamauthor=J.+R.+Thomasonauthor=A.+Gopalsamyauthor=G.+Ciszewski&title=Inhibition+of+Tpl2+kinase+and+TNF%CE%B1+production+with+1%2C7-naphthyridine-3-carbonitriles%3A+Synthesis+and+structure-activity+relationships&doi=10.1016%2Fj.bmcl.2005.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DTam%26aufirst%3DS.%2BY.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DCiszewski%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Tpl2%2520kinase%2520and%2520TNF%25CE%25B1%2520production%2520with%25201%252C7-naphthyridine-3-carbonitriles%253A%2520Synthesis%2520and%2520structure-activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D23%26spage%3D5288%26epage%3D5292%26doi%3D10.1016%2Fj.bmcl.2005.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchandani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span> </span><span class="NLM_article-title">Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-α production in human whole blood</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3485</span><span class="NLM_x">–</span> <span class="NLM_lpage">3488</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2009.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3485-3488&issue=13&author=J.+Wuauthor=N.+Greenauthor=R.+Hotchandaniauthor=Y.+Huauthor=J.+Condonauthor=A.+Huangauthor=N.+Kailaauthor=H.-Q.+Liauthor=S.+Gulerauthor=W.+Li&title=Selective+inhibitors+of+tumor+progression+loci-2+%28Tpl2%29+kinase+with+potent+inhibition+of+TNF-%CE%B1+production+in+human+whole+blood&doi=10.1016%2Fj.bmcl.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHotchandani%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCondon%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DGuler%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DSelective%2520inhibitors%2520of%2520tumor%2520progression%2520loci-2%2520%2528Tpl2%2529%2520kinase%2520with%2520potent%2520inhibition%2520of%2520TNF-%25CE%25B1%2520production%2520in%2520human%2520whole%2520blood%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3485%26epage%3D3488%26doi%3D10.1016%2Fj.bmcl.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Green, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph-McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchandani, R.</span><span> </span><span class="NLM_article-title">Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor α (TNFα) production: Selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4728</span><span class="NLM_x">–</span> <span class="NLM_lpage">4745</span><span class="refDoi"> DOI: 10.1021/jm070436q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070436q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4728-4745&issue=19&author=N.+Greenauthor=Y.+Huauthor=K.+Janzauthor=H.-Q.+Liauthor=N.+Kailaauthor=S.+Gulerauthor=J.+Thomasonauthor=D.+Joseph-McCarthyauthor=S.+Y.+Tamauthor=R.+Hotchandani&title=Inhibitors+of+tumor+progression+loci-2+%28Tpl2%29+kinase+and+tumor+necrosis+factor+%CE%B1+%28TNF%CE%B1%29+production%3A+Selectivity+and+in+vivo+antiinflammatory+activity+of+novel+8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles&doi=10.1021%2Fjm070436q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm070436q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070436q%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DGuler%26aufirst%3DS.%26aulast%3DThomason%26aufirst%3DJ.%26aulast%3DJoseph-McCarthy%26aufirst%3DD.%26aulast%3DTam%26aufirst%3DS.%2BY.%26aulast%3DHotchandani%26aufirst%3DR.%26atitle%3DInhibitors%2520of%2520tumor%2520progression%2520loci-2%2520%2528Tpl2%2529%2520kinase%2520and%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520%2528TNF%25CE%25B1%2529%2520production%253A%2520Selectivity%2520and%2520in%2520vivo%2520antiinflammatory%2520activity%2520of%2520novel%25208-substituted-4-anilino-6-aminoquinoline-3-carbonitriles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4728%26epage%3D4745%26doi%3D10.1021%2Fjm070436q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaisrivongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span> </span><span class="NLM_article-title">Discovery of indazoles as inhibitors of Tpl2 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4758</span><span class="NLM_x">–</span> <span class="NLM_lpage">4761</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2011.06.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4758-4761&issue=16&author=Y.+Huauthor=D.+Coleauthor=R.+A.+Dennyauthor=D.+R.+Andersonauthor=M.+Ipekauthor=Y.+Niauthor=X.+Wangauthor=S.+Thaisrivongsauthor=T.+Chamberlainauthor=J.+P.+Hall&title=Discovery+of+indazoles+as+inhibitors+of+Tpl2+kinase&doi=10.1016%2Fj.bmcl.2011.06.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DThaisrivongs%26aufirst%3DS.%26aulast%3DChamberlain%26aufirst%3DT.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520indazoles%2520as%2520inhibitors%2520of%2520Tpl2%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4758%26epage%3D4761%26doi%3D10.1016%2Fj.bmcl.2011.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiriadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fix-Stenzel, S.</span><span> </span><span class="NLM_article-title">Discovery of thieno[2,3-<i>c</i>]pyridines as potent COT inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4952</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2008.08.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4952-4955&issue=18&author=D.+Georgeauthor=M.+Friedmanauthor=H.+Allenauthor=M.+Argiriadiauthor=C.+Barberisauthor=A.+Bischoffauthor=A.+Clabbersauthor=K.+Cusackauthor=R.+Dixonauthor=S.+Fix-Stenzel&title=Discovery+of+thieno%5B2%2C3-c%5Dpyridines+as+potent+COT+inhibitors&doi=10.1016%2Fj.bmcl.2008.08.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DH.%26aulast%3DArgiriadi%26aufirst%3DM.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBischoff%26aufirst%3DA.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DCusack%26aufirst%3DK.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DFix-Stenzel%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520thieno%255B2%252C3-c%255Dpyridines%2520as%2520potent%2520COT%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D18%26spage%3D4952%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2008.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cusack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fix-Stenzel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaumont, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, T.</span><span> </span><span class="NLM_article-title">Identification of a selective thieno[2,3-<i>c</i>]pyridine inhibitor of COT kinase and TNF-α production</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1722</span><span class="NLM_x">–</span> <span class="NLM_lpage">1725</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2009.01.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1722-1725&issue=6&author=K.+Cusackauthor=H.+Allenauthor=A.+Bischoffauthor=A.+Clabbersauthor=R.+Dixonauthor=S.+Fix-Stenzelauthor=M.+Friedmanauthor=Y.+Gaumontauthor=D.+Georgeauthor=T.+Gordon&title=Identification+of+a+selective+thieno%5B2%2C3-c%5Dpyridine+inhibitor+of+COT+kinase+and+TNF-%CE%B1+production&doi=10.1016%2Fj.bmcl.2009.01.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.088%26sid%3Dliteratum%253Aachs%26aulast%3DCusack%26aufirst%3DK.%26aulast%3DAllen%26aufirst%3DH.%26aulast%3DBischoff%26aufirst%3DA.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DR.%26aulast%3DFix-Stenzel%26aufirst%3DS.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DGaumont%26aufirst%3DY.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520selective%2520thieno%255B2%252C3-c%255Dpyridine%2520inhibitor%2520of%2520COT%2520kinase%2520and%2520TNF-%25CE%25B1%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D1722%26epage%3D1725%26doi%3D10.1016%2Fj.bmcl.2009.01.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, M.</span><span> </span><span class="NLM_article-title">Identification and SAR of a new series of thieno[3,2-<i>d</i>]pyrimidines as Tpl2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5952</span><span class="NLM_x">–</span> <span class="NLM_lpage">5956</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.bmcl.2011.07.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5952-5956&issue=19&author=Y.+Niauthor=A.+Gopalsamyauthor=D.+Coleauthor=Y.+Huauthor=R.+Dennyauthor=M.+Ipekauthor=J.+Liuauthor=J.+Leeauthor=J.+P.+Hallauthor=M.+Luong&title=Identification+and+SAR+of+a+new+series+of+thieno%5B3%2C2-d%5Dpyrimidines+as+Tpl2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.07.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DY.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDenny%26aufirst%3DR.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DJ.%2BP.%26aulast%3DLuong%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520SAR%2520of%2520a%2520new%2520series%2520of%2520thieno%255B3%252C2-d%255Dpyrimidines%2520as%2520Tpl2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D19%26spage%3D5952%26epage%3D5956%26doi%3D10.1016%2Fj.bmcl.2011.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabbers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, H.</span><span> </span><span class="NLM_article-title">Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-κB1 p105</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.abb.2005.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.abb.2005.06.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2005&pages=64-74&author=Y.+Jiaauthor=C.+M.+Quinnauthor=N.+J.+Bumpauthor=K.+M.+Clarkauthor=A.+Clabbersauthor=J.+Hardmanauthor=A.+Gagnonauthor=J.+Kamensauthor=M.+J.+Tomlinsonauthor=N.+Wishartauthor=H.+Allen&title=Purification+and+kinetic+characterization+of+recombinant+human+mitogen-activated+protein+kinase+kinase+kinase+COT+and+the+complexes+with+its+cellular+partner+NF-%CE%BAB1+p105&doi=10.1016%2Fj.abb.2005.06.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2005.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2005.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DClark%26aufirst%3DK.%2BM.%26aulast%3DClabbers%26aufirst%3DA.%26aulast%3DHardman%26aufirst%3DJ.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DKamens%26aufirst%3DJ.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DAllen%26aufirst%3DH.%26atitle%3DPurification%2520and%2520kinetic%2520characterization%2520of%2520recombinant%2520human%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520kinase%2520COT%2520and%2520the%2520complexes%2520with%2520its%2520cellular%2520partner%2520NF-%25CE%25BAB1%2520p105%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2005%26volume%3D441%26spage%3D64%26epage%3D74%26doi%3D10.1016%2Fj.abb.2005.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gutmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinniger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmiedeberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieffel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatthar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparrer, H.</span><span> </span><span class="NLM_article-title">The crystal structure of cancer osaka thyroid kinase reveals an unexpected kinase domain fold</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">15210</span><span class="NLM_x">–</span> <span class="NLM_lpage">15218</span><span class="refDoi"> DOI: 10.1074/jbc.M115.648097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1074%2Fjbc.M115.648097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=15210-15218&issue=24&author=S.+Gutmannauthor=A.+Hinnigerauthor=G.+Fendrichauthor=P.+Drueckesauthor=S.+Antzauthor=H.+Mattesauthor=H.+Moebitzauthor=S.+Ofnerauthor=N.+Schmiedebergauthor=A.+Stojanovicauthor=S.+Rieffelauthor=A.+Straussauthor=T.+Troxlerauthor=R.+Glattharauthor=H.+Sparrer&title=The+crystal+structure+of+cancer+osaka+thyroid+kinase+reveals+an+unexpected+kinase+domain+fold&doi=10.1074%2Fjbc.M115.648097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.648097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.648097%26sid%3Dliteratum%253Aachs%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DHinniger%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DAntz%26aufirst%3DS.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DSchmiedeberg%26aufirst%3DN.%26aulast%3DStojanovic%26aufirst%3DA.%26aulast%3DRieffel%26aufirst%3DS.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGlatthar%26aufirst%3DR.%26aulast%3DSparrer%26aufirst%3DH.%26atitle%3DThe%2520crystal%2520structure%2520of%2520cancer%2520osaka%2520thyroid%2520kinase%2520reveals%2520an%2520unexpected%2520kinase%2520domain%2520fold%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D24%26spage%3D15210%26epage%3D15218%26doi%3D10.1074%2Fjbc.M115.648097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Capraro, H.-G.; Furet, P.; Garcia-Echeverria, C.; Stauffer, F.</span><span> </span><span class="NLM_article-title">Preparation of 1H-imidazo[4,5-c]quinolines for the treatment of protein kinase dependent diseases</span>. WO 2005054238 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=H.-G.+Capraro&author=P.+Furet&author=C.+Garcia-Echeverria&author=F.+Stauffer&title=Preparation+of+1H-imidazo%5B4%2C5-c%5Dquinolines+for+the+treatment+of+protein+kinase+dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCapraro%26aufirst%3DH.-G.%26atitle%3DPreparation%2520of%25201H-imidazo%255B4%252C5-c%255Dquinolines%2520for%2520the%2520treatment%2520of%2520protein%2520kinase%2520dependent%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeuillet-Ritzler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, X.</span><span> </span><span class="NLM_article-title">High-throughput lipophilicity measurement with immobilized artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span><span class="refDoi"> DOI: 10.1021/jm049377w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049377w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2571-2576&issue=7&author=B.+Fallerauthor=H.+P.+Grimmauthor=F.+Loeuillet-Ritzlerauthor=S.+Arnoldauthor=X.+Briand&title=High-throughput+lipophilicity+measurement+with+immobilized+artificial+membranes&doi=10.1021%2Fjm049377w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049377w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049377w%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DGrimm%26aufirst%3DH.%2BP.%26aulast%3DLoeuillet-Ritzler%26aufirst%3DF.%26aulast%3DArnold%26aufirst%3DS.%26aulast%3DBriand%26aufirst%3DX.%26atitle%3DHigh-throughput%2520lipophilicity%2520measurement%2520with%2520immobilized%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D7%26spage%3D2571%26epage%3D2576%26doi%3D10.1021%2Fjm049377w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haasen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Dorazio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voshol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Characterization of kinase inhibitors using reverse phase protein arrays</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">785</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1007/978-1-61779-286-1_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1007%2F978-1-61779-286-1_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=21901595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls12rsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=785&publication_year=2011&pages=79-107&author=G.+Martiny-Baronauthor=D.+Haasenauthor=D.+D%E2%80%99Dorazioauthor=J.+Vosholauthor=D.+Fabbro&title=Characterization+of+kinase+inhibitors+using+reverse+phase+protein+arrays&doi=10.1007%2F978-1-61779-286-1_7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of kinase inhibitors using reverse phase protein arrays</span></div><div class="casAuthors">Martiny-Baron, Georg; Haasen, Dorothea; D'Dorazio, Daniel; Voshol, Johannes; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">785</span>
        (<span class="NLM_cas:issue">Protein Microarrays</span>),
    <span class="NLM_cas:pages">79-107</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Using the reverse protein array platform in combination with planar waveguide technol., which allows detection of proteins in spotted cell lysates with high sensitivity in a 96-well microtiter-plate format for growing, treating, and lysing cells was shown to be suitable for this approach and indicates the usefulness of the technol. as a screening tool for characterization of large nos. of kinase inhibitors.  In this study, we have used reverse protein arrays to profile kinase inhibitors in various cellular pathways in order to unravel their MoA.  Multiplexing and simultaneous anal. of several phospho-proteins within the same lysate allows (1) the estn. of inhibitor concns. needed to shut down an entire pathway, (2) the estn. of inhibitor selectivity, and (3) the comparison of inhibitors of different kinases within one assay.  For example, parallel anal. of p-InsR, p-PKB, p-GSK-3, p-MEK, p-ERK, and p-S6rp in insulin treated A14 cells allows profiling for inhibitors of the InsR, PI3K, PKB, mTor, RAF, and MEK.  Selective kinase inhibitors revealed different specific inhibitory pattern of the analyzed phospho-read outs.  Altogether, multiplexed anal. of reverse (phase) protein arrays is a powerful tool to characterize kinase inhibitors in a semi-automated low to medium throughput assay format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3rYjntFLlLbVg90H21EOLACvtfcHk0liS3I0w-g-2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls12rsLw%253D&md5=a8fdf4164f6c66c6baad923c1b14eba8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-286-1_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-286-1_7%26sid%3Dliteratum%253Aachs%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Dorazio%26aufirst%3DD.%26aulast%3DVoshol%26aufirst%3DJ.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520kinase%2520inhibitors%2520using%2520reverse%2520phase%2520protein%2520arrays%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D785%26spage%3D79%26epage%3D107%26doi%3D10.1007%2F978-1-61779-286-1_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dreiem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonnum, F.</span><span> </span><span class="NLM_article-title">Thiophene is toxic to cerebellar granule cells in culture after bioactivation by rat liver enzymes</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.neuro.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1016%2Fj.neuro.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=15474614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlCnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=959-66&issue=6&author=A.+Dreiemauthor=F.+Fonnum&title=Thiophene+is+toxic+to+cerebellar+granule+cells+in+culture+after+bioactivation+by+rat+liver+enzymes&doi=10.1016%2Fj.neuro.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Thiophene is Toxic to Cerebellar Granule Cells in Culture After Bioactivation by Rat Liver Enzymes</span></div><div class="casAuthors">Dreiem, Anne; Fonnum, Frode</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-966</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several compds. that are not neurotoxic by themselves can cause toxic effects in vivo after enzymic bioactivation.  Thiophene is an industrial solvent known to produce degeneration primarily of the granule cells in the cerebellum when administered to animals in vivo.  The mechanism for thiophene toxicity is not known, although it was suggested that thiophene metab. may lead to formation of oxidative intermediates that could function as the ultimate toxicants.  In the present work the authors have used rat cerebellar granule cells (CGCs) in culture combined with rat liver postmitochondrial (S9) fraction as a source of biotransformation enzymes to test the toxicity of thiophene in vitro.  The results demonstrate that thiophene is toxic to rat cerebellar granule cells in culture only after biotransformation.  Furthermore, the toxic effects were reduced by cytochrome P 450 (CYP) inhibitors and by scavengers of reactive mols. (α-tocopherol, reduced glutathione, and phenyl-N-tert-butylnitrone).  These findings support the hypothesis that thiophene requires metab. to produce the ultimate toxicant, and that the cytochrome P 450 enzyme system is involved in the metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPyIPxFRH5kLVg90H21EOLACvtfcHk0liS3I0w-g-2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlCnsbY%253D&md5=c9a3d1817a07439502259258434c676f</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuro.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuro.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDreiem%26aufirst%3DA.%26aulast%3DFonnum%26aufirst%3DF.%26atitle%3DThiophene%2520is%2520toxic%2520to%2520cerebellar%2520granule%2520cells%2520in%2520culture%2520after%2520bioactivation%2520by%2520rat%2520liver%2520enzymes%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26issue%3D6%26spage%3D959%26epage%3D66%26doi%3D10.1016%2Fj.neuro.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, K.</span><span> </span><span class="NLM_article-title">Thiophene, a sulfur-containing heterocyclic hydrocarbon, causes widespread neuronal degeneration in rats</span> <span class="citation_source-journal">Neuropathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1046/j.1440-1789.2000.00348.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1046%2Fj.1440-1789.2000.00348.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=283-288&author=F.+Moriauthor=K.+Tanjiauthor=K.+Wakabayashi&title=Thiophene%2C+a+sulfur-containing+heterocyclic+hydrocarbon%2C+causes+widespread+neuronal+degeneration+in+rats&doi=10.1046%2Fj.1440-1789.2000.00348.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1789.2000.00348.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1789.2000.00348.x%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DF.%26aulast%3DTanji%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3DThiophene%252C%2520a%2520sulfur-containing%2520heterocyclic%2520hydrocarbon%252C%2520causes%2520widespread%2520neuronal%2520degeneration%2520in%2520rats%26jtitle%3DNeuropathology%26date%3D2000%26volume%3D20%26spage%3D283%26epage%3D288%26doi%3D10.1046%2Fj.1440-1789.2000.00348.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Albrechtsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H.</span><span> </span><span class="NLM_article-title">Histochemical investigation of thiophen necrosis in the cerebellum of rats</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1007/BF00684431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1007%2FBF00684431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=4769151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADyaE2cXht1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1973&pages=217-223&author=R.+Albrechtsenauthor=H.+Jensen&title=Histochemical+investigation+of+thiophen+necrosis+in+the+cerebellum+of+rats&doi=10.1007%2FBF00684431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Histochemical investigation of thiophen necrosis in the cerebellum of rats</span></div><div class="casAuthors">Albrechtsen, R.; Jensen, H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-23</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Selective necrosis of the granular layer of the cerebellum was induced in 14 of 25 rats by s.c. injection of thiophen (I) [110-02-1].  Pyknosis of the granular cell nuclei was seen before any alteration in enzymes in the cytoplasm.  After the termination of I injections there was a tempory fall in the NADH-tetrazolium reductase [37219-67-3] in the Purkinje cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g14s9KqBW7Vg90H21EOLACvtfcHk0liS3I0w-g-2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXht1ygs7w%253D&md5=4acd93f2dcf8383f0ac8a203e8c5c5e3</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1007%2FBF00684431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00684431%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrechtsen%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DH.%26atitle%3DHistochemical%2520investigation%2520of%2520thiophen%2520necrosis%2520in%2520the%2520cerebellum%2520of%2520rats%26jtitle%3DActa%2520Neuropathol.%26date%3D1973%26volume%3D26%26spage%3D217%26epage%3D223%26doi%3D10.1007%2FBF00684431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span> </span><span class="NLM_article-title">Drug-metabolizing ability of molybdenum hydroxylases</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.2133/dmpk.21.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2133%2Fdmpk.21.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=16702728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=83-98&author=S.+Kitamuraauthor=K.+Sugiharaauthor=S.+Ohta&title=Drug-metabolizing+ability+of+molybdenum+hydroxylases&doi=10.2133%2Fdmpk.21.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing ability of molybdenum hydroxylases</span></div><div class="casAuthors">Kitamura, Shigeyuki; Sugihara, Kazumi; Ohta, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-98</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  Molybdenum hydroxylases, which include aldehyde oxidase and xanthine oxidoreductase, are involved in the metab. of some medicines in humans.  They exhibit oxidase activity toward various heterocyclic compds. and aldehydes.  The liver cytosol of various mammals also exhibits a significant reductase activity toward nitro, sulfoxide, N-oxide, and other moieties, catalyzed by aldehyde oxidase.  There is considerable variability of aldehyde oxidase activity in liver cytosol of mammals: humans show the highest activity, rats and mice show low activity, and dogs have no detectable activity.  On the other hand, xanthine oxidoreductase activity is present widely among species.  Interindividual variation of aldehyde oxidase activity is present in humans.  Drug-drug interactions assocd. with aldehyde oxidase and xanthine oxidoreductase are of potential clin. significance.  The drug-metabolizing ability of molybdenum hydroxylases and variation of the activity are described here by the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIDBvL67GcbVg90H21EOLACvtfcHk0ljxF6g7m3zYCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1akurc%253D&md5=0698f203efaf5b2cf20f373af3cd4f28</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.83%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DDrug-metabolizing%2520ability%2520of%2520molybdenum%2520hydroxylases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D83%26epage%3D98%26doi%3D10.2133%2Fdmpk.21.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: An enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span><span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+An+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0ljxF6g7m3zYCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520An%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Potent inhibition of human liver aldehyde oxidase by raloxifene</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1124/dmd.32.1.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1124%2Fdmd.32.1.89" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=89-97&author=R.+S.+Obach&title=Potent+inhibition+of+human+liver+aldehyde+oxidase+by+raloxifene&doi=10.1124%2Fdmd.32.1.89"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.1.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.1.89%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPotent%2520inhibition%2520of%2520human%2520liver%2520aldehyde%2520oxidase%2520by%2520raloxifene%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D89%26epage%3D97%26doi%3D10.1124%2Fdmd.32.1.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Borer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seewald, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schawalder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreng, D. E.</span><span> </span><span class="NLM_article-title">Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis</span> <span class="citation_source-journal">Am. J. Vet. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.2460/ajvr.2003.64.1429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.2460%2Fajvr.2003.64.1429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=14620781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1429-1437&author=L.+R.+Borerauthor=J.+E.+Peelauthor=W.+Seewaldauthor=P.+Schawalderauthor=D.+E.+Spreng&title=Effect+of+carprofen%2C+etodolac%2C+meloxicam%2C+or+butorphanol+in+dogs+with+induced+acute+synovitis&doi=10.2460%2Fajvr.2003.64.1429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis</span></div><div class="casAuthors">Borer, Luc R.; Peel, John E.; Seewald, Wolfgang; Schawalder, Peter; Spreng, David E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Veterinary Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1437</span>CODEN:
                <span class="NLM_cas:coden">AJVRAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    
            (<span class="NLM_cas:orgname">American Veterinary Medical Association</span>)
        </div><div class="casAbstract">Objective-To compare the analgesic and anti-inflammatory effect of single doses of carprofen, etodolac, meloxicam, and butorphanol in dogs with induced acute synovitis (acute pain model) via kinetic gait anal. and orthopedic evaluation and examine measurement of serum C-reactive protein (CRP) concn. as an indicator of treatment efficacy.  Animals-12 Beagles and 6 addnl. Beagles that were used only in serum CRP analyses.  Procedure-Acute synovitis was induced in right stifle joints of dogs via intra-articular injection of monosodium urate soln.  Treatments included butorphanol (0.2 mg/kg, IV), carprofen (4 mg/kg, PO), etodolac (17 mg/kg, PO), or meloxicam (0.2 mg/kg, PO); control dogs received no treatment.  The procedure was repeated (3-wk intervals) until all dogs received all treatments including control treatment.  Lameness was assessed on a biomech. force platform and via orthopedic evaluations of the stifle joints; blood was collected to monitor serum CRP concn.  Results-Compared with control dogs, treated dogs had significantly different vertical ground reaction forces and wt.-bearing scores.  Greatest improvement in lameness was obsd. in carprofen-treated dogs.  Etodolac had the fastest onset of action.  Compared with butorphanol treatment, only carprofen and etodolac were assocd. with significantly lower pain scores.  An increase in serum CRP concn. was detected after intra-articular injection in all dogs; this change was similar among groups.  Conclusions and Clin. Relevance-Carprofen, etodolac, and meloxicam had greater efficacy than butorphanol in relief of acute pain.  Carprofen was most effective overall.  In this acute pain model, serum CRP anal. was not useful to assess drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzzOwixde-s7Vg90H21EOLACvtfcHk0ljxF6g7m3zYCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eiurk%253D&md5=c510cbfe1cd7963e2b4ab7b4708945c4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2460%2Fajvr.2003.64.1429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2460%252Fajvr.2003.64.1429%26sid%3Dliteratum%253Aachs%26aulast%3DBorer%26aufirst%3DL.%2BR.%26aulast%3DPeel%26aufirst%3DJ.%2BE.%26aulast%3DSeewald%26aufirst%3DW.%26aulast%3DSchawalder%26aufirst%3DP.%26aulast%3DSpreng%26aufirst%3DD.%2BE.%26atitle%3DEffect%2520of%2520carprofen%252C%2520etodolac%252C%2520meloxicam%252C%2520or%2520butorphanol%2520in%2520dogs%2520with%2520induced%2520acute%2520synovitis%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D2003%26volume%3D64%26spage%3D1429%26epage%3D1437%26doi%3D10.2460%2Fajvr.2003.64.1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, L.; Dillon, M. P.; Feng, L.; Hawley, R. C.; Yang, M.</span><span> </span><span class="NLM_article-title">Novel pyrazole-substituted arylamides</span>. WO 2009077367 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Chen&author=M.+P.+Dillon&author=L.+Feng&author=R.+C.+Hawley&author=M.+Yang&title=Novel+pyrazole-substituted+arylamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DNovel%2520pyrazole-substituted%2520arylamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lhKXVAUKupqKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhKXVAUKupqKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhKXVAUKupqKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER version 2.11.5; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>The PyMOL Molecular Graphics System, Version 1.5.0.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+Version+1.5.0.4%3B+Schr%C3%B6dinger%2C+LLC%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frémaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span> </span><span class="NLM_article-title">Assay development and screening of a serine/threonine kinase in an on-chip mode using Caliper nanofluidics technology</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1177/1087057106286653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1177%2F1087057106286653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=16751332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2gsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=359-368&author=D.+Perrinauthor=C.+Fr%C3%A9mauxauthor=A.+Scheer&title=Assay+development+and+screening+of+a+serine%2Fthreonine+kinase+in+an+on-chip+mode+using+Caliper+nanofluidics+technology&doi=10.1177%2F1087057106286653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology</span></div><div class="casAuthors">Perrin, Dominique; Fremaux, Christele; Scheer, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Kinases are key targets for drug discovery.  In the field of screening in general and esp. in the kinase area, because of considerations of efficiency and cost, radioactivity-based assays tend to be replaced by alternative, mostly fluorescence-based, assays.  Today, the limiting factor is rarely the no. of data points that can be obtained but rather the quality of the data, enzyme availability, and cost.  In this article, the authors describe the development of an assay for a kinase screen based on the electrophoretic sepn. of fluorescent product and substrate using a Caliper-based nanofluidics environment in on-chip incubation mode.  The authors present the results of screening a focused set of 32,000 compds. together with confirmation data obtained in a filtration assay.  In addn., they have made a small-scale comparison between the on-chip and off-chip nanofluidics screening modes.  In their hands, the screen in on-chip mode is characterized by high precision most likely due to the absence of liq. pipetting; an excellent confirmation rate (62%) in an independent assay format, namely, filtration; and good sensitivity.  This study led to the identification of 4 novel chem. series of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoxLYDe_xvrVg90H21EOLACvtfcHk0lhdeJ0-sQsRpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2gsL8%253D&md5=fb2ba529cbf74f0a8a863cee2bf793fb</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1177%2F1087057106286653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106286653%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DFr%25C3%25A9maux%26aufirst%3DC.%26aulast%3DScheer%26aufirst%3DA.%26atitle%3DAssay%2520development%2520and%2520screening%2520of%2520a%2520serine%252Fthreonine%2520kinase%2520in%2520an%2520on-chip%2520mode%2520using%2520Caliper%2520nanofluidics%2520technology%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D359%26epage%3D368%26doi%3D10.1177%2F1087057106286653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dunne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, J.</span><span> </span><span class="NLM_article-title">Comparison of on-chip and off-chip microfluidic kinase assay formats</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1089/154065804323056468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1089%2F154065804323056468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=121-129&author=J.+Dunneauthor=H.+Reardonauthor=V.+Trinhauthor=E.+Liauthor=J.+Farinas&title=Comparison+of+on-chip+and+off-chip+microfluidic+kinase+assay+formats&doi=10.1089%2F154065804323056468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1089%2F154065804323056468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065804323056468%26sid%3Dliteratum%253Aachs%26aulast%3DDunne%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DH.%26aulast%3DTrinh%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DFarinas%26aufirst%3DJ.%26atitle%3DComparison%2520of%2520on-chip%2520and%2520off-chip%2520microfluidic%2520kinase%2520assay%2520formats%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2004%26volume%3D2%26spage%3D121%26epage%3D129%26doi%3D10.1089%2F154065804323056468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cohen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin-Dixon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforov, T. T.</span><span> </span><span class="NLM_article-title">A microchip-based enzyme assay for protein kinase A</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1006/abio.1999.4204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10.1006%2Fabio.1999.4204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=10452803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Wktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=89-97&author=C.+B.+Cohenauthor=E.+Chin-Dixonauthor=S.+Jeongauthor=T.+T.+Nikiforov&title=A+microchip-based+enzyme+assay+for+protein+kinase+A&doi=10.1006%2Fabio.1999.4204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">A microchip-based enzyme assay for protein kinase A</span></div><div class="casAuthors">Cohen, Claudia B.; Chin-Dixon, Emily; Jeong, Sang; Nikiforov, Theo T.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A microchip-based enzyme assay for protein kinase A (PKA) is described.  The microchips were prepd. by std. photolithog. techniques.  The assay reagents were placed in wells on the microchips, and electro-osmosis was used to transport aliquots of these reagents into the network of etched channels, where the enzymic reaction takes place.  PKA catalyzes the transfer of a phosphate group from ATP to the Ser residue of the heptapeptide, LRRASLG (Kemptide).  The outcome of the enzymic reaction was assessed by performing an on-chip electrophoretic sepn. of the fluorescently labeled peptide substrate and product.  All liq.-handling steps were performed by controlling the electro-osmotically driven flow from reagent and buffer wells using elec. current.  On-chip dilns. of the peptide substrate, ATP, and H-89, a known PKA inhibitor, were performed, and the kinetic consts. (Km, Ki) of these compds. were detd.  This prototype assay demonstrates the usefulness of microchips for performing enzymic assays for which fluorogenic substrates cannot easily be designed.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgeuQtBqd6bVg90H21EOLACvtfcHk0lhdeJ0-sQsRpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Wktbk%253D&md5=341a9838daa1fd47d84d72f9f09479f7</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4204%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DC.%2BB.%26aulast%3DChin-Dixon%26aufirst%3DE.%26aulast%3DJeong%26aufirst%3DS.%26aulast%3DNikiforov%26aufirst%3DT.%2BT.%26atitle%3DA%2520microchip-based%2520enzyme%2520assay%2520for%2520protein%2520kinase%2520A%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D89%26epage%3D97%26doi%3D10.1006%2Fabio.1999.4204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4y85" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4y85','PDB','4y85'); return false;">PDB: 4y85</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3alo" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3alo','PDB','3alo'); return false;">PDB: 3alo</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3vn9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3vn9','PDB','3vn9'); return false;">PDB: 3vn9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2dyl" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2dyl','PDB','2dyl'); return false;">PDB: 2dyl</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1atp" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1atp','PDB','1atp'); return false;">PDB: 1atp</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dn5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dn5','PDB','4dn5'); return false;">PDB: 4dn5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00598">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_73208"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00598">10.1021/acs.jmedchem.6b00598</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structures of intermediates <b>11</b>–<b>23</b> with yields of corresponding synthetic steps; siRNA knockdown data demonstrating the COT-dependency of the TNF-pathway in A431 cells; experimental details for the determinations of the high-throughput equilibrium solubility, the human plasma protein binding, the kinase selectivity, the analyses of the samples for the investigation of the biotransformation, and the isolation of a metabolite as well as for the determination of the pharmacokinetic parameters; X-ray data collection and refinement statistics; and kinase selectivity profiles of compounds <b>32</b> and <b>33</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data for compounds <b>1</b>–<b>48</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_001.pdf">jm6b00598_si_001.pdf (450.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00598/suppl_file/jm6b00598_si_002.csv">jm6b00598_si_002.csv (2.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00598&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00598%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00598" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679956da88663285","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
